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Thesis Abstract 
 
 
Background: Tight glycaemic control is a key target for the management of Type 2 diabetes 
mellitus (T2DM). Exercise is regarded as an important adjunct treatment and a principal 
lifestyle consideration for T2DM management. However, the association between the timing 
of exercise performance and both the timing of meal consumption and diurnal time has only 
been recently considered having an important role in maintaining glycaemic control. The 
overarching aim of this thesis therefore was to investigate the importance of exercise time on 
glycaemic control in individuals with T2DM and at risk of T2DM. 
 
Specific Aims: Within this thesis, two systematic reviews were completed to understand the 
effect of exercise timing on both acute and chronic glycaemic control measures. The aim of 
Systematic Review One (Chapter 2) was to review the literature related to exercise timing, 
relative to meal consumption, and glycaemic control in individuals with T2DM. While the aim 
of Systematic Review Two (Chapter 3) was to assess the literature related to the diurnal timing 
of exercise performance and glycaemic control in T2DM individuals. In addition, a training 
study was conducted to examine the chronic effect of the diurnal timing of exercise 
performance (morning vs. evening) on glycaemic control measures. The study sought to 
determine the impact of diurnal exercise timing on i) glycaemic control and insulin sensitivity 
measures (Study Part One: Chapter 4) and; ii) postprandial glucose (PPG) and insulin (PPI) 
responses (Study Part Two: Chapter 5) in overweight non-T2DM/T2DM individuals enrolled 
into a 12-week supervised multi-modal exercise training program. 
 
Methods: Systematic searches of online databases were performed to identify articles 
published in English from inception to October 2017 for both systematic reviews.  Thereafter, 
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two authors independently extracted data and evaluated the quality of studies using the 
Cochrane Collaboration Data Collection Form and Cochrane Collaboration Risk of Bias 
Assessment Tool respectively. A qualitative synthesis was performed on the included studies 
with the results summarized in tables for both systematic reviews (Chapter 2 and 3). In addition, 
a training study was conducted to examine the chronic effect of the diurnal timing of exercise 
performance (morning vs. evening) on glycaemic control measures. In the training study 
(Chapter 4 and 5), individuals completed a 12-week supervised multi-modal exercise training 
program (3 days per week; each session: 30 minutes walking protocol and 4 resistance-based 
exercises for 3 sets of 12-18 repetitions).  
  
Results: In Systematic Review One (Chapter 2), a total of 19 (346 participants) randomized 
controlled trials (RCTS) that employed either an acute crossover (n = 17) or longitudinal 
parallel-groups (n = 2) design were included in the qualitative synthesis. The main findings of 
this review were that postprandial exercise performed between 30 to 60 minutes after meal 
consumption appears to more consistently improve glycemia (glucose concentrations and 
glucose-AUC) and insulin-AUC when compared to an acute exercise bout performed prior to 
a meal. In Systematic Review Two (Chapter 3), 18 studies (321 participants: 17 crossover and 
2 parallel-groups) were included for qualitative analysis. Comparisons of the studies indicate 
greater improvements in glucose concentrations when exercise was performed in the morning, 
however, similar improvements in glucose-AUC were seen for both morning and evening 
groups. In addition to the large heterogeneity in study design of the included studies, the 
observations from both systematic reviews were largely based on indirect comparisons between 
the studies given the limited number of studies that directly investigated the timing of exercise 
(meal consumption: 3 trials; diurnal timing: nil). Thus, it remains inconclusive to whether i) 
postprandial exercise is more effective in improving glycaemic control when compared to pre-
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prandial exercise and ii) morning or evening exercise is more effective for glycaemic control 
management in T2DM individuals. However, there were no group differences for any variables 
(all p ≥ 0.4). With regards to the impact of manipulating the diurnal timing of exercise 
performance on long term glycaemic control (Study Part One: Chapter 4), 12-weeks of multi-
modal exercise training significantly reduced (main effect of time: all p < 0.01) glycosylated 
haemoglobin (amEX vs pmEX: -0.27 vs. -0.25%), fasting glucose (amEX vs pmEX: -0.9 vs. -
1.18 mmol/L), fasting insulin (amEX vs pmEX: -23.8 vs. -22.35 pmol/L), HOMA2-IR (both 
groups: -0.5) and fructosamine (amEX vs. pmEX: -34.5 vs. -29.6 ± 51.2 µmol/L). However, 
these reductions were not different between the intervention groups for any variables (all p ≥ 
0.4). Thus, irrespective of the diurnal timing of exercise training, 12-weeks of multi-modal 
exercise training significant improved glycaemic control in both overweight non-T2DM and 
T2DM individuals. However, the diurnal (morning versus evening) timing of exercise training 
did not result in additional benefits to glycaemic outcomes. Given that tight glycaemic control 
necessitates the management of both fasting glucose and PPG concentrations, with 
accumulating evidence suggesting that PPG excursions better predict death from all causes and 
cardiovascular disease (CVD) compared to fasting glucose alone, Study Part Two (Chapter 5) 
showed similar results to that of Study Part One with regards to PPG and PPI responses. 12-
weeks of multi-modal exercise training significantly reduced (main effect of time, p < 0.01) 
PPG and PPI concentrations during the mixed meal tolerance test (MMTT), with no group 
differences observed (p = 0.69). However, a significantly greater reduction in PPG-iAUC was 
observed for the pmEX group (-78.56 mmol/L) when compared to the amEX group (-33.22 
mmol/L) at post-intervention (p = 0.03).  Although a trend may exist to indicate that evening 
exercise performance may have a greater impact on PPG responses, results from Study Part 
Two indicate similar findings to that of Study Part One, in that the performance of a multi-
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modal training program is an effective method to improve PPG and PPI responses. However, 
the diurnal timing of exercise performance may not provide any additional benefits. 
 
Conclusions: The findings presented in this thesis provide evidence for effect of strategically 
manipulating the diurnal timing of exercise performance on glycaemic control for both 
overweight non-T2DM and T2DM individuals. Despite the diurnal manipulation of exercise 
timing not indicating any additional benefits for glycaemic control management, this thesis 
may have provided plausible explanations effect of diurnal timing of exercise on components 
of glucose variability observed by a T2DM individual on a daily basis. Specifically, morning 
exercise may potentially lower glucose excursions experienced during the extended dawn 
phenomenon while evening exercise may potentially allow for an overall reduction in glucose 
excursions throughout the day by lowering the early morning ‘spike’ in glucose resulting from 
the dawn phenomenon. This results provides a clinically meaningful explanation for 
strategically manipulating the timing of exercise performance for glycaemic control 
management in T2DM individuals, given that, failing to address both the dawn and extended 
dawn phenomenon has been proposed to potentially contribute to inadequate glycaemic control 
and increase the progression of diabetes related complications. More importantly, this thesis 
the performance of regular exercise based on current exercise guidelines is an effective 
management tool for i) improving glycaemic control and insulin sensitivity; ii) reducing body 
anthropometric measures and; iii) improving cardiovascular health. This indicates that the 
consistent performance of exercise is a vital component for both the prevention and 
management of T2DM.  
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1.1 Background 
 
Diabetes mellitus (DM) has a global prevalence of approximately 9% among adults (1), 
accounts for approximately 12% of global health expenditure (1) and is the 6th leading cause 
of global mortality (2). Consequently, DM is a recognised 21st century epidemic (3). Nearly 
90-95% of all DM cases are classified as type 2 diabetes mellitus (T2DM), a condition 
characterized by a relative insulin deficiency which is usually accompanied by insulin 
resistance (4), although the level of resistance is highly heterogeneous (5). Individuals with 
T2DM and who demonstrate poor glycaemic control are particularly susceptible to T2DM 
morbidities and mortality (3, 6, 7). Thus, improving glycaemic control, measured via a 
reduction in glycosylated haemoglobin (HbA1c), to ≤7% (which may vary according to 
individual patient profiles) is the standard treatment goal for individuals with T2DM (7-9). 
 
Increased levels of exercise have long been considered an important adjunct in treatment of 
T2DM and an effective method to improve long-term glycaemic control (10, 11). Yanai et al. 
(12) stated that structured exercise training was associated with a reduction in HbA1c levels 
0.67% when compared to control participants, with a further reduction of HbA1c levels (-0.9%) 
associated with structured exercise durations exceeding 150 min/week. These results indicate 
that exercise i) is an effective method of glycaemic management for individuals with T2DM 
and; ii) the improvements observed in these exercise training programs are comparable with 
those observed using metformin monotherapy (-1.1%) (13). Lifestyle interventions (dietary and 
exercise therapy, coupled with weight-loss targets) have also been shown to be highly effective 
in the prevention of T2DM in individuals at-risk of T2DM. Indeed, the diabetes prevention 
program (14) demonstrated a 58% relative risk reduction for T2DM compared with a 31% 
reduction for those on Metformin (850 mg twice daily). Importantly, when the individual 
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contributions of diet and exercise were independently assessed in the Da Qing IGT and 
Diabetes Study (15), the exercise intervention demonstrated a greater relative risk reduction 
(46%) versus the diet-only intervention (31%). For this reason, exercise is a cornerstone in both 
the prevention and management of T2DM (16).  
 
Exercise training of at least six weeks duration in individuals with T2DM consistently 
demonstrates relative risk reductions for development of T2DM and improvements in HbA1c 
levels in individuals with T2DM (4, 17), however, there are large variances in the magnitude 
of improvements observed within and between studies (12, 17). Beyond inter-individual 
differences such as age, sex and duration since T2DM diagnosis of participants, these variations 
likely arise due to differences within programmatic components of the FITT (frequency, 
intensity, type and time) principle associated with exercise prescription (18). Umpierre et al. 
(19) found there was a potential for HbA1c levels to be further reduced by approximately -
0.39% for every extra session of exercise performance completed each week, indicating the 
dose-response effect of exercise performance frequency. Grace et al. (20) concluded in a review 
of the impact of different aerobic exercise training intensities in T2DM individuals on 
glycaemic responses that moderate and high intensity exercise resulted in differing levels of 
HbA1c reductions. Concerning the type of exercise modalities used for T2DM interventions, 
aerobic and resistance exercises have traditionally been isolated within the training programs. 
However, Church et al. (21) reported the combination of both aerobic and resistance training 
resulted in significantly greater reductions in HbA1c levels (-0.45%) as compared to aerobic (-
0.25%) or resistance (-0.17%) training alone after 9 months. The time component of exercise 
prescription refers to the duration of exercise, with Yanai et al. (12) showing structured exercise 
durations of >150 mins/week resulted in significantly greater reductions in HbA1c as compared 
to durations of ≤150 mins/week (-0.80% vs. -0.36%, respectively). Currently it is 
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acknowledged that multi-modal exercise (resistance and aerobic exercise training), of at least 
moderate intensity and >150 mins/week will significantly improve HbA1c levels (4, 17, 20). 
Based on the varying differences in HbA1c reductions associated with the different components 
of the FITT principle, strategically manipulating each of these variables allow for the optimal 
beneficial effects of exercise for the management of glycaemic control in T2DM individuals.  
 
Despite the universal acknowledgement of exercise as an important component for the 
prevention and management of T2DM, the role of exercise timing in affecting glycaemic 
control has only been recently considered and is gaining considerable attention. The timing of 
exercise can be categorized into i) exercise timing in relation to meal consumption (i.e. 
preprandial and postprandial) and; ii) the diurnal timing of exercise (i.e. morning and evening). 
Recent evidence (22, 23) along with two reviews (24, 25) have shown that acute exercise 
performance in the postprandial period improves glycaemic control to a greater degree than 
exercise performed in the preprandial period. Moreover, comparison of acute exercise 
interventions performed at different times in the day suggest alterations in the glycemic 
response (22, 25). However, to the best of our knowledge, no studies have directly explored 
the impact of diurnal exercise timing on glycaemic control over the longer-term. As such, there 
is a need to examine the impact of exercise timing on glycaemic control and associated 
outcomes in individuals at risk of T2DM and individuals with T2DM.  
 
1.2 Purpose of the Thesis 
 
The role of diurnal feeding patterns have long been acknowledged, with the adage “Eat 
Breakfast Like a King, Lunch Like a Prince, and Dinner Like a Pauper” commonly used in 
popular culture. More recently, the role of time-restricted feeding has garnered increasing 
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interest (26-28). However, while clinicians and researchers struggle with how-best to engage 
individuals in physical activity programs, the role of diurnal exercise timing and potential 
benefits associated with “temporal optimization” of exercise has largely gone unexplored. 
Given diurnal variations in peripheral insulin sensitivity are well acknowledged (e.g. (28)), we 
sought to determine the importance of diurnal exercise timing on glycaemic control in 
individuals at risk of developing T2DM and glycemic management in individuals with T2DM.  
 
Therefore, the purpose of this thesis was to i) systematically review the literature to determine 
the impact of exercise timing in relation to meal consumption (Chapter 2) and diurnal exercise 
timing (Chapter 3) on glycaemic control in individuals with T2DM; ii) determine the effect of 
diurnal exercise timing on the circadian rhythm and longer-term glycaemic-related outcomes 
(Chapter 4), as well as the postprandial glucose and insulin responses during an extended 
mixed-meal tolerance (Chapter 5), after 12-weeks of multi-modal exercise training. The results 
from the systematic reviews and the longitudinal study are expected to provide evidence in 
support of a role for diurnal exercise-timing in freely-living individuals at risk of developing 
T2DM or with T2DM.  
 
Specifically, we hypothesised that i) based on current evidence, postprandial exercise (Chapter 
2) and morning exercise (Chapter 3) will result in greater improvements in glycaemic control 
measures when compared to pre-prandial and evening exercise performance, respectively; ii) 
12-weeks of multi-modal training performed in the morning will result in greater improvements 
in glycaemic control than evening exercise performance; and iii) 12-weeks of supervised 
evening exercise training will improve PPG and insulin responses to a greater degree than 
compared to morning exercise training. The development of each of these hypotheses are 
provided within each chapter.   
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2.1 Abstract 
Purpose: The timing of exercise relative to meal consumption has recently been identified as 
potentially moderating the effectiveness of exercise on glycemic responses in type 2 diabetes 
mellitus (T2DM). The aim of this study was to systematically review the literature related to 
exercise timing, relative to meal consumption, and glycemic control in individuals with T2DM. 
Methods: Systematic searches in PubMed, EMBASE, CINAHL, Cochrane Library and 
ClinicalTrials.gov Registry databases were performed to identify articles published in English 
from inception to October 2017. Two authors independently extracted data and evaluated the 
quality of studies using the Cochrane Collaboration Data Collection Form and Cochrane 
Collaboration Risk of Bias Assessment Tool respectively. A qualitative synthesis was 
performed on the included studies, and results summarized in tables. Results: 19 randomized 
controlled trials (RCTs) with a total of 346 participants were included. Improvements in 
glycemia (glucose concentrations and glucose-AUC) and insulin-AUC appeared more 
consistent when exercise was performed during the post-meal period as compared to the pre-
meal period, however, this observation was largely based on indirect comparisons between 
studies. Conclusions: There is some evidence from RCTs that exercise performed 30 min after 
meal consumption may convey greater improvements in glycemic control for individuals with 
T2DM. However, there are only two studies which have directly assessed the role of exercise 
timing on glycemic management and adopted methodologies are heterogeneous. Future low 
risk trials in this field are warranted.  
 
Key Words: Glycaemic control, exercise timing, postprandial, systematic review 
 
Systematic review registration: PROSPERO CRD42017054666    
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2.2 Introduction 
The maintenance of tight glycemic control is a key objective in the management of individuals 
with Type 2 Diabetes Mellitus (T2DM) (1). Tight glycemic control necessitates the 
management of fasting glucose (FG) as well as the postprandial glucose excursions (PPG) (2). 
Exercise will transiently improve the muscle’s insulin sensitivity and insulin responsiveness 
over the subsequent hours and days (3, 4), resulting in reduced PPG excursions (5-7). This 
reduction in PPG excursions largely accounts for the consistent improvements in glycosylated 
hemoglobin (HbA1c; (8)) observed with exercise training (-0.6% to -0.89% versus control; (9-
12)). As a result of these clinically meaningful improvements in HbA1c, exercise, and physical 
activity more broadly, are recognized as important adjuvant treatments in the management of 
T2DM (13). Together with dietary modifications (14), exercise is a principal lifestyle 
consideration within clinical management guidelines for T2DM (15).  
 
The association between the timing of exercise and the timing of meals has long been 
acknowledged on blood lipid profiles (16), but only recently has this association been identified 
as playing a potentially important role in maintaining glycemic control (17-20). For instance, 
Heden et al. (20) showed exercise conducted in the postprandial period significantly reduced 
the glucose area under the curve (AUC) in individuals with T2DM relative to pre-prandial 
exercise. These improvements in glycaemia through postprandial exercise have been identified 
in some recent findings (18-20) and the current position statement by the American Diabetes 
Association (ADA) includes reference to differences in glucose control when exercise is 
performed in the fasted, pre-prandial or postprandial state (13).  However, there is need for this 
evidence to be systematically reviewed. Therefore, the aim of this systematic review was to 
assess the effect of exercise timing in relation to meal consumption, on glycemia and glycemic 
control in individuals with T2DM. 
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2.3 Methods 
Search Strategy 
This systematic review was reported in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta – Analyses (PRISMA) Statement (Appendix A) and registered 
with the International Prospective Register of Systematic Reviews (PROSPERO 
CRD42017054666) (21).  
 
A systematic search was performed in Medline (PubMed), EMBASE, CINAHL, Cochrane 
Library and the ClinicalTrials.gov registry utilizing a combination of Medical Subject 
Headings (MeSH) and key words to identify potentially relevant studies. The search syntax 
was designed for PubMed (Appendix B) and adapted for use in the remaining databases. All 
databases were searched from inception to September 2017. In addition, reference lists of all 
retrieved papers were manually searched to identify any potentially relevant studies not 
identified by the database search. 
 
We included randomized controlled trials examining the effects of exercise (acute exercise and 
exercise training) on glycemic control and insulin response in adults diagnosed with T2DM. 
For inclusion, the exercise protocols of potentially eligible studies had to comprise quantifiable 
(frequency, intensity, time and type) bouts of physical activity, which were planned, structured 
and repetitive in movement. All exercise durations ranging from acute single exercise bouts to 
extended exercise training programs were included. We excluded observational or uncontrolled 
studies and studies that did not report the timing of exercise performance with reference to 
meal consumption. In addition, studies that were not fully reported or written in English 
language were excluded from this systematic review. 
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Outcome measures 
Glycemic control encompasses the three components of the glucose triad: (i) glycosylated 
hemoglobin, (ii) fasting glucose and, (iii) postprandial glucose (22). While glycosylated 
hemoglobin is the criterion measure for chronic glycemic control (12, 23, 24), reflecting the 
previous 8-12 weeks (25), it does not necessarily capture the magnitude of change in diurnal 
glucose (8, 26, 27). Suh et al. (28) reported the glucose AUC following a glucose challenge as 
a precise assessment of postprandial glucose (PPG) excursions. Therefore, to ensure a broad 
assessment of glycemic control, we included the following as primary review outcomes: (i) 
HbA1c; (ii) FG; (iii) PPG (postprandial glucose concentrations reported after a glucose load); 
and, (iv) glucose AUC. Considering the importance of insulin and in particular, the association 
between hyperinsulinemia and increased cardiovascular disease (CVD) mortality rates (29-31), 
the secondary review outcomes were postprandial insulin concentrations and insulin AUC after 
a glucose load. 
 
Data extraction and quality analysis 
Potential studies were exported to Covidence Systematic Review Software (Veritas Health 
Innovation, Melbourne, Australia) for assessment. Following removal of duplicate references, 
two independent authors (ST and SC) completed the title and abstract screening process in a 
blinded manner against the eligibility criteria. Disagreements were resolved by a third author 
(TF). Thereafter, a full text assessment was completed in a blinded manner by two independent 
review authors (ST and MF). Similarly, all disagreements were resolved by a third author (TF). 
Reasons for excluding each study at the full-text stage were recorded. When insufficient 
information was available, we contacted corresponding authors to obtain additional 
information. Upon the completion of the full-text assessment, data extraction for the included 
studies was completed independently by two authors (ST and MF) utilizing the Cochrane 
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Collaboration Data Collection Form (32). The following information was extracted from each 
of the included studies: (i) experimental conditions; (ii) total number of participants; (iii) age; 
(iv) gender; (v) body mass index; (vi) T2DM duration; (vii) exercise protocols; (viii) exercise 
timing and; (ix) comparisons in outcome measures of glycemic control and insulin.  Variations 
in data extraction were resolved by consensus (ST and MF). Seventeen authors were contacted 
for additional information.   
 
The assessment of risk of bias for each study was completed by utilizing the Cochrane 
Collaboration’s tool for assessing risk of bias (33). The tool assesses bias for each study from 
seven evidence-based domains: (i) random sequence generation; (ii) allocation concealment; 
(iii) blinding of participants and personnel; (iv) blinding of outcome assessment; (v) incomplete 
outcome data; (vi) selective reporting and; (vii) other sources of bias. Two independent authors 
(ST and MF) provided a judgement (low risk of bias/ high risk of bias/ unclear) for each of the 
aforementioned domains, and all disagreements were resolved by consensus. 
 
Statistical analysis 
A qualitative syntheses of trial results were summarized in tables stratified by study design and 
outcome type (HbA1c, PPG, FG, glucose AUC; fasting and postprandial insulin concentration, 
insulin AUC). As a consequence of i) the heterogeneity in study methodology; ii) the high 
proportion of studies reporting on small sample sizes; iii) the low number of studies directly 
comparing exercise-timing (pre- versus post-meal) on outcome measures; we did not perform 
the planned random-effects meta-analysis. The direction of the observed association for each 
of the outcome measures was graphically presented by constructing forest plots (SigmaPlot, 
version 13.0; Systat Software, San Jose, CA) using standardized mean differences (SMDs, 
[Cohen’s d]). The SMDs were calculated for each condition presented within respective studies 
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using comprehensive meta-analysis (version 3.3.070), and interpreted as small (d = 0.2), 
moderate (d = 0.5) or large (d = 0.8) (34). 
 
2.4 Results 
Search Results 
Our search strategy identified 6,407 unique studies, of which, 19 randomized clinical trials 
(346 participants) were included following assessment of selection criteria (Figure 2-1) (20, 
35-52). Included trials were published between 1997 and 2017, and employed either a 
crossover (n = 17) (20, 35-50) or parallel-groups design (n = 2) (51, 52).  
 
Characteristics of Included Studies 
At baseline, participants had a mean age of 55.4 years (95% CI [52.6, 58.1]), mean HbA1c of 
7.3 % [7.2, 7.4], mean body mass index (BMI) of 29.8 kg.m-2 [28.0, 31.6] and a mean T2DM 
duration of 7.4 years [6.8, 8.0]. Within the 17 crossover trials, PPG concentration was used as 
a measure of glycemic control in 13 of the trials, while glucose AUC was used in 10 of the 
crossover trials (Table 1-1; Figure 2-2A, 2-2B). The percentage of female participants was 
9.3%. Of the 19 included trials, 15 trials investigated the effects of aerobic-based exercises 
(cycle ergometer: n = 9; treadmill walk: n = 6) (35-42, 44-51) and 4 trials investigating 
resistance exercises (20, 43, 48, 52). With regards to the timing of exercise performance, three 
trials compared pre-meal exercise to a no-exercise control (38, 39, 44), 13 trials compared post-
meal exercise to a no-exercise control (35, 37, 40-43, 45-51), 2 trials compared pre-meal 
exercise and post-meal exercise to a no-exercise control (20, 36), and one trial compared pre-
meal exercise and post-meal exercise (52) for glycemia and glycemic control. A detailed 
summary of the results for both acute crossover and parallel-group trials are presented in Table 
1-1 and 2-2, respectively. 
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Figure 2-1. Study Selection Process 
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Table 2-1. Summary of included randomized controlled crossover trials 
 
Author Participants 
Characteristics 
Standardized Meal Exercise Characteristics Study Outcomes (Exercise vs. Control) 
Glycemic Control Insulin Response 
PPG GAUC PPI IAUC 
Colberg 
(2009)(36) 
12 subjects (6 females) 
Age: 61 y  
BMI: 35 kg.m-2 
T2DM duration: 11 y 
430kcal dinner [t = 30] 
 
CHO:    50%  
Fat:       18%   
Protein: 32% 
 
Control: no exercise     
Pre-meal exercise: 20mins of treadmill walking at a 
self-selected pace (3.5 METs) [t = 0] 
→ → NA NA 
Post-meal exercise: 20mins of treadmill walking at 
a self-selected pace (3.5 METs) [t = 60] 
→ → NA NA 
Colberg 
(2014)(35) 
12 subjects (9 females) 
Age: 59 y 
BMI: 35 kg.m-2 
T2DM duration: 6 y 
300kcal dinner [t = 30] Control: no exercise     
Post-meal table tennis: 30mins of table tennis 
against an iPong robot (4 METs) [t = 60] 
 NA NA NA 
Post-meal walking: 30mins of treadmill walking at 
a self-selected pace (4 METs) [t = 60] 
 NA NA NA 
Erickson 
(2017)(37) 
8 subjects (3 females) 
Age: 60 y 
BMI: 34 kg.m-2 
T2DM duration: NR 
Breakfast meal [t = 0] 
 
CHO:    65%  
Fat:       25%   
Protein: 10% 
Control: no exercise     
Post-meal interval walking: Three 10min bouts of  
interval treadmill walking  at 50% VO2max (3.5 
METs) [t = 30] 
  NA NA 
Gill  
(2007)(38) 
10 male subjects 
Age: 49 y 
BMI: 31 kg.m-2 
T2DM duration: 4 y 
1028kcal breakfast [t = 0] 
 
CHO:    43%  
Fat:       49%   
Protein: 1% 
Control: no exercise     
Pre-meal exercise: 90mins of treadmill walking at 
70% of HRmax (3.5 METs) [between t = -960 and -
1080] 
 →   
Heden 
(2014)(20) 
13 subjects (8 females) 
Age: 49 y 
BMI: 37 kg.m-2 
T2DM duration: 4 y 
Dinner meal [t = 0] 
 
CHO:    50%  
Fat:       35%   
Protein: 15% 
Control: no exercise     
Pre-meal exercise: 3 sets of 10 repetitions of 8 
resistance exercises at 10RM (3.5 METs) [t = -75] 
→  →  
Post-meal exercise: 3 sets of 10 repetitions of 8 
resistance exercises at 10RM (3.5 METs)[t = 45] 
→  →  
 
PPG: postprandial glucose; GAUC: area under the glucose curve; PPI: postprandial insulin; IAUC: area under the insulin curve; CHO: carbohydrates; RM: repetition 
maximum;  NA: not assessed; →: no significant difference reported between conditions; : significant difference between exercise and control conditions 
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Author Participants 
Characteristics 
Standardized Meal Exercise Characteristics Study Outcomes (Exercise vs. Control) 
Glycemic Control Insulin Response 
PPG GAUC PPI IAUC 
Karstoft 
(2014)(39) 
10 subjects (3 females) 
Age: 60 y 
BMI: 28 kg.m-2 
T2DM duration: 6 y 
450kcal MMTT [t = 105] 
 
CHO:    55%  
Fat:       30%   
Protein: 15% 
 
Control: no exercise 
 
    
Pre-meal interval walking: Twenty 3min bouts of 
slow (54% of VO2peak; 3.5 METs) and fast (89% 
VO2peak; 5 METs) intervals treadmill walking   
[t = 0] 
 
→ NA → NA 
Pre-meal continuous walking: 60mins of treadmill 
walking at 70% of HRmax  (3.5 METs) [t = 0] 
→ NA → NA 
Larsen 
(1997)(40) 
9 male subjects 
Age: 60 y 
BMI: 29 kg.m-2 
T2DM duration: NR 
6.9kcal/kg breakfast [t = 0] 
 
CHO:    56%  
Fat:       30%   
Protein: 14% 
 
14.1 kcal/kg lunch [t = 240] 
 
CHO:    53%  
Fat:       31%   
Protein: 16% 
Control: no exercise     
Post-meal exercise: 45mins of cycling on an 
ergometer at 50% of VO2peak (3.5 METs) [t = 45] 
NA  NA  
Larsen 
(1999)(41) 
8 male subjects 
Age: 60 y 
BMI: 29 kg.m-2 
T2DM duration: NR 
6.9kcal/kg breakfast [t = 0] 
 
CHO:    56%  
Fat:       30%   
Protein: 14% 
 
14.1kcal/kg lunch [t = 240] 
 
CHO:    53%  
Fat:       31%   
Protein: 16% 
Control: no exercise     
Post-meal exercise: 4 intermittent cycling bouts on 
an ergometer at 50% (3.5 METs) and 100% (7 
METs) of VO2peak [t = 45] 
→ → → → 
 
PPG: postprandial glucose; GAUC: area under the glucose curve; PPI: postprandial insulin; IAUC: area under the insulin curve; CHO: carbohydrates; NR: not reported;  NA: 
not assessed; →: no significant difference reported between conditions; : significant difference between exercise and control conditions 
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Author Participants 
Characteristics 
Standardized Meal Exercise Characteristics Study Outcomes (Exercise vs. Control) 
Glycemic Control Insulin Response 
PPG GAUC PPI IAUC 
Manders 
(2010)(42) 
9 male subjects 
Age: 57 y 
BMI: 29 kg.m-2 
T2DM duration: 9 y 
52.5kcal/kg breakfast [t = 0] 
 
CHO:    61%  
Fat:       26%   
Protein: 13% 
 
28.9kcal/kg per meal for 3 
subsequent meals 
[t = 330, 630 and 1410] 
 
CHO:    58%  
Fat:       30%   
Protein: 11% 
Control: no exercise     
Post-meal low intensity exercise: 60mins of cycling 
on an ergometer at 35% of Wmax (3.5 METs)  
[t = 60] 
→  NA NA 
 
Post-meal high intensity exercise: 30mins of 
cycling on an ergometer at 70% of Wmax (6.8 
METs) [t = 60] 
→ → NA NA 
Moreira 
(2012)(43) 
9 male subjects 
Age: 47 y 
BMI: 29 kg.m-2 
T2DM duration: 5 y 
285kcal breakfast [t = -120] 
 
CHO:    63%  
Fat:       29%   
Protein: 8% 
Control: no exercise     
Post-meal low intensity exercise: 3 sets of 30 
repetitions of 6 resistance exercises at 23% of 1RM 
(3.5 METs) [t = 0] 
NA  NA NA 
Post-meal moderate intensity exercise: 3 sets of 16 
repetitions of 6 resistance exercises at 43% of 1RM 
(4 METs) [t = 0] 
NA  NA NA 
Oberlin 
(2014)(44) 
9 subjects (5 females) 
Age: 60 y 
BMI: 36 kg.m-2 
T2DM duration: NR 
1600-2400kcal per meal for 
6 meals [ t = 0, 300, 600, 
1440, 1740 and 2040] 
 
CHO:    51%  
Fat:       31%   
Protein: 18% 
Control: no exercise     
Pre-meal exercise: Two 20min bouts of treadmill 
walking and 20mins of cycling on an ergometer at 
60% of HRR (3.5 METs) [t = -90] 
→ → NA NA 
PPG: postprandial glucose concentration; GAUC: area under the glucose curve; PPI: postprandial insulin; IAUC: area under the insulin curve; CHO: carbohydrates; NR: not 
reported; RM: repetition maximum;  NA: not assessed; →: no significant difference reported between conditions; : significant difference between exercise and 
control conditions 
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Author Participants 
Characteristics 
Standardized Meal Exercise Characteristics Study Outcomes (Exercise vs. Control) 
Glycemic Control Insulin Response 
PPG GAUC PPI IAUC 
Rasmussen 
(1999)(45) 
12 subjects (4 females) 
Age: 56 y 
BMI: 29 kg.m-2 
T2DM duration: 8 y 
 
 
436kcal breakfast [t = 0] 
 
CHO:    48%  
Fat:       38%   
Protein: 14% 
Control: no exercise     
Post-meal exercise: 30mins of cycling on an 
ergometer at 40% of VO2peak (3.5 METs) [t = 30] 
NA → NA → 
Tobin 
(2008)(46) 
8 male subjects 
Age: 59 y 
BMI: 29 kg.m-2 
T2DM duration: NR 
 
680kcal breakfast [t = 0] 
CHO:    8%  
Fat:       84%   
Protein: 8% 
Control: no exercise     
Post-meal exercise: 60mins of cycling on an 
ergometer at 60% of VO2peak (5 METs) [t = 90] 
 NA   
Van Dijk 
(2012)(48) 
INS 
15 male subjects 
Age: 60 y 
BMI: 30 kg.m-2 
T2DM duration: 14 y 
 
OGLM 
15 male subjects 
Age: 61 y 
BMI: 30 kg.m-2 
T2DM duration: 7 y 
Total of 2485kcal for 3 
meals after exercise 
[t = 240, 570 and 1440] 
 
CHO:    57%  
Fat:       30%   
Protein: 13% 
 
 
Control: no exercise 
 
    
Post-meal endurance exercise: 45mins of cycling on 
an ergometer at 50% of Wmax (4 METs) [t = 150] 
 NA NA NA 
Post-meal resistance exercise: 5 sets of 10 
repetitions for 4 resistance exercises at 40-75% of 
1RM (3.5 METs) [t = 150] 
 NA NA NA 
PPG: postprandial glucose; GAUC: area under the glucose curve; PPI: postprandial insulin; IAUC: area under the insulin curve; CHO: carbohydrates; NR: not reported; INS: 
exogenous insulin treatment; OGLM: oral glucose-lowering medication; RM: repetition maximum;  NA: not assessed; →: no significant difference reported between 
conditions; : significant difference between exercise and control conditions 
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Author Participants 
Characteristics 
Standardized Meal Exercise Characteristics Study Outcomes (Exercise vs. Control) 
Glycemic Control Insulin Response 
PPG GAUC PPI IAUC 
Van Dijk 
(2012)(49) 
NIDDM 
16 male subjects 
Age: 60 y 
BMI: 30 kg.m-2 
T2DM duration: 5 y 
 
IDDM 
14 male subjects 
Age: 60 y 
BMI: 31 kg.m-2 
T2DM duration: 12 y 
Total of 4922kcal for 6 
meals [t = 240, 570, 1440, 
1680, 2010 and 2880] 
 
CHO:    55%  
Fat:       31%   
Protein: 14% 
 
 
Control: no exercise 
 
    
Post-meal single bout exercise: 60mins of cycling 
on an ergometer at 50% of Wmax (4 METs) [t = 150] 
NA  NA NA 
Post-meal multiple bouts exercise: Two 30min 
bouts of cycling on an ergometer at 50% of Wmax (4 
METs) [t = 0 and t = 1440] 
NA  NA NA 
Van Dijk 
(2013)(50) 
20 male subjects 
Age: 64 y 
BMI: 30 kg.m-2 
T2DM duration: 8 y 
Total of 2342kcal for 3 
meals [t = 0, 240 and 510] 
 
CHO:    50%  
Fat:       35%   
Protein: 15% 
Control: no exercise 
 
    
Post-meal walking: Three 15min bouts of walking 
at approximately 3 METs [t = 45, 285 and 555] 
→  NA  
Post-meal cycling: 45mins of cycling on an 
ergometer at 50% of Wmax (4 METs)[t = 45] 
  NA  
Van Dijk 
(2013)(47) 
NIDDM 
37 male subjects 
Age: 59 y 
BMI: 30 kg.m-2 
T2DM duration: 7 y 
. 
IDDM 
23 male subjects 
Age: 60 y 
BMI: 30 kg.m-2 
T2DM duration: 12 y 
Total of 2413kcal for 3 
meals [t = 240, 510 and 
1440] 
 
CHO:    56%  
Fat:       30%   
Protein: 14% 
 
Control: no exercise 
 
    
Post-meal exercise: 45 to 60mins of cycling on an 
ergometer at 35-50% of Wmax (3.5 – 4 METs) 
[t = 90] 
 NA NA NA 
PPG: postprandial glucose; GAUC: area under the glucose curve; PPI: postprandial insulin; IAUC: area under the insulin curve; CHO: carbohydrates; NIDDM: non-insulin 
dependent diabetes mellitus; IDDM: insulin dependent diabetes mellitus  NA: not assessed; →: no significant difference reported between conditions; : significant 
difference between exercise and control conditions 
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Table 2-2. Summary of included parallel-group studies 
Author Participants Characteristics Exercise Characteristics Study Outcomes (Exercise vs. Control) 
Glycemic Control Insulin Response 
HbA1c PG FG PPG FI IS 
Vancea  
(2009)(51)  
Control 
20 subjects  
Age: 56 y 
BMI: 28 kg.m-2 
T2DM duration: 6 y 
 
Control: no exercise       
3x/week exercise (G3) 
14 subjects 
Age: 57 y 
BMI: 30 kg.m-2 
T2DM duration: 5 y 
 
G3: 30 min of treadmill walking performed 3 
times per week for 20 weeks at 60-70% HRmax (3.5 
METs). Each session was performed after a meal. 
 
→ NA → → NA NA 
5x/week exercise (G5) 
9 subjects 
Age: 59 years,  
BMI: 30 kg.m-2 
T2DM duration: 6 y 
G5: 30 min of treadmill walking performed 5 
times per week for 20 weeks at 60-70% HRmax (3.5 
METs). Each session was performed after a meal. 
→ NA   NA NA 
Wycherley 
(2010)(52) 
Post protein snack exercise (P0) 
18 male and female subjects  
Age: 56 y 
BMI: 35 kg.m-2 
T2DM duration: NR 
 
P0: 2 sets of 8-12 repetitions of 8 resistance 
exercises performed 3 times per week after a 
protein snack at 70-85% 1RM (3.5 METs) for 16 
weeks 
  NA NA   
Pre protein snack exercise (P2) 
16 male and female subjects  
Age: 56 y 
BMI: 36 kg.m-2 
T2DM duration: NR 
P2: 2 sets of 8-12 repetitions of 8 resistance 
exercises performed 3 times per week prior to a 
snack at 70-85% 1RM (3.5 METs) for 16 weeks  
  NA NA   
 
HbA1c: glycosylated hemoglobin; PG: plasma glucose concentration; FG: fasting glucose; PPG: postprandial glucose; FI: fasting insulin; IS: insulin sensitivity as 
measured by HOMA2-IR CHO; NR: not reported; NA: not assessed; RM: repetition maximum 
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Risk of Bias 
The risk of bias assessment (Appendix C) revealed insufficient reporting across most categories 
being assessed. In particular, methods for generating the allocation sequence and the allocation 
concealment were unclear (or at high risk of bias in one study; (20, 37)). Although all studies 
were deemed to have a low risk of bias with respect to the blinding of participants and 
personnel, the blinding of outcome assessment was unclear due to insufficient information for 
all included studies with the exception of two, Heden et al. (20) and Karstoft et al. (39), which 
were judged to have a high risk of bias since the crossover assignments of the interventions 
were open-labelled. Treatment of incomplete data were judged as a low risk of bias in 15 
studies, since sufficient information was provided for assessment of completeness of outcome 
data, including attrition and exclusions from the final analysis. Due to insufficient information, 
four trials received an unclear judgement for bias relating to incomplete data. Six studies (35, 
43, 47, 51) were deemed to have a low risk of bias for selective outcome reporting and seven 
studies (37, 39, 47-50, 52) were deemed to have a low risk of bias for other sources; the 
remaining 12 studies were judged as having an unclear risk of bias for selective reporting and 
other sources due to insufficient information being presented. In addition, 13 of the 17 authors 
that were contacted for additional information responded. 
 
Changes in Glucose Concentrations and AUC 
Data from trials assessing the effect of exercise timing on PPG concentrations (Figure 2-2A) 
showed 5 (total of 8 trials) reported a significant benefit of exercise conducted in the post-meal 
period compared to a no-exercise control condition; while 2 trials (total of 5) demonstrated 
significant improvements when exercise was performed in the pre-meal period. 
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Data from trials assessing the effect of exercise timing on glucose AUC showed improvements 
in 2 of 4 trials when exercise was performed in the pre-meal period (relative to no-exercise 
control); and 4 of 9 trials when exercise was performed in the post-meal period (Figure 2-2B). 
 
Of the two parallel-group trials, Vancea et al. (51) reported that 20 weeks of post-meal aerobic 
exercise training led to greater decreases in HbA1c (-1.30% [-2.56, -0.04]), fasting glucose (-
4.02 mmol/L [-5.64, -2.39]) and postprandial glucose (-3.09 mmol/L [-5.94, -0.23]) compared 
to a no-exercise control. Wycherley et al. (52) reported that 16 weeks of resistance exercise 
training performed prior to a protein snack resulted in no differences in HbA1c or average 
glucose concentrations compared to similar resistance exercise training performed after a 
protein snack (-0.1% [-0.36, -0.16] and -0.1 mmol/L [-0.7, 0.5] respectively). 
 
Changes in Insulin Concentrations and AUC 
All 3 trials assessing the effect of exercise timing (Pre-meal versus control: 3 trials; Post-meal 
versus control: 1 trials) on postprandial insulin concentration showed significant reductions in 
insulin concentration when exercise was performed in the pre-meal period (Figure 2-3A). 
Insulin AUC (Figure 2-3B) was decreased in all (4 out of 4) trials assessing exercise in the 
post-meal period and the 2 trials comparing exercise in the pre-meal period to the no-exercise 
control.   
 
Wycherley et al. (52) reported that 16 weeks of resistance training performed prior to a protein 
snack did not change fasting insulin concentration (-9.6 ρmol/L [-14.42, -4.78]) when 
compared to the resistance exercise training performed after a protein snack. 
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2A 
 
2B 
 
Figure 2-2. Pre-meal and post-meal exercise versus control on glucose concentrations (2A) 
and glucose AUC (2B) 
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3A 
 
3B 
 
Figure 2-3. Pre-meal and post-meal exercise versus control on insulin concentrations (3A) 
and insulin AUC (3B) 
 
2.5 Discussion 
Exploratory evidence suggests a potentially important relationship between exercise-timing 
and meal consumption (18, 19). This systematic review of exercise-based interventions for 
T2DM included 19 randomized controlled trials, of which 17 were cross-sectional studies and 
2 studies were parallel-group designs, to explore this question in greater detail. The findings of 
this review are i) acute postprandial exercise appeared to more consistently improve glycemia 
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(glucose concentrations and glucose-AUC) than when compared to an acute exercise bout 
performed prior to a meal; (ii) insulin concentrations are improved acutely following pre-meal 
exercise, while both preprandial and postprandial exercise improve the acute insulin AUC. 
Large heterogeneity in study design and methodology precluded a meta-analysis of included 
data; specifically, the timing and frequency of blood samples; exercise type and duration; 
composition and caloric content of the meal used during the glucose-challenge; and the timing 
of the exercise bout relative to the meal were too variable. No randomized controlled trials 
directly assessed the effect of manipulating exercise timing within a training program on long-
term glycemic control; while only two studies (20, 52) directly assessed the effect of 
manipulating exercise timing on acute glucose and insulin concentrations.  
 
Acute glucose and insulin responses to meals: Effect of exercise-timing 
Large intra-study variability in glucose concentrations (Figure 2-2A and 2-2B) were identified 
in the studies of Karstoft, (39) Manders (42) and Oberlin (44). This variability may in part be 
explained by the time-span between meal consumption and exercise performance. Postprandial 
exercise performed within 30 min after meal consumption (35-37) lowered glucose 
concentrations levels by a greater amount (SMD: -1.76)  as compared to postprandial exercise 
performed 30 to 60 min (20, 41, 50), 60 to 90 min (47) and 120 to 150 min (48) after the 
consumption of a meal (SMD: -0.27; -0.93 and; -0.95, respectively). Accordingly, exercise 
performed between 30 and 60 min (20, 36, 37, 40, 45, 50) after the consumption of a meal 
resulted in a greater change in glucose AUC (SMD: -1.25) when compared to postprandial 
exercise performed  between 60 and 120 min (42) and 120 to 150 min (43, 49) after meal 
consumption (SMD -0.46 and; -0.43 respectively). These observations align with conclusions 
by Chacko (18) that a single bout of light to moderate intensity physical activty performed 30 
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min after a meal resulted in the simultaneous blunting of the glucose peak and risk of 
hypoglycaemia.  
 
The effect of pre-meal exercise on blood glucose responses was not as consistent as that 
observed when exercise was performed in the postprandial period (Figure 2-2A and 2-2B). 
There was large variability in the glucose responses between-studies, which may in part be 
explained by the time-span between meal consumption and exercise performance. In particular, 
the two studies (38, 44) which resulted in significant improvements (SMD: -1.55 and -1.31, 
respectively) in glucose AUC, conducted the exercise the day prior (~16-18 h prior) to the 
breakfast meal, (38) or observed the improvement in the second meal (~4.5 h post-exercise) 
but not in the first meal (~30 min) post-exercise (44). There was a consistent and appropriate 
effect of acute exercise blunting the insulin response to meals (Figure 2-3A and 2-3B) which 
occurred irrespective of exercise timing.  
 
Effect of exercise-timing within an exercise training program on glycaemic control: 
Clinical implications 
Two studies meeting inclusion criteria into this systematic review assessed the longer-term 
effects (i.e., >12 weeks) of exercise on glycaemia. Structured aerobic exercise training (20 
week intervention) conducted either 3 or 5 times per week after a meal, resulted in non-
significant changes in HbA1c when compared to a control group (spontaneous exercise 
encouraged; unsupervised and timing of exercise not discussed); however, fasting and 
postprandial glucose concentrations were significantly reduced (fasting: ~2.3 mmol/L; 
postprandial glucose: ~1.1 mmol/L) when training was performed 5 times per week (51). The 
effect of resistance exercise training performed either immediately after ingestion of a protein 
snack or 2 h prior to a protein snack on measures of glycaemia were assessed over the course 
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of a 16 week lifestyle intervention program (52). While both interventions resulted in 
significant reductions in HbA1c (-1.1 ± 0.1%), fasting glucose (-1.9 ± 1.7 mmol/L) and insulin 
(-6.1 ± 6.7 mU/L), there were no between-group differences. 
         
Exercise training has been shown to exert meaningful changes on glycaemia in individuals with 
T2DM (9, 12) and when training exceeds 150 min, HbA1c has been shown to be reduced by 
0.89% [-1.26%, -0.51%] (12). In combination with dietary changes, HbA1c may indeed reduce 
by 1.1% with the addition of exercise training, which compares favourably to the ~1% 
improvement in HbA1c with a single oral hypoglycaemic agent (53). However, based on 
available evidence (two studies), it appears manipulating exercise-timing within a training 
program does not appear to be critical for eliciting greater improvements in glycaemic control. 
Based on the limited evidence and large heterogeneity in the two studies addressing this 
question, further work in this field is warranted.      
 
Exercise-timing relative to meal ingestion: Potential mechanisms explaining the 
interaction 
An acute bout of exercise is associated with an increased rate of glucose uptake in individuals 
with normoglycaemia, impaired glucose tolerance (IGT) and T2DM (54, 55). However, acute 
exercise performed in the preprandial (and fasted) state is associated with a reduced or 
unaltered glucose tolerance in individuals with normoglycaemia, IGT and T2DM (56-59). This 
paradox is explained on account of increased endogenous glucose production (i.e. increased 
hepatic glucose release) and increased exogenous glucose appearance (54). Indeed, whole-
body rate of glucose disappearance during a glucose tolerance test has been shown to increase 
24% when exercise preceeds the test (30 min prior), however, glucose appearance from 
exogenous (primary) and endogenous (secondary) sources increased by ~25% (59). The 
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increased exogenous-glucose appearance after exercise is unlikely to result from altered 
gastrointestinal emptying rates (expected to decrease only during high-intensity exercise and 
effect does not appear to persist post-exercise (60)), but may arise as a response to increased 
intestinal permeability (61), although this is speculative and reflective of paracellular uptake 
rather than transport-specific uptake. The overwhelming majority of glucose is absorbed from 
the intestinal lumen via the sodium dependent glucose cotransporter (SGLT-1) which also 
plays the pivotal role in the release of incretins (glucose-dependent insulinotropic peptide, GIP; 
glucagon-like-peptide 1, GLP-1) (62). While dietary intake is known to alter SGLT-1 
transporter density (63), whether exercise may modulate SGLT-1 activity (transport or incretin 
response) is unknown. An improved understanding of these mechanisms may have important 
clinical and practical implications, in particular with respect to the timing of meals relative to 
exercise or general physical activity.    
 
Strength and Limiations of the Review 
The strength of this systematic review is the inclusion of recent and relevant randomized 
controlled trials that investigated the temporal effect of exercise performance on critical 
measures of T2DM management. In addition, findings from this review have clinical 
applicability given that included participants were restricted to T2DM individuals. There is 
physiological evidence suggesting a potentially important role for the timing of exercise 
performance relative to meal ingestion on glycaemic and insulin variability; a better 
understanding of the optimal time for exercise performance relative to meal intake to allow 
more effective management of glycaemic control in T2DM individuals is clinically relevant 
and important. A limitation of this review is the exclusion of studies based on language (i.e. 
non-english studies).  
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The extant literature curently lacks homogenenity with respect to primary outcome measures 
(i.e. fasting glucose, HbA1c, glucose AUC), analyses of outcome measures (i.e. incremental 
AUC, total AUC, time-period comprising AUC, number of samples performed during the 
AUC), types of exercise interventions (frequency, intensity, type and duration of exercise), 
test-meal composition and the reporting of outcome measures at different time-points. Specific 
to the exercise interventions, exercise characteristics of studies ranged from activities such as 
table tennis, walking (low-, moderate- and high-intensity), resistance exercise (low- and 
moderate-intensity) and combined aerobic-resistance exercise; wherein estimated metabolic 
equivalents (MET) ranged from 42 MET-min to 315 MET-min (mean ± SD; 167.9 ± 70.2 
MET-min).  Additionally, the findings of this systematic review are reliant on the quality of 
the included studies, whereby, majority of the studies were deemed unclear during risk of bias 
assessment (Appendix C). The large heterogeneity in prior studies precluded the performance 
of a meta-analysis. With respect to exercise training, it is noteworthy that acute changes in 
glycaemic control and insulin responses may not translate to chronic responses associated with 
longer-term interventions. Finally, only 9.3% of participants in included studies were female. 
It is recommended that future research investigates the longer-term (>12 weeks) effect of 
manipulating exercise-timing relative to meal ingestion (i.e., 30 min pre-meal versus 30 min 
post-meal), and adopt an exercise-intervention based on current best-evidence (i.e., supervised 
combination of aerobic and resistance-based exercise; at least 50 min per session, three times 
per week) with clinically relevant outcome measures (fasting glucose; oral glucose tolerance 
test; HbA1c) in a gender-balanced cohort of individuals with T2DM.     
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2.6 Conclusions 
Structured exercise exceeding the minimum recommendations (i.e., >150 min of exercise per 
week) can result in HbA1c reductions of 0.89% (12) which is comparable to changes associated 
with diabetes medications adopted as monotherapy (HbA1c reduction ~1.0%) (53). This 
systematic review explored the current evidence assessing the importance of exercise timing 
relative to meal ingestion from randomized controlled trials, and considered this evidence in 
light of known physiological mechanisms. The main findings were that postprandial exercise 
performed between 30 to 60 min after meal consumption appeared to result in more consistent 
reductions in glucose concentration and glucose AUC when compared to a control group. 
However, there is insufficient evidence to directly compare the benefits of exercise performed 
in the preprandial and postprandial periods on glucose concentration (acutely) or glucose 
control (longer-term; i.e., >12 weeks), or indeed, assess the relative importance of this variable 
(exercise-timing relative to meal ingestion) relative to other exercise programming variables. 
More broadly, insufficient studies have investigated the role of exercise-timing on glycemic 
control in female participants with T2DM. Clincally, postprandial exercise confers the 
advantage of reducing the risk of hypoglycemia when compared to preprandial exercise in 
individuals with T2DM. Whether strategic manipulation of exercise-timing results in clinically 
meaningful changes in glycemic control (i.e. HbA1c) when adopted as part of a logitudinal 
exercise training protocol; and explain some of the individual variance observed in HbA1c in 
response to exercise-training interventions, is currently not known and requires investigation.  
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3.1 Abstract 
Background: The diurnal timing of exercise performance may potentially be an important 
variable in mediating glycemic control for the management of type 2 diabetes mellitus 
(T2DM). The objective of this systematic review was assess the literature related to the diurnal 
timing of exercise performance and glycemic control in individuals with T2DM.   
 
Methods: Systematic searches of randomized controlled trials published in English were 
performed in PubMed, EMBASE, CINAHL, Cochrane Library and ClinicalTrials.gov Registry 
databases from inception to June 2018. Two authors independently utilized the Cochrane 
Collaboration Risk of Bias Assessment Tool and The Cochrane Collaboration Data Collection 
Form for the completion of study quality assessment and data extraction of articles, 
respectively. A qualitative synthesis was performed on the included studies, and results 
summarized in tables.  
 
Results: Eighteen studies (321 participants) were included in the final data synthesis. No study 
directly assessed this question. Trial data between studies conducted in the evening or morning 
were compared and suggest both morning and evening exercise result in greater improvements 
in glucose outcomes, with the standardized mean difference (SMD) in glucose area under the 
curve (AUC) for morning exercise trials (8 included studies) ranging from -0.21 (95% CI: -
1.01, 0.59) to -3.36 (95% CI: -4.79, -1.92) and the glucose AUC for evening exercise ranging 
from -0.12 (95% CI: -0.92, 0.68) to -1.20 (95% CI: -2.76, 0.36) relative to control (no exercise) 
conditions. 
 
Conclusions: Current evidence regarding the importance of diurnal exercise-timing on 
glycaemic control is inconclusive.  Despite the fundamental nature of the question, no studies 
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have addressed this in individuals with T2DM and future low risk trials in this field are 
warranted. 
 
Registration: International Prospective Register of Systematic Reviews (PROSPERO 
CRD42017054666). 
 
Key Points: 
1. In this systematic review, irrespective of exercise timing, improvements in acute 
glycaemic outcomes consistently favoured exercise interventions as compared to 
control conditions. This may indicate that exercise performance is a paramount 
component in exercise prescription for increased benefits in glycaemia management for 
T2DM.  
2. The diurnal timing of exercise performance may be an important component to further 
increase the benefits of exercise in T2DM management. However, the magnitude of its 
effect on glycaemic management remains elucidated and future low risk trials are 
warranted. 
 
Key Words: Glycemic control, exercise, diurnal timing, systematic review 
 
3.2 Introduction 
Type 2 diabetes mellitus (T2DM) is one of the leading causes of mortality in most developed 
countries (1, 2), accounting for approximately 8.4% of global all-cause mortality in 2013 (3). 
Current estimates identify a continuing increase in global prevalence in T2DM (4), with the 
greatest rates of increased prevalence occurring in low- and middle-income countries (5). 
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Despite substantial phenotypic heterogeneity with T2DM (6), poor glycemic control with rates 
of morbidity and mortality increasing proportionally with poorer glycemic control (7, 8]) are 
characteristic of individuals with T2DM.  
 
Maintenance of tight glycemic control is a critical objective in the management of T2DM. 
Increasing physical activity is an effective therapy for improving glycemic control (9-17) and 
therefore it is a recognized adjunct in the management of T2DM. Accordingly, the American 
Diabetes Association (ADA) guidelines recommend adults to engage in at least 150 min/week 
of physical activity, comprising both aerobic and resistance exercise training on a daily basis, 
or at least, not allowing more than two days to elapse between exercise sessions (18). The acute 
response of plasma glucose to exercise varies with alterations in exercise intensity, duration, 
frequency and type, and this has been well characterized in previous reviews (18-22). While 
the acute response of plasma glucose to exercise are well defined—albeit partly moderated by 
participant characteristics—the longer term glycemic effect of modifying the intensity, 
duration, frequency and type of exercise within training programs is less clear (18-22), and 
complicated by additional confounders such as diet and exercise adherence. The evidence 
supporting superiority of one training variable over another is limited, although increases in 
volume (particularly duration; (23)) appear particularly important in conveying the positive 
effects of exercise on glycemic management.   
 
More recently, the association between poor sleep patterns and increased risk of T2DM (24) 
have prompted interest in exploring the role of the circadian timing system on glycemic control. 
The circadian timing system regulates metabolic, immunological, neurological and endocrine 
processes via a complex interaction between central (i.e., bilateral suprachiasmatic nuclei of 
the hypothalamus) and peripheral (i.e., liver, muscle, adipose, pancreatic cells) pathways (25, 
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26). The peripheral pathways—or molecular clocks within peripheral tissue—appear 
particularly susceptible to entrainment either directly or indirectly by feeding and exercise (25-
28); wherein alterations in the timing of these can result in desynchronization between the 
various metabolic, neurologic and endocrine processes (26). This desynchronization can have 
negative health consequences, such as disrupting the rhythmic secretion of particular hormones 
(e.g. ghrelin (29)), although negative health consequences may be reversed once the circadian 
system is reset (30). The assessment of exercise timing on glycemic management in individuals 
with T2DM has emerged in the wake of this literature (31-34). The timing of exercise relative 
to nutrient ingestion (feeding) is an emerging area of interest, wherein preliminary support 
suggests beneficial glycemic responses for exercise performed in the postprandial period (32-
35). With respect to diurnal timing of exercise, it is known that acute exercise performed at 
different times of the day alters metabolic processes (e.g. lipid metabolism (36)), endocrine 
concentration and responses (37) and autonomic function (38). The aim of this systematic 
review therefore, was to assess the available evidence from randomized controlled trials 
(RCTs) assessing effects of diurnal exercise timing on glycemic control in individuals with 
T2DM. 
 
3.3 Methods 
Protocol and Registration 
This systematic review was reported in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta – Analyses (PRISMA) Statement and registered with the 
International Prospective Register of Systematic Reviews (PROSPERO CRD42017054666) 
(39). 
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Data sources and searches 
Potential studies were identified by systematically searching Medline (PubMed), EMBASE, 
CINAHL, Cochrane Library and the ClinicalTrials.gov Registry electronic databases. The 
search syntax was designed for PubMed (Appendix E) and applied to the remaining databases. 
All databases were searched from the inception to June 2018 for full reports written in the 
English language. In addition, reference lists of all retrieved papers were manually searched to 
identify any potentially relevant studies not identified by the database search. 
 
Eligibility Criteria 
The inclusion criteria were RCTs that examined the diurnal effects of exercise on measures of 
glycemic control and insulin response in adults diagnosed with T2DM. The exercise 
interventions of included studies had to be quantifiable based on the frequency, intensity, type 
and time of day that exercise was performed. To provide a comprehensive review of the 
available literature, exercise durations ranging from acute single exercise bouts to extended 
exercise training programs were included. Observational or uncontrolled studies and studies 
that did indicate the diurnal timing of exercise performance were excluded from this systematic 
review. 
 
Outcome measures 
Glycemic control encompasses the three components of the glucose triad: (i) glycosylated 
hemoglobin, (ii) fasting glucose (FG) and, (iii) postprandial glucose (40). While glycosylated 
hemoglobin (HbA1c) is the criterion measure for chronic glycemic control (41-43), reflecting 
the previous 8-12 weeks (44), it may not necessarily capture the magnitude of change in diurnal 
glucose (45-47). While the magnitude change may best be presented by the change from fasting 
glucose concentration to the peak glucose concentration, the commonly adopted sampling 
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time-points do not capture peak glucose concentrations. Suh et al. (48) identified area under 
the curve (AUC) as an acceptable measure of postprandial glucose (PPG) excursions. 
Therefore, to account for varied perspectives of glycemic control, we included the following 
as primary review outcomes: (i) HbA1c, (ii) FG, (iii) PPG (postprandial glucose concentrations 
reported after a glucose load) and, (iv) glucose AUC. Considering the association between 
hyperinsulinemia and increased cardiovascular disease (CVD) mortality rates (49-51), the 
secondary review outcomes were postprandial insulin concentrations and AUC after a glucose 
load. 
 
Data extraction and quality assessment 
Potential studies were exported to Covidence Systematic Review Software (Veritas Health 
Innovation, Melbourne, Australia) for assessment. Following removal of duplicate references, 
two independent authors (ST and SC) completed the title and abstract screening process in a 
blinded manner against the selection criteria. Disagreements were resolved by a third author 
(TF). Thereafter, a full text assessment was completed in a blinded manner by two review 
authors independently (ST and MF). Similarly, all disagreements were resolved by a third 
author (TF). Reasons for excluding each study at the full-text stage were recorded. When 
insufficient information was available, corresponding authors of included studies were 
contacted to obtain additional information. 
 
Upon the completion of the full-text assessment, data extraction for the included studies was 
completed independently by two authors (ST and MF) utilizing the Cochrane Collaboration 
Data Collection Form (52). The following information was extracted from each of the included 
studies: (i) experimental conditions; (ii) total number of participants; (iii) age; (iv) gender; (v) 
body mass index; (vi) T2DM duration; (vii) exercise protocols; (viii) exercise timing and; (ix) 
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comparisons in outcome measures of glycemic control and insulin. Variations in data extraction 
were resolved by consensus (ST and MF). Seventeen authors were contacted for additional 
information.  
 
The assessment of risk of bias for each study was completed by utilizing the Cochrane 
Collaboration’s tool for assessing risk of bias (53). The tool assesses bias for each study from 
seven domains: (i) random sequence generation; (ii) allocation concealment; (iii) blinding of 
participants and personnel; (iv) blinding of outcome assessment; (v) incomplete outcome data; 
(vi) selective reporting and; (vii) other sources of bias. Two independent authors (ST and MF) 
provided a judgement (low risk of bias/ high risk of bias/ unclear) for each of the 
aforementioned domains, and all disagreements were resolved by consensus. 
 
Data synthesis and analysis 
A qualitative synthesis of trial results were summarized in tables stratified by study design and 
outcome type (HbA1c, PPG, FG, glucose AUC) and insulin. As a consequence of i) the 
heterogeneity of studies; ii) the number of studies reporting on small sample sizes; iii) the 
insufficient number of studies completing direct comparisons of the effects of exercise-timing 
on outcome measures; we were unable to perform a quantitative synthesis with meta-analysis. 
Instead, the direction of the observed association for each of the outcome measures was 
graphically presented by constructing forest plots (SigmaPlot, version 13.0; Systat Software, 
San Jose, CA) to report standardized mean differences (SMD’s [Cohen’s d]) between exercise 
conditions. All analyses were performed with Comprehensive Meta-Analysis (CMA) software 
(version 3.3.070). SMDs were interpreted as small (d = 0.2), moderate (d = 0.5) or large (d = 
0.8) (54). 
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3.4 Results 
Study selection and characteristics 
Our initial search identified 7333 trials, of which 18 RCTs (321 participants), published 
between 1997 and 2018, met our selection criteria and were included in the qualitative analysis 
(55-70) (Figure 3-1). Of these, either a crossover (n = 16) (56-68, 70) or parallel-groups design 
(n = 2) (55, 69) was employed.  
 
At baseline, participants had a mean (95% CI) age 57.9 years (55.2, 60.5) years, HbA1c of 8.2 
% (8.1, 8.3), body mass index (BMI) of 30.6 (28.9, 32.2) kg.m-2 and T2DM duration of 7.2 
(5.2, 9.3) years. The percentage of male and female participants were 82.7% and 17.3% 
respectively. Of the 18 included trials, 16 trials investigated the effects of aerobic-based 
exercises (cycling: n = 7; walking: n = 6; cycle ergometer and treadmill walk: n =2) (55-57, 
59-62, 64-70), and three resistance exercise protocols (resistance exercise only: n = 2; 
resistance exercise and cycling: n = 1) (58, 63, 68). With regards to the timing of exercise 
performance, 15 trials compared morning exercise to a no-exercise control (55, 59-70), and 
three trials compared evening exercise to a no-exercise control (56-58) for glycemia and 
glycemic control. A detailed summary of the results for both acute crossover and parallel-group 
trials are presented in Table 3-1 and 3-2 respectively. 
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Figure 3-1. Study Selection Process
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Table 3-1. Summary of included randomized controlled crossover trials 
 
 
Author Participants 
Characteristics 
Exercise Timing; 
additional variables* 
Exercise Characteristics  Study Outcomes  
(Exercise vs. Control) 
Type Duration 
 
Intensity METs  Glycemic Control  Insulin Response 
 GC GAUC  IC IAUC 
Colberg 
(2009) (53) 
12 subjects (6 females) 
Age: 61 y  
BMI: 35 kg.m-2 
T2DM duration: 11 y 
Evening [1800–1900h]; 
2 conditions: 
Control: NEx 
 
      
Pre-Meal Exercise  
(PRE) 
TM Walking  20 min M-HR: 111bpm  
(40% of HRR) 
3.5  → →  NA NA 
Post-Meal Exercise 
(POST) 
TM Walking  20 min M-HR: 113bpm  
(40% of HRR) 
3.5  → →  NA NA 
Colberg 
(2014) (52) 
12 subjects (9 females) 
Age: 59 y 
BMI: 35 kg.m-2 
T2DM duration: 6 y 
Evening [1800–1900h] Control: NEx       
Table tennis: 
iPong robot  
30 min M-HR: 97 bpm  
(61% of HRmax) 
4   NA  NA NA 
TM Walking 30 min M-HR: 122bpm  
(76% of HRmax) 
4   NA  NA NA 
Erickson 
(2017) (66) 
8 subjects (3 females) 
Age: 60 y 
BMI: 34 kg.m-2 
T2DM duration: NR 
Morning [NR] Control: NEx       
Interval 
walking  
3x10 min 50% VO2max 3.5     NA NA 
Heden 
(2014) (54) 
13 subjects (8 females) 
Age: 49 y 
BMI: 37 kg.m-2 
T2DM duration: 4 y 
Evening [NR];   
2 conditions: 
Control: NEx       
Pre-Meal Exercise  
(PRE) 
Resistance 
Training 
3x10 reps 
8 exercises 
10 RM 3.5  →   → NA 
Post-Meal Exercise 
(POST) 
Resistance 
Training 
3x10 reps 
8 exercises 
10 RM 3.5  →   → NA 
*Where multiple conditions are noted. METs: metabolic equivalents; GC: glucose concentration; GAUC: area under the glucose curve; IC: insulin concentration; IAUC: area under 
the insulin curve; NEx: no exercise; TM: treadmill; M-HR: mean heart rate; NA: not assessed; NR; not reported; RM: repetition maximum 
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Author Participants 
Characteristics 
Exercise Timing; 
additional variables* 
Exercise Characteristics  Study Outcomes  
(Exercise vs. Control) 
Type Duration 
 
Intensity METs  Glycemic Control  Insulin Response 
 GC GAUC  IC IAUC 
Karstoft 
(2014) (55) 
12 subjects (6 females) 
Age: 61 y  
BMI: 35 kg.m-2 
T2DM duration: 11 y 
Morning [0900h] Control: NEx       
Interval 
Walking  
20x3 min SB: 54% of VO2peak 
FB: 89% of VO2peak 
3.5  → NA  → NA 
Continuous 
Walking  
60 min 70% of HRmax 3.5  → NA  → NA 
Larsen 
(1997) (56) 
 
12 subjects (9 females) 
Age: 59 y 
BMI: 35 kg.m-2 
T2DM duration: 6 y 
Morning [0930h] Control: NEx       
Cycling 
Ergometer  
45 min 50% of VO2peak 3.5  NA   NA  
 
Larsen 
(1999) (57) 
8 subjects (3 females) 
Age: 60 y 
BMI: 34 kg.m-2 
T2DM duration: NR 
Morning [0930h] Control: NEx       
Cycling 
Ergometer 
4 bouts 2x 50% of VO2peak 
2x 100% of VO2peak 
3.5  → NA  → NA 
Manders 
(2010) (58) 
13 subjects (8 females) 
Age: 49 y 
BMI: 37 kg.m-2 
T2DM duration: 4 y 
Morning [0900h] Control: NEx       
LI Cycling 
Ergometer 
60 min 35% of Wmax 3.5     NA NA 
HI Cycling 
Ergometer 
30 min 70% of Wmax 6.8  → →  NA NA 
Moreira 
(2012) (59) 
9 male subjects 
Age: 47 y 
BMI: 29 kg.m-2 
T2DM duration: 5 y 
Morning [0800-0830h] Control: NEx       
LI 
Resistance 
Training 
3x30 reps 
6 exercises 
23% of 1RM 3.5  NA   NA NA 
MI 
Resistance 
Training 
3x16 reps 
6 exercises 
46% of 1RM 4  NA   NA NA 
*Where multiple conditions are noted. METs: metabolic equivalents; GC: glucose concentration; GAUC: area under the glucose curve; IC: insulin concentration; IAUC: area under 
the insulin curve; NEx: no exercise; SB: slow bout; FB: fast bout; LI: low intensity; MI: moderate intensity; HI: high intensity: NA: not assessed; NR; not reported; RM: 
repetition maximum 
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Author Participants 
Characteristics 
Exercise Timing; 
additional variables* 
Exercise Characteristics  Study Outcomes  
(Exercise vs. Control) 
Type Duration 
 
Intensity METs  Glycemic Control  Insulin Response 
 GC GAUC  IC IAUC 
Oberlin 
(2014) (60) 
 
9 subjects (5 females) 
Age: 60 y 
BMI: 36 kg.m-2 
T2DM duration: NR 
Morning [0630h] 
 
Control: NEx       
Combined: 
 
1 bout x TM 
1 bout x CE 
40 min 
 
TM: 20 min  
CE: 20 min 
 
 
TM: 60% of HRR 
CE: 60% of HRR 
3.5  → →  NA NA 
Rasmussen 
(1999) (61) 
12 subjects (4 females) 
Age: 56 y 
BMI: 29 kg.m-2 
T2DM duration: 8 y 
Morning [1030-1100h] 
 
Control: NEx       
Cycling 
Ergometer  
30 min 40% of VO2peak 3.5  NA   NA  
 
Tobin 
(2008) (62) 
8 male subjects 
Age: 59 y 
BMI: 29 kg.m-2 
T2DM duration: NR 
Morning [NR] 
 
 
Control: NEx       
Cycling 
Ergometer 
60 min 60% of VO2peak 5   NA    
Van Dijk 
(2012) (64) 
INS 
15 male subjects 
Age: 60 y 
BMI: 30 kg.m-2 
T2DM duration: 14 y 
 
OGLM 
15 male subjects 
Age: 61 y 
BMI: 30 kg.m-2 
T2DM duration: 7 y 
Morning [1100–1145h] 
 
Control: NEx       
Cycling 
Erogmeter 
45 min 35% of Wmax 3.5   NA  NA NA 
Resistance 
Training 
5x10 reps 
4 exercises 
40-75% of 1RM 4   NA  NA NA 
*Where multiple conditions are noted. METs: metabolic equivalents; GC: glucose concentration; GAUC: area under the glucose curve; IC: insulin concentration; IAUC: area under 
the insulin curve; NEx: no exercise; SB: slow bout; FB: fast bout; LI: low intensity; MI: moderate intensity; HI: high intensity: NA: not assessed; NR; not reported; RM: 
repetition maximum 
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Author Participants 
Characteristics 
Exercise Timing; 
additional variables* 
Exercise Characteristics  Study Outcomes  
(Exercise vs. Control) 
Type Duration 
 
Intensity METs  Glycemic Control  Insulin Response 
 GC GAUC  IC IAUC 
Van Dijk 
(2012) (64) 
NIDDM 
16 male subjects 
Age: 60 y 
BMI: 30 kg.m-2 
T2DM duration: 5 y 
 
IDDM 
14 male subjects 
Age: 60 y 
BMI: 31 kg.m-2 
T2DM duration: 12 y 
Morning [1000h] 
 
 
Control: NEx       
Cycling 
Ergometer 
(Single) 
60 min 50% of Wmax 4  NA   NA NA 
Cycling 
Ergometer 
(Multiple) 
2 x 30 min 50% of Wmax 4  NA   NA NA 
Van Dijk 
(2013) (63) 
20 male subjects 
Age: 64 y 
BMI: 30 kg.m-2 
T2DM duration: 8 y 
Morning [0915–1000h] Control: NEx       
Walking  3 x 15 min M-HR: 78bpm 
(50% of HRmax) 
3  →   NA  
Cycling 
Ergometer 
45 min 50% of Wmax 4     NA  
Van Dijk 
(2013) (63) 
NIDDM 
37 male subjects 
Age: 59 y 
BMI: 30 kg.m-2 
T2DM duration: 7 y 
 
IDDM 
23 male subjects 
Age: 60 y 
BMI: 30 kg.m-2 
T2DM duration: 12 y 
Morning [1000–1100h] 
 
Control: NEx       
Cycling 
Ergometer 
45 to 60 min 35-50% of 
VO2peak 
3.5 – 4   NA  NA NA 
*Where multiple conditions are noted. METs: metabolic equivalents; GC: glucose concentration; GAUC: area under the glucose curve; IC: insulin concentration; IAUC: area under 
the insulin curve; NEx: no exercise; M-HR: mean heart rate; NA: not assessed; NR; not reported 
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Table 3-2. Summary of included longitudinal parallel group studies 
 
Author Participants 
Characteristics 
Exercise Characteristics Study Outcomes (Exercise vs. Control) 
Glycemic Control  Insulin Response 
HbA1c GC FG PPG  IC IS 
Belli 
(2011) (51) 
Control 
10 female subjects  
Age: 56 y 
BMI: 29.9 kg.m-2 
T2DM duration: 3.7 y 
Control: no exercise training        
Training Group (TG) 
9 female subjects 
Age: 53 y 
BMI: 32.2 kg.m-2 
T2DM duration: 4.4 y 
TG: 20 to 60 minutes of walking on an outdoor track 3 times 
per week for 12 weeks at VT velocity (5 METs). Each session 
was performed between 0800 and 1000h. 
 NA → NA  NA NA 
Vancea  
(2009) (65)  
Control 
20 subjects  
Age: 56 y 
BMI: 28 kg.m-2 
T2DM duration: 6 y 
Control: no exercise training        
3x/week exercise (G3) 
14 subjects 
Age: 57 y 
BMI: 30 kg.m-2 
T2DM duration: 5 y 
G3: 30 minutes of treadmill walking performed 3 times per 
week for 20 weeks at 60-70% HRmax (3.5 METs). Each 
session was performed after breakfast. 
 
→ NA → →  NA NA 
5x/week exercise (G5) 
9 subjects 
Age: 59 years,  
BMI: 30 kg.m-2 
T2DM duration: 6 y 
G5: 30 minutes of treadmill walking performed 5 times per 
week for 20 weeks at 60-70% HRmax (3.5 METs). Each 
session was performed after breakfast.  
→ NA    NA NA 
HbA1c: glycosylated hemoglobin; GC: glucose concentration; FG: fasting glucose; PPG: postprandial glucose; IC: insulin concentration; IS: insulin sensitivity; NA: not assessed;  
NR: not reported; VT: ventilatory threshold 
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Risk of Bias Assessment 
The 18 included trials were assessed for risk of bias and revealed insufficient evidence across 
most categories (Appendix F). In particular, methods for generating the allocation sequence 
and allocation concealment were unclear in 94% (17/18) and 89% (16/18) of the included 
studies. All studies presented adequate information with regards to the blinding of participants 
and personnel. However, the blinding of outcome assessors was unclear for 89% (16/18). The 
treatment of incomplete outcome data were deemed as a low risk of bias in 78% (14/18) of the 
trials due to sufficient information provided for the assessment of completeness of outcome 
data, which included information regarding attrition and exclusions from final analysis. Most 
of the studies were judged as having unclear risk of bias for both the assessment of selective 
reporting and other sources of bias due to insufficient information being presented, with only 
38% (7/18) and 33% (6/18) of the included trials being judged as low risk of bias, respectively. 
 
Changes in Postprandial Glucose Concentrations and AUC 
Data from trials assessing the acute effect of exercise timing on glucose concentrations (Figure 
3-2A) showed 88% (8/9) of trials reported a significant benefit of morning exercise when 
compared to a no-exercise control condition; while 33% (1/3) of trials demonstrated significant 
improvements when evening exercise was performed compared to a no-exercise control 
condition. Studies assessing the effect of exercise timing on glucose AUC showed significant 
improvements in 75% (6/8) of trials when exercise was performed in the morning (relative to 
no-exercise control); and 50% (1/2) of trials when exercise was performed in the evening 
(Figure 3-2B).  
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2A 
 
2B 
 
AUC: area under the curve; SMD: standardized mean difference; CI: confidence interval 
 
Figure 3-2. Morning and evening exercise versus control on glucose concentrations (2A) and, 
glucose AUC (2B) 
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Of the two parallel-group trials, Belli et al. (55) reported that 12 weeks of morning aerobic 
exercise training led to a significant reduction in HbA1c (-1.3% [-1.50, -1.10]) but a non-
significant reduction in FG (-1.77 mmol/L [-2.40, -1.00]) compared to a no-exercise control. 
Vancea et al. (69) reported that 20 weeks of morning aerobic exercise training led to greater 
decreases in HbA1c (-1.30% [-2.56, -0.04]), FG (-4.02 mmol/L [-5.64, -2.39]) and PPG (-3.09 
mmol/L [-5.94, -0.23]) compared to a no-exercise control. 
 
Changes in Postprandial Insulin Concentrations and AUC 
Of the three trials that assessed the effect of morning exercise on postprandial insulin 
concentrations, only one trial showed significant reductions in insulin concentrations when 
compared to a no-exercise control. No differences were reported in one trial that assessed the 
effect of evening exercise on insulin concentrations. Insulin AUC was significantly decreased 
in 75% (3/4) of the trials that assessed exercise in the morning when compared to a no-exercise 
control. No trials assessed the effect of evening exercise on insulin AUC. 
 
3.5 Discussion 
This systematic review of exercise-based interventions for T2DM included 18 randomized 
controlled trials, of which 16 were cross-over studies and 2 studies were parallel-group designs. 
Unfortunately, no RCTs assessed the direct effect of manipulating exercise timing within a 
training program on long-term glycemic control.  Based on the available evidence, the findings 
of this review are i) irrespective of exercise-timing, acute glycemic outcomes consistently 
favoured exercise compared to control; ii) average glucose concentrations were improved in 
4/11 trials conducted in the morning, 3/4 trials conducted in the evening; while, iii) glucose-
AUC was improved in 4/11 trials conducted in the morning and 0/2 trials conducted in the 
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evening. Large heterogeneity in study design and methodology precluded a meta-analysis of 
included data. Specifically, the timing and frequency of blood samples, exercise type and 
duration, composition and timing of test-meals, and the timing of the exercise bout relative to 
meal consumption (i.e. before or after) were too variable for analyses. As a consequence, there 
is insufficient evidence to conclude the importance of diurnal timing of exercise on glycemic 
regulation or claim either morning exercise or evening exercise as conveying greater glycaemic 
benefits to individuals with T2DM.  
 
Effect of exercise-timing on acute glycemic responses  
Early morning exercise performance (0600-0900h) may potentially lower glucose by a greater 
amount than late morning exercise (0900-1200h) (glucose concentrations (59, 62, 64, 67, 68): 
SMD: -1.19 and -0.84, respectively; glucose AUC (60, 62-65, 67, 68): SMD: -1.39 and -0.50, 
respectively). Due to the heterogeniety in the composition and timing of meals, it was not 
possible to identify whether this effect was due to acute elevations in baseline levels, reduced 
peaks in glucose concentration, or more rapid return to baseline glucose concentrations.  
 
Studies assessing the effect of evening exercise on glycemic responses included walking (56, 
57), table tennis (56) and resistance training (58) exercise, with three of the four conditions 
demonstrating significant improvements in glucose concentrations (Figure 3-2A). However, 
the studies reporting glucose AUC (57, 58) did not demonstrate the same magnitude-effect, 
wherein each condition favoured exercise compared to control, but this was not significant in 
either condition (Figure 3-2B).  
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Effect of exercise-timing within an exercise training program on glycemic control 
Exercise training has been shown to exert meaningful reductions in HbA1c by 0.73% [-1.06% 
to -0.40%] (43, 71). Within these training programs, variables such as exercise type, frequency, 
intensity and duration have been exhaustively considered in regards to the management of 
glycemic control (71, 72). Accordingly, when training exceeds the recommended  150 min,  
HbA1c has been shown to be reduced by 0.89% [-1.26% to -0.51%] (43). Only two studies 
assessing the longer-term effects of exercise on glycemic control, met the inclusion criteria of 
this systematic review. In one study, aerobic exercise training performed 3 mornings per week 
for 12 weeks resulted in a significant decrease in HbA1c (~0.6%); however, non-significant 
changes were reported for fasting glucose (-0.5mmol/L) (55). Vancea et al. (69) investigated 
the effect of structured morning aerobic exercise training (20 week intervention) conducted 
either 3 or 5 times per week on blood glucose responses and reported non-significant changes 
in HbA1c when compared to a control group (spontaneous exercise encouraged; unsupervised 
and timing of exercise not discussed). However, fasting and postprandial glucose 
concentrations were significantly reduced (fasting: ~2.3 mmol/L; postprandial glucose: ~1.1 
mmol/L) when training was performed 5 times per week.      
 
Effect of exercise-timing: Potential mechanisms and clinical implications 
Despite the recognized importance of regular physical activity and exercise in managing 
individuals with T2DM, physical activity levels in individuals with T2DM remain below 
national norms (73). In particular, older adults (≥65 y.o.) with T2DM are 31-34% less likely to 
engage in physical activity than similarly aged individuals without DM (74). While increased 
frequency, duration and intensity of exercise are associated with improved glycemic 
management (23, 69-71, 75, 76), these findings have not translated well into clinical practice. 
If the diurnal timing of exercise is identified as an important training variable in future research, 
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the manipulation of this variable will likely present as an attractive alternative to patients and 
enhance translation into practice, although this is yet to be determined.  
  
The regulation of glucose concentrations by the circadian system (25-28) along with the role 
of exercise in entraining circadian oscillations (28), provides an intriguing mechanism 
underlying potential influences of diurnal exercise timing in individuals with T2DM. 
Desynchronization of the circadian system in response to feeding, physical activity and sleep 
is linked with impaired insulin sensitivity (26) and may further explain, at least in part, the 
characteristic metabolic inflexibility in T2DM (77, 78). In contrast, time restricted feeding in 
mice was shown to reset the circadian clock which was associated with improvements in insulin 
sensitivity and lipid profiles (30). While exercise is known to entrain the circadian system, the 
potential impact of this in clinical patients, including T2DM require exploration. Further, it 
may indeed be plausible that individuals with T2DM but different chronotypes respond better 
to exercise performed at different times of the day. Unfortunately, there is limited available 
evidence from RCTs in the extant literature and further work is required to determine whether 
an optimal diurnal time for exercise exists and if so, how this may be moderated by an 
individual’s chronotype.  
  
Strength and Limiations of the Review 
The strength of this systematic review is the specific inclusion of recent and relevant 
randomized controlled trials that investigated the temporal effect of exercise performance on 
critical measures of T2DM management. In addition, findings from this review have specific 
clinical applicability to the T2DM population given that included participants were restricted 
to T2DM individuals. Given that the difference in the timing of exercise performance may play 
a large role in glycemic and insulin variability, the diurnal timing of exercise performance may 
provide a better understanding of the optimal time for exercise performance to allow for 
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effective management of glycaemic control in T2DM individuals. A limitations of this review 
were the exclusion of studies based on langugage (i.e. non-english studies).  
 
The extant literature curently lacks homogenenity with respect to primary outcome measures 
(i.e. fasting glucose, HbA1c, glucose AUC), analyses of outcome measures (i.e. incremental 
AUC, total AUC, time-period comprising AUC, number of samples performed during the 
AUC), types of exercise interventions (frequency, intensity, type and duration of exercise), 
specific timing of exercise performance and the reporting of outcome measures at different 
time-points. Additionally, the findings of this systematic review are reliant on the quality of 
the included studies, whereby, the majority of the studies were deemed unclear during risk of 
bias assessment (Appendix F) and female participants were underrepresented in the included 
studies (i.e. males vs females: 83% vs. 17%). The limitations of these prior studies precluded 
the performance of a meta-analysis. With respect to exercise training, it is noteworthy that acute 
changes in glycemic control and insulin responses may not translate to chronic responses 
assocaited with longer-term interventions. It is recommended that future research investigates 
the longer-term (>12 weeks) effect of manipulating exercise-timing relative to diurnal timing 
(i.e., morning versus evening exercise interventions), and adopt an exercise-intervention based 
on current best-evidence (i.e., supervised combination of aerobic and resistance-based 
exercise; at least 50 min per session, three times per week) with clinically relevant outcome 
measures (fasting glucose; oral glucose tolerance test; HbA1c) in individuals with T2DM.     
 
3.6 Conclusions 
Despite mechanistic rationale for an optimal diurnal timing of exercise from concurrent 
research in the exercise and circadian clock literature (25-28), the current evidence from RCTs 
is not sufficient to state whether morning or evening exercise is superior in improving glycemic 
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control. Indeed, there are no studies which have directly assessd this question, likely due to 
heterogenous methodology. Whether the strategic manipulation of exercise-timing results in 
clinically meaningful changes in glycemic control (i.e. HbA1c) for individuals with T2DM is 
currently not known and requires investigation. 
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4.1 Abstract 
Despite acknowledgement of exercise as a cornerstone in the management of Type 2 diabetes 
mellitus (T2DM), the importance of exercise timing has only recently been considered.  
Purpose: This study sought to determine the effect of diurnal exercise timing on glycemic 
control in individuals enrolled in a 12-week supervised multi-modal exercise training program. 
A secondary aim was to determine the effect of diurnal exercise timing on the circadian rhythm 
of wrist sin temperature. Methods: Forty sedentary overweight men (n=17) and women (n =23) 
with and without (n=20) T2DM diagnosis (age: 51±13 years; BMI: 30.9±4.2 kg/m2) were 
randomly allocated to either a morning (amEX) or evening (pmEX) exercise training group. 
The supervised 12-week (3 days/week) program, comprised 30 minutes moderate intensity 
walking and 4 resistance-based exercises (3 sets, 12-18 repetitions each). Glycemic outcomes 
(glycated haemoglobin, HbA1c; fasting glucose, FG; fasting insulin, FI; homeostasis model 
assessment of insulin resistance, HOMA2-IR), body anthropometrics (weight, BMI; body fat), 
cardiorespiratory fitness (CRF) and wrist skin temperature were assessed at baseline and post-
intervention. Results: No significant group (amEX versus pmEX) by time interactions were 
observed for any glycemic variables (all p≥0.42). However, exercise training improved (main 
effect of time: all p<0.01) HbA1c, FG, FI and HOMA2-IR. Exercise training significantly 
reduced body fat and increased CRF. There were no significant interaction effects or main 
effects of time observed in any of the circadian parameters assessed in the current study.  
Conclusions: Twelve weeks of multi-modal exercise training improves glycemic control in 
overweight non-T2DM and T2DM individuals. Under free-living conditions, no distinct 
glycemic benefits were associated with three exercise-training sessions performed either in the 
morning or evening and did not appear to alter circadian rhythm.  
 
Key Words: diurnal timing, diabetes mellitus, glycemic control, insulin sensitivity  
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Trial Registration: ANZCTR ACTRN12616001172493    
 
4.2 Introduction 
Declining rates of physical activity (PA) have partially contributed to the increased prevalence 
in obesity over the past few decades (1, 2). This is concerning since obesity is acknowledged 
as the primary risk factor for the development of Type 2 diabetes mellitus (T2DM) (3) and a 
low level of PA is an independent risk factors for T2DM (4-6). Epidemiological evidence has 
shown vigorous physical activity performed at least once per week, can reduce the (up to) 8-
year incidence of T2DM in both women (Age-adjusted Relative Risk, 0.67; Age and body-
mass index adjusted Relative Risk, 0.84) (5) and men (Age-adjusted Relative Risk, 0.64; Age 
and body-mass index adjusted Relative Risk, 0.71) (6)) relative to no vigorous physical 
activity. Consequently, physical inactivity is regarded as an important modifiable risk factor 
for T2DM (7), with an increase in both general physical activity and scheduled exercise 
considered to be important adjuncts in both the prevention and the treatment of T2DM (8).  
 
Exercise improves glycemic control via both local acute skeletal muscle responses and chronic 
adaptations (9), as well as systemic responses and adaptations in hepatic, neural, immune, 
endocrine and metabolic factors (10). Each of these responses are in turn moderated by the 
intensity, duration and type of exercise performed, and when embedded within a training 
program, these responses are moderated by the frequency of exercise (1, 11). The timing of 
exercise relative to meal ingestion has now emerged as potentially moderating the effect of 
exercise on glycemic control (12-17), with postprandial exercise appearing to be most 
beneficial to glycemic control. Whether diurnal exercise-timing (i.e., morning vs. evening) 
effects glycemia or glycemic control, has to the best of our knowledge, not been directly 
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compared. Therefore, the primary aim of this study was to determine the impact of diurnal 
exercise timing within the context of a 12-week supervised multi-modal exercise training 
program on glycemic control in sedentary, overweight individuals both with and without 
T2DM. Given the evidence that demonstrate a higher glucose tolerance occurring in the 
morning than in the evening in healthy individuals (12, 13), we hypothesised that morning 
exercise would result in greater improvements in glycemic control than exercise performed in 
the evening.    
 
In a parallel line of research investigating the role of the circadian system in metabolic 
disturbance (i.e., obesity and T2DM) (18-22), exercise has been identified as a stimuli capable 
of affecting the circadian system (19-21). The circadian system in humans is complex, 
comprising a network of cellular clocks which possess the ability to autonomously maintain a 
circadian rhythm (20, 21). Despite their autonomous ability, the alignment of these clocks to 
both external cues (zeitgebers) such as light and dark cycles, as well as to each other (i.e., the 
clocks between tissues) is important (20, 23). Specifically, misalignment/disruption of these 
clocks may result in metabolic disturbance, while metabolic disturbance may lead to 
misalignment in clocks (18-20). Exercise (physical activity) is an important external cue able 
to shift the circadian rhythm (e.g., clock gene expression) in both the suprachiasmatic nucleus 
(SCN; central clock) of the hypothalamus (24) and skeletal muscle (19, 21) and if consistently 
maintained may entrain or align these clocks. A secondary aim of the study therefore, was to 
determine whether three days per week of exercise, performed either in the morning or evening 
is sufficient to shift the phase of the circadian rhythm of body temperature measured at the skin 
(25). We hypothesised that exercise would result in skin temperature entrainment, as evidenced 
by divergent responses in morning- and evening-exercise, respectively.      
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4.3 Methods 
Using a parallel study design, participants were randomly allocated into 12-week multi-modal 
exercise training intervention either performed in the morning (amEX) or in the evening 
(pmEX). The study was approved by Murdoch University Human Research Ethics Committee, 
Western Australia, and written informed consent was obtained from all participants prior to 
commencement of the study. All investigations were conducted according to the principles 
expressed in the Declaration of Helsinki. The CONSORT checklist is available as supporting 
information (Appendix H). 
 
Study Participants 
The study recruited non-smoking, sedentary (< 150 min of exercise per week), overweight 
(BMI ≥ 27kg/m2) men and women between the ages of 18 and 65 years. Participants were not 
eligible for this study if they were unable to exercise or had a condition known to be aggravated 
by exercise assessed using the Exercise and Sports Science Australia pre-exercise screening 
tool. In addition, participants were excluded if they: (i) were using insulin; (ii) have had surgery 
for weight loss; (iii) had prior history of heart, lung, kidney, endocrine or liver disease and; (vi) 
experienced recent weight loss ≥4kg in previous month.  Participants with T2DM were allowed 
to continue their oral hypoglycemic medications at the usual dose, frequency and time while 
participating in the study.  
 
Using a medium effect size (f = 0.25), a sample size of 34 participants was deemed sufficient 
to provide 80% power to detect (α-error probability value set at .05) within-between 
interactions (Two groups: amEX, pmEX) using measures taken at pre- and post-intervention 
time-points. To account for possible attrition, we increased the target sample size to forty 
participants (Appendix J). Participants were recruited via public advertisements and enrolled 
 76 
 
between October 2016 and August 2017 and followed up until December 2017. The primary 
investigator of the study (ST) completed the recruitment of participants. 
 
Experimental Procedures 
At baseline, participants attended the Murdoch University Exercise Physiology laboratory after 
an overnight fast during which body anthropometrics (body composition, height, weight and 
waist circumference) were measured along with the assessment of peak oxygen consumption 
(VO2 peak). Additionally, venous blood samples were drawn for the assessment of glycosylated 
haemoglobin, glucose and insulin. Participants were then fitted with an accelerometer 
(Actigraph) and a wrist skin temperature device (Thermochron iBotton DS1922L, Maxim 
Integrated Products, Inc., Sunnyvale, CA, USA) for 7 days prior to commencement of the 
intervention (exercise program). Thereafter, participants were assigned in a balanced treatment 
allocation ratio (i.e., 1:1) into either the amEX or pmEX training groups. The allocation to the 
training groups was completed in a blinded fashion using a computer-generated numbered list 
consisting of 1’s and 2’s that represented the amEX and pmEX groups, respectively. Each 
participant was assigned with a unique study ID for identification and allocation purposes. This 
ID was forwarded to an independent investigator (TF; blinded to the identity of the participants) 
who assigned each ID to a training group using randomly permutated blocks (each block n = 
6-12; http://www.randomisation.com) with males and females counterbalanced across groups 
via generation of two separate lists (one for allocation of males; one for allocation of females).  
Mid-intervention VO2 peak  assessment was completed in Week 6 to determine improvements 
in participant’s fitness levels and to adjust the training workload accordingly. In Week 12-13, 
participants completed their post-intervention assessments, which were identical to the baseline 
assessments, at least 24 h after the last training session, but no more than 96 h after the last 
training session.  
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Exercise Intervention 
All participants completed three supervised (by a trained exercise physiologist) exercise 
training sessions per week, for a total of 12 weeks, at the Strength and Conditioning laboratory 
in Murdoch University. Participants in both the amEX and pmEX groups completed their 
training sessions between 0800-1000h and 1700-1900h, respectively. Participants were 
required to consume a snack/meal at least 1 hour prior to the start of each training session. Each 
training session consisted of both an aerobic (AER) and resistance (RE) exercise component, 
with an approximate session duration of 60 min. Each training session started off with the AER 
which consisted of 30 min of treadmill walking at 60-70% of VO2 peak. This intensity was 
prescribed in accordance to the American Heart Association scientific statement (26). 
Thereafter, participants performed four different RE involving the major muscle groups (i.e. 
Leg press, Bench press, Military press and Lat-pulldown). Three sets of each exercise were 
performed at 45%, 50% and 55% of individually tested one repetition maximums (1RM) for 
18, 15 and 12 repetitions, with 60 s of rest between sets during Week 1 – 4, Week 5 – 8 and 
Week 9 – 12; respectively. These training intensities were shown to be effective in improving 
glycemic control with no adverse events being reported other than mild muscle soreness in 
obese and/or elderly diabetic patients (27). Prior to the commencement of the training 
intervention, the 1RM for each participant had to be determined. The exercises in the 1RM test 
were completed in the following order: Leg press, Bench press, Lat-pulldown and Military 
press. Two warm up sets (1st set: 10 repetitions; 2nd set: 5 repetitions) were completed with 2 
minutes rest in between sets. Thereafter, participants attempted their 1RM for each exercise 
with 3 minutes recovery between each sets and 5 minutes recovery between exercise. 
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Outcome measures 
The main outcome measures of the study were the change in glycemic control (HbA1c and FG), 
insulin sensitivity (FI and HOMA2-IR) and fructosamine (as a short-term marker of glycemic 
control). The secondary outcome measures included changes in body anthropometrics, VO2 peak 
and skin temperature (at wrist). Assessors of outcome measures were blinded to the treatment 
allocations. 
 
Biochemical analyses. Glycosylated haemoglobin (HbA1c) was measured by an independent 
pathology laboratory (Western Diagnostic Pathology, Perth, Western Australia), while plasma 
glucose (FG) and fructosamine (FRA; unadjusted for serum albumin) were measured using a 
COBAS analyser (COBAS Integra 400 plus, Roche Diagnostics Ltd, Switzerland). Plasma 
insulin (FI) was measured using enzyme linked immunoassay (Mercodia; Uppsala, Sweden). 
The computerized homeostatic model assessment (HOMA2-IR) was used as a surrogate 
measure of insulin resistance based on fasting glucose and insulin concentrations (28). 
 
Body weight, body composition and cardiorespiratory fitness. Body weight was calculated 
using a calibrated electronic digital scale and body composition was measured using dual-
energy X-ray absorptiometry (DXA) to assess for total body fat mass (BF) and fat free mass 
(FFM). Waist circumference was measured on a horizontal plane at the narrowest point 
between the lower costal border (10th rib) and the uppermost lateral border of the iliac crest. 
Cardiorespiratory fitness (peak oxygen consumption; VO2 peak) was measured using a treadmill 
walking test protocol whilst simultaneously breathing through a mask connected to a metabolic 
cart (ParvoMedics TrueOne 2400) via plastic tubing. Rating of perceived exertion and heart 
rate were recorded throughout the test. The treadmill test protocol started at a speed of 3.5 
km/hr at 0% incline, with the speed progressively increasing by 1 km/hr every 2 minutes. Once 
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a speed of 6.5km/hr was achieved, incline was increased by 2% every 2 minutes while the 
speed was maintained at 6.5 km/hr throughout these stages. 
 
Peripheral skin temperature. Wrist skin temperature was continuously recorded 
(Thermochron iBotton DS1922L) for 7 days pre-intervention (prior to exercise training 
starting) and at the post-intervention time point (>24 h after the final training session). The use 
of iButtons for human skin temperature measurement has been previously reviewed (25) and 
shown to have an accuracy of -0.09°C with a precision of 0.05°C. For this study, the iButton 
resolution was set at 0.0625°C, with sampling every 15 min and the real-time clock 
synchronized with that of the computer.  
 
Missing data and recording artefacts (recordings of skin temperature under 28°C) from the 
iButton were excluded from the analysis (less than 3% of the readings). The data from each 
participant collected across the 7 days of recording at the pre-intervention time period, and the 
post-intervention time period were then analysed for four rhythmic parameters (MESOR, 
rhythm adjusted mean; amplitude, half the range of daily excursions; acrophase, time of the 
daily peak; period, duration of each cycle) using the Cosinor software (available at: 
https://www.circadian.org/softwar.html). All data are presented relative to local time to 
minimise possible errors from the sleep-onset data recorded from the Actigraph.     
 
Statistical Analyses 
Statistical analyses were performed using SPSS (v.24, IBM, Chicago, IL, USA). Treatment 
effects were estimated using linear mixed models (LMM) to assess for any changes over time 
(pre- and post-intervention) in the primary and secondary outcome measures between the two 
intervention groups (amEX and pmEX). The primary hypothesis of interest was the group by 
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time interaction, which were modelled as fixed effects with a random intercept (to account for 
differences at baseline) and these were examined with pairwise comparisons of the estimated 
marginal means. Since this trial included only active comparators (i.e. amEX and pmEX), main 
effects for time were also of interest, and these were examined using pairwise comparisons of 
the estimated marginal means. Bivariate regressions were assessed using a Pearson 
correlational analysis (rp). Statistical significance was set at p < 0.05. The magnitude of change 
for each outcome measure was reported using Hedge’s g, and interpreted as small (g = 0.2), 
moderate (g = 0.5) or large (g = 0.8) (29). Data are presented as means ± standard deviation. 
 
4.4 Results 
Forty adults with (n = 20) or without T2DM (n = 20) diagnosis completed the study (Table 4-
1; Appendix J). At baseline, there were no significant differences between the groups (Table 
4-1; all p ≥ 0.25), with the exception of age (amEX: 57 ± 5 years vs. pmEX: 51 ± 13 years; p 
= 0.04). No significant differences (p = 0.48) were reported for the adherence rate between 
amEX (32 ± 2 out of 36 sessions) and pmEX (31 ± 2 out of 36 sessions) during the 12-week 
training intervention. 
 
Biochemical Analysis 
There were no significant interaction effects between group (amEX, pmEX) and time (pre- and 
post-intervention) observed in any of the glycemic control measures (all p ≥ 0.42; Table 4-2). 
However, significant improvements were observed in each of the primary outcome measures 
(HbA1c, FG, FI, HOMA2-IR, fructosamine) in response to the exercise training (main effect of 
time, all p < 0.01), with effect sizes ranging from 0.23 to 0.9 in the amEX group and ranging  
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Table 4-1. Baseline characteristics 
 amEX Group (n = 20) pmEX Group (n = 20) p value 
Males/Females (n) 9/11 8/12 NA 
T2DM (n) 10 10 NA 
T2DM Duration (years) 13 ± 1 13 ± 2 0.62 
Antidiabetic Medication (n)    
Metformin 6 6  
Thiazolidinediones 2 1  
Sulfonylureas 3 2  
Meglitinides 0 1  
Age (years) 57 ± 5 51 ± 13 0.04* 
HbA1c (%) 6.9 ± 1.2 6.8 ± 1.7 0.89 
HbA1c (mmol/mol) 51.1 ± 13.4 49.9 ± 17.5 0.82 
Fasting Glucose (mmol/L) 7.7 ± 2.1 8.3 ± 3.7 0.51 
Fasting Insulin (pmol/L) 88.3 ± 33.9 80.9 ± 29.7 0.47 
HOMA2-IR 1.8 ± 0.7 1.7 ± 0.7 0.70 
Fructosamine (µmol/L) 262.5 ± 45.2 259.8 ± 53.6 0.87 
BMI (kg/m2) 31.2 ± 3.8 30.9 ± 4.2 0.81 
Total Body Fat Mass (kg) 27.3 ± 7.9 28.8 ± 7.4 0.55 
Total Fat Free Mass (kg) 56.9 ± 12 55.2 ± 9.5 0.61 
Total VAT Mass (kg) 9.1 ± 3.5 8.2 ± 2.2 0.32 
VO2peak (mL/min/kg) 22.5 ± 6.1 22.8 ± 4.5 0.86 
Sleep Onset 
Pre-Intervention (h) 
Post-Intervention (h) 
 
2317 ± 0.33 
2320 ± 0.20 
 
2301 ± 0.34 
2245 ± 0.03 
 
0.58 
0.37 
Awakening 
Pre-Intervention (h) 
Post-Intervention (h) 
 
0703 ± 0.03 
0657 ± 0.03 
 
0712 ± 0.90 
0634 ± 0.04 
 
0.52 
0.22 
Data are mean ± SD.  
*Significant difference between amEX and pmEX groups (p < 0.05). 
amEX: morning exercise group; pmEX: evening exercise group; T2DM: type 2 diabetes mellitus; HbA1c: 
glycosylated haemoglobin; HOMA2-IR: homeostatic model of insulin resistance; BMI: body mass index; 
VAT: visceral adipose tissue; VO2peak: peak oxygen consumption 
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Table 4-2. Changes in glycaemic control, insulin sensitivity and physiological measures from baseline to post-intervention for non-T2DM and 
T2DM individuals 
 
  Overall (n = 40)  T2DM (n = 20) 
  amEX 
(n = 20) 
pmEX 
(n =20) 
p – value  amEX 
(n = 10) 
pmEX 
(n =10) 
p – value 
Group x Time 
Effect 
Time 
Effect 
Group 
Effect 
 Group x Time 
Effect 
Time 
Effect 
Group 
Effect 
             
HbA1c (%) Week 0 6.85 ± 1.23 6.79 ± 1.66     7.91  ± 0.74 8.04  ± 1.44    
Week 12 6.58 ± 1.1 6.54 ± 1.46     7.34  ± 0.81 7.64  ± 1.35    
Change -0.27 ± 0.24 -0.25 ± 0.23     -0.57  ± 0.13 -0.4  ± 0.12    
 ES 0.23 0.16 0.79 < 0.01† 0.90  0.57 0.32 0.86 < 0.01† 0.79 
Fasting Glucose 
(mmol/L) 
Week 0 7.68 ± 1.70 8.28 ± 3.72     9.02  ± 1.33 10.32  ± 4.33    
Week 12 6.78 ± 1.45 7.10 ± 2.41     7.76  ± 1.33 8.52  ± 2.69    
Change -0.9 ± 0.68 -1.18 ± 1.40     -1.27  ± 0.75 -1.80  ± 1.77    
 ES 0.56 0.37 0.42 < 0.01† 0.55  0.91 0.53 0.39 < 0.01† 0.39 
Fasting Insulin 
(pmol/L) 
Week 0 88.34 ± 33.94 80.96 ± 29.74     81.75  ± 27.91 85.27  ± 24.58    
Week 12 64.47 ± 23.45 58.62 ± 22.07     62.57  ± 21.50 64.41 ± 18.92    
Change -23.87 ± 27.78 -22.35 ± 22.72     -19.18  ± 17.76 -20.85  ± 17.18    
 ES 0.8 0.83 0.85 < 0.01† 0.40  0.74 1.06 0.83 < 0.01† 0.79 
HOMA2-IR Week 0 1.78 ± 0.66 1.70 ± 0.71     1.74 ± 0.57 1.94 ± 0.7    
Week 12 1.26 ± 0.46 1.16 ± 0.45     1.28 ± 0.44 1.35 ± 0.4    
Change -0.52 ± 0.53 -0.54 ± 0.48     -0.46 ± 0.36 -0.59 ± 0.46    
 ES 0.9 0.9 0.92 < 0.01† 0.58  0.18 0.99 0.49 < 0.01†
* 0.54 
Fructosamine 
(µmol/L) 
Week 0 262.5 ± 45.2 259.8 ± 53.6     286.5 ± 44.6 287.9 ± 57.7    
Week 12 227.9 ± 77.8 230.2 ± 61.9     235.2 ± 108.5 267.9 ± 65.4    
Change -34.5 ± 78.9 -29.6 ±51.2     -51.3 ± 107.9 -20 ± 61.6    
 ES 0.53 0.5 0.70 < 0.01
†* 0.99  0.61 0.32 0.10 0.09 0.50 
Overall: combined results of non-T2DM and T2DM individuals; T2DM: only results of T2DM individuals 
 
†Significant difference between baseline and post-intervention (p < 0.05).  Data are mean ± SD.  
 
T2DM: type 2 diabetes mellitus; amEX: morning exercise group; pmEX: evening exercise group; HbA1c: glycosylated haemoglobin; HOMA2-IR: homeostatic model 
of insulin resistance; ES: effect size (Hedge’s g) 
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from 0.16 to 0.9 in the pmEX group. The HbA1c level was significantly (All p ≤ 0.002) 
correlated with FG (rp = 0.743), Fructosamine (rp = 0.511) and HOMA2-IR (rp = 0.346).  
Glycemic changes in the sub-cohort of individuals diagnosed with T2DM were assessed 
following the exercise training (Table 4-2). Similar to the overall cohort, there were no 
significant time by group interactions (all p ≥ 0.10), but significant improvements in HbA1c, 
FG, FI and HOMA2-IR after the 12-week intervention (main effect of time, all p < 0.01) were 
observed. Individual changes—identified by training group and T2DM status—in primary 
outcome measures (HbA1c, FG, FI, HOMA-IR) are presented in Figure 4-1. 
 
 
 
Figure 4-1. Individual changes in measures of glycaemic control and insulin sensitivity for both 
amEX and pmEX groups from baseline to post-intervention. : T2DM individuals (amEX); 
: non-T2DM individuals (amEX); : T2DM individuals (pmEX) and; : non-T2DM 
individuals (pmEX). 
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Anthropometric measures and cardiorespiratory fitness 
There were no significant time by group interaction effects observed in any measures of body 
anthropometrics (body weight, BMI, waist circumference, body fat and visceral adipose tissue 
mass; All p ≥ 0.27) or VO2 peak (p ≥ 0.36) (Table 4-3). There were, however, significant pre- 
and post-intervention improvements (main effect of time, p < 0.01) in VO2 peak and all 
anthropometric measures except FFM (p = 0.22; Table 4-3).   
 
Secondary Analysis: Assessing glycemic changes in ‘Responders’ and ‘non-responders’ 
To assess whether individuals demonstrating the greatest response to training were also those 
demonstrating the greatest improvements in glycemic control, data from all individuals were 
collapsed across groups (amEX T2DM and non-T2DM; pmEX T2DM and non-T2DM). 
Response to training was based on an increase in VO2 peak above 3.5 ml/min/kg (Figure 4-2A) 
and a decrease in total body fat (kg; ≥ 2.1 kg body fat; Figure 4-2B). While responders tended 
to demonstrate more consistent improvements (VO2 peak responders: g = 0.18-0.28, n = 23; total 
body fat responders: g = 0.16-0.46, n = 21) these did not reach statistical significance (All p ≥ 
0.19).      
 
Peripheral skin temperature responses 
There were no significant time (pre, post) by group (amEX, pmEX) interaction effects observed 
in any of the rhythmic parameters assessed in the overall cohort (All p ≥ 0.43; Fig 4-3). When 
changes in peripheral skin temperature were graphed (Figure 4-3), there appear to be divergent 
responses to the exercise intervention between ~0630h to ~1430h, with the peripheral skin 
temperature in the pmEX group tending to decrease during this time period and the peripheral 
skin temperature increasing in the amEX group. Statistical analysis however, did not confirm 
this observation in the overall cohort. However, when the rhythmic parameters in only the 
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T2DM cohort were assessed, a significant interaction effect was observed in the Acrophase 
parameter (Figure 4-3).     
 
Table 4-3. Changes in body anthropometrics and cardiovascular fitness from baseline to post-
intervention in both amEX and pmEX groups 
  amEX 
(n = 20) 
pmEX 
(n =20) 
p – value 
Group x Time 
Effect 
Time 
effect 
Group 
effect 
Body weight (kg) Week 0 84.3 ± 12.6 84.1 ± 14    
Week 12 82 ± 12.1 81.9 ± 13.5    
Change -2.3 ± 1.4 -2.2 ± 1.8    
 ES 0.18 0.16 0.99 < 0.01† 0.97 
BMI (kg/m2) Week 0 31.2 ± 3.8 30.9 ± 4.2    
Week 12 30.4 ± 3.7 30.1 ± 4.1    
Change -0.8 ± 0.3 -0.8 ± 0.7    
 ES 0.21 0.19 0.92 < 0.01† 0.80 
Waist circumference (cm) Week 0 101 ± 9.9 103.8 ± 11.6    
Week 12 97.6 ± 9.3 99.5 ± 11.9    
Change -3.4 ± 1.8 -4.3 ± 2.9    
 ES 0.35 0.36 0.27 < 0.01† 0.48 
Total fat-free mass (kg) Week 0 56.9 ± 12 55.2 ± 9.5    
Week 12 57.4 ± 11.6 55.6 ± 9.7    
Change 0.5 ± 2.7 0.4 ± 1.4    
 ES 0.04 0.04 0.97 0.22 0.60 
Total body fat mass (kg) Week 0 27.4 ± 8 28.8 ± 7.4    
Week 12 25 ± 8 26.3 ± 7.7    
Change -2.4 ± 1.6 -2.5 ± 1.5    
 ES 0.29 0.32 0.72 < 0.01† 0.59 
Total VAT mass (kg) Week 0 0.9 ± 0.3 0.8 ± 0.3    
Week 12 0.8 ± 0.3 0.7 ± 0.3    
Change -0.1 ± 0.1 -0.1 ± 0.01    
 ES 0.36 0.37 0.33 
 
< 0.01† 0.36 
VO2peak (ml/kg/min) Week 0 22.5 ± 6.1 22.8 ± 4.2    
Week 12 26.5 ± 5.8 26.9 ± 4.1    
Change 4 ± 1.7 4.1 ± 4.6    
 ES 0.66 0.88 0.89 < 0.01† 0.84 
Data are mean ± SD 
 
†Significant difference between baseline and post-intervention (p < 0.05) 
 
amEX: morning exercise group; pmEX: evening exercise group; BMI: body mass index; VAT: visceral 
Adipose Tissue; VO2peak: peak oxygen consumption; ES: effect size (Hedge’s g) 
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Figure 4-2. Individuals changes in VO2peak (2A) and body composition (2B) from baseline to 
post-intervention and comparison of changes in HbA1c, insulin resistance and fructosamine 
between responders (black column) and non-responders (grey column). 
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Figure 4-3. Changes in peripheral skin temperature from pre- to post-exercise training. Group 
mean data are presented in the top panels with difference (95% Confidence Intervals presented 
in the bottom two panels. Data are presented relative to the time of day (local time).   
 
The rhythmic parameters at the pre-intervention time-point, were compared between non-T2D 
and T2DM. There were no significant differences between these groups (T2DM; non-T2DM) 
in either the MESOR (non-T2DM: 33.56 ± 0.79°C; T2DM: 33.65 ± 0.78°C; p = 0.71), 
Amplitude (non-T2DM: 0.93 ± 0.55°C; T2DM: 1.06 ± 0.40°C; p = 0.36) or the Acrophase 
(non-T2DM: -112.65 ± 112.72; T2DM: -82.6 ± 64.86; p = 0.32). 
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4.5 Discussion 
The primary aim of this study was to determine the impact of diurnal timing of a multi-modal 
exercise program on glycemic control in previously sedentary, overweight individuals with and 
without T2DM. The main finding of this study was that 12-weeks of multi-modal exercise 
training in overweight T2DM and non-T2DM individuals resulted in significant improvements 
in measures of glycemic control (HbA1c; Fasting insulin and glucose; HOMA2-IR), an effect 
which was independent of whether the exercise was performed in the morning (amEX) or 
evening (pmEX). Similarly, significant improvements in body anthropometrics (body weight, 
BMI, waist circumference, total body fat mass, VAT mass) and cardiorespiratory fitness (VO2 
peak) were observed in response to the exercise training, but these responses were independent 
of exercise timing. In secondary analyses on responders and non-responders (according to 
changes in body-fat mass or VO2 peak), a non-significant trend (small-moderate effect size) was 
observed which favoured glycemic improvements in responders. A secondary aim of this study 
was to determine the effect of morning and evening exercise on the circadian rhythm of wrist 
skin temperature.  The results of this study were that three days per week of exercise performed 
either in the evening or in the morning over the 12 week period did not cause significant 
changes in the circadian rhythm of wrist temperature.        
 
Effect of exercise timing on glycemic control and insulin sensitivity  
Glycemic control incorporates both FG and PPG excursions and may be quantified by HbA1c 
levels, which together comprise the three components of the glucose triad (30). Accordingly, 
FG in the cohort recruited to this study explained 55% variance in the HbA1c levels. In response 
to the 12 week exercise intervention, significant improvements in FG (-1.04 mmol/L) and 
HbA1c (-0.26%) were observed, but there were no significant group by time interactions (Table 
2). This finding suggests that under free-living conditions with no additional lifestyle 
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modifications (e.g. diet), the diurnal timing of exercise training may not be an important 
variable to consider, at least in the short-medium term (12 weeks). These findings in the overall 
cohort were reflected in the T2DM cohort, albeit that improvements in individuals with T2DM 
were considerably greater (FG: -1.54 mmol/L; HbA1c: -0.45%). These improvements in HbA1c 
are in agreement with previous findings from meta-analyses in individuals with T2DM (mean-
weighted decrease in HbA1c from 0.66% to 0.80%; (31, 32)) and a longer-term (9 month), 
randomized controlled exercise intervention (within-group HbA1c change: -0.23%; (33)). 
Interestingly, the greatest within-group benefits in HbA1c (~0.29% reduction) for individuals 
randomized to the combination exercise group in the study by Church et. al. (33), was observed 
at the 12-16 week training period. With respect to the clinical findings in the current study, it 
is noteworthy that 8 individuals with T2DM achieved the <7% HbA1c recommendation (34) 
(pre-intervention: 2/20 individuals achieved recommendation; post-intervention: 10/18 
individuals achieved recommendation) and this was independent of the timing of exercise. 
 
Two additional markers of glycemia were included in the current study, the HOMA2-IR and 
fructosamine. Fructosamine is a short-term (1-3 weeks), non-specific marker of glycation, 
thereby complementing HbA1c values in short-medium term intervention trials (35). 
Specifically, fructosamine appears to be a useful marker for assessment of chronic kidney 
disease, both in individuals with and without T2DM (35). Exercise training had a significant 
effect on fructosamine levels in the overall cohort, reducing the concentration by 32.05 µmol/L, 
which is a magnitude similar to that approaching the difference between individuals with or 
without a history of diabetes (44.2 µmol/L). The HOMA2-IR was also included in the current 
study and used as a marker of insulin sensitivity (26, 28). The HOMA2-IR is particularly useful 
in individuals at risk of T2D, and the finding in the current study reflect this with significant 
improvements observed in the overall cohort (-0.53 mmol.L-1) and the largest magnitude 
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effects observed in this variable from pre- to post-intervention (g = 0.9). This change in the 
overall cohort largely reflects changes in insulin concentration.                
 
Effect of exercise timing on body anthropometrics and cardiovascular fitness 
There were no significant time by group interaction effects in any of the anthropometric 
measures or in the VO2 peak, indicating that under the current conditions, exercise timing was not 
shown to play a significant role in observed changes (Table 4-2). This is in contrast to results 
from Alizadeh et al (36), who showed significantly greater reductions in BMI and body weight 
after 6 weeks of exercise training (2 times per week) in the morning versus evening in 
overweight inactive females. The findings in Alizadeh may in part be explained by changes in 
caloric intake, with participants in the morning group reducing energy intake by a greater 
amount than participants in the evening group (Morning exercise: 362 kcal reduction from 
baseline; Evening exercise: 28 kcal reduction from baseline).  
 
There were significant main effects for time in the VO2peak response and all anthropometric 
measures except total fat-free mass (p = 0.22) in the current study. The observed improvements 
in body weight, waist circumference and body fat mass  were comparable to the improvements 
reported by Church et al. (33) after 9 months of multi-modal exercise in T2DM individuals. 
Using a combined exercise training program in T2DM individuals, Yavari et al. (37) reported 
similar reductions in BMI (-0.8 kg/m2) after 12-weeks. With regards to cardiorespiratory 
fitness, Park et al. (38) reported a significant improvement in VO2 peak (4.6 ml/kg/min) after a 
12 weeks combined exercise program in females with abdominal obesity, which were similar 
to the improvements in VO2peak observed in our study (amEX: 4.0 ml/kg/min; pmEX: 4.1 
ml/kg/min). These findings suggest combined exercise training is an effective tool for both the 
prevention and the management of T2DM, given that excess weight is an established risk factor 
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for T2D and the association between body fat accumulation and increased insulin resistance 
(39). It is noteworthy that the magnitude change in waist circumference and measures of fat 
mass (ES: 0.29 – 0.37) are greater than body weight (ES: 0.16 – 0.18) which can be attributed 
to the lack of change in total fat free mass (ES: 0.04). Additionally, improvements in VO2 peak 
allows for the reduction in the risk of cardiovascular disease (40), given that T2DM individuals 
between the age of 55 and 60 years have a 10-year CVD risk of 7-11% (41). 
 
The overall cohort were divided into responders and non-responders to the exercise program 
according to their improvements in VO2 peak and total body fat mass. The 3.5 ml/kg/min cut 
point was based on the associated 10-25% reduction in mortality risk for every 1MET 
(3.5kg/ml/min) increase in exercise capacity (40). The cut-point (-2.1 kg) to identify 
responders and non-responders for total fat mass over 12 weeks was calculated using the 
following assumptions: ~600 kcal were expended per session, ratio of fat loss and muscle loss 
was 70:30. These assumptions result in an approximate 250g weight loss (175g fat loss) per 
week. Direct comparison of these groups, demonstrates favourable glycemic improvements in 
responders versus non-responders, but these were not significantly different.           
 
Effect of exercise timing on circadian rhythm of skin temperature 
Changes in the circadian rhythm of skin temperature were assessed in response to the exercise 
intervention, with the hypothesis being divergent responses in the circadian rhythm of wrist 
skin-temperature. While a circadian rhythm in skin temperature was evident, the rhythm 
parameters assessed (MESOR, Amplitude, Acrophase) did not demonstrate a significant 
interaction effect (All p ≥ 0.43) or a main effect of time (All p ≥ 0.35). Findings from this study 
therefore suggest that three supervised exercise sessions per week of moderate intensity 
adopted in isolation (i.e., no other lifestyle intervention), are insufficient to significantly change 
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the circadian rhythm parameters as assessed by the cosinor function of wrist skin temperature 
collected over 7 days. It may be plausible that higher intensity exercise or greater duration of 
exercise may result in a shift in the circadian rhythm—given that circulating metabolites may 
alter cellular clocks (and vice versa (19, 23)) and greater intensity is expected to yield greater 
shifts in metabolites—however, it is more likely that consistent exercise (i.e., increased 
frequency from 3 sessions per week) performed at a set diurnal time more likely leads to 
circadian entrainment, although this is an area which requires further work. Further analysis 
comparing individuals with T2DM and without T2DM did not reveal significant differences in 
the circadian parameters, excluding Acrophase, despite prior research suggesting reduced 
amplitudes and elevated MESOR in the circadian rhythm of body temperature (measured via 
thermometer) in T2DM individuals versus individuals with pre-diabetes (42). In individuals 
with metabolic syndrome however, reduction in the amplitude of the circadian rhythm of wrist 
skin temperature was revealed to be associated with triglycerides (43) which explained 33% of 
the variability in amplitude. Unfortunately the current study did not measure triglyceride 
concentrations.  A plausible explanation for the significant group interaction (p = 0.01) 
observed for changes in Acrophase between the amEX and pmEX may be due to the changes 
in sleeping patterns associated with the T2DM individuals in each group, which is supported 
by the significant group interaction (p = 0.01) observed with the time component of circadian 
cycles presented. 
 
Strengths and Limitations 
The main strength of the study was implementation of a structured, supervised exercise training 
program comprising up to approximately 180 min per week of exercise in individuals with 
T2DM or at risk of developing T2DM. The multi-component (resistance training and aerobic 
training) exercise training program is associated with the greatest benefits glycemic benefits 
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(33), adheres with current guidelines (11) and allows modification of the FITT (frequency, 
intensity, type and time) principle to ensure individualisation (44). Research has shown that 
structured exercise durations of >150mins allowed for greater reductions in HbA1c when 
compared to durations of ≤150mins (-0.80% vs. -0.36%, respectively) (45). An additional 
strength of the study was that every exercise session throughout the training program was 
supervised. There is evidence that exercise supervision results in improved glycemic control 
and insulin sensitivity while unsupervised exercise leads to a decline in exercise compliance 
and glycemic control (46).  
 
While the study had a number of strengths, there were also limitations of the study. The main 
limitation of this study was the relatively small sample size and the absence of a no-exercise 
(non-active) control group. There is sufficient evidence demonstrating the benefits of exercise 
on glycemic control in individuals with T2DM (11) and therefore an active-control group is 
more appropriate, however, given the nature of the study aim (i.e. whether the timing of 
exercise is important), an appropriate comparator condition was challenging. Future research 
may seek to conduct a two-arm randomized controlled trial, where participants cross-over at 
the completion of the first stage (i.e., morning exercise for 12 weeks followed by evening 
exercise for 12 weeks). In addition, the size of the sample was not sufficient to allow sub-cohort 
analyses (i.e. four sub-groups: pmEX OW, pmEX T2DM, amEX OW, amEX T2DM) or 
explore individual differences more thoroughly using advanced multiple linear regression 
analyses. The absence of dietary control, and specifically controlling the diurnal timing of meal 
ingestion (beyond the postprandial-exercise requirement), may have masked the magnitude-
change observed. In order to minimise potential confounders within the study (i.e., not 
introducing additional requirements) participants were asked to maintain their usual dietary 
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habits, however, change in circadian rhythm may require a concerted effort on both diet and 
exercise.     
 
4.6 Conclusions 
This study showed that 12-weeks of multi-modal exercise training can improve glycemic 
control, cardiorespiratory fitness and body-composition in overweight individuals with and 
without T2DM. This improvement occurs independent of exercise timing (morning or evening) 
and without additional dietary restriction. Current evidence supports an important role for 
exercise volume (47) and exercise intensity (11) in improving glycemic control for individuals 
with T2DM, and a burgeoning body of literature suggests a role for the timing of exercise 
relative to meal ingestion (13-17) on glycemic control, however, the evidence does not 
currently support an important role for manipulating the diurnal timing of exercise. It is 
important to note that the circadian rhythm of skin temperature was not affected under the 
conditions adopted in the current study. It may therefore be necessary for future research to 
increase the volume of morning or evening exercise to determine whether exercise alone is 
sufficient to entrain the circadian rhythm and how this may impact glycemic control. 
Additionally, simultaneous manipulation of the timing of meals (beyond the meal immediately 
preceding exercise) with the timing of exercise may help entrain the circadian system and 
ultimately glycemic control. 
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    postprandial glucose responses: A 
    randomised controlled trial. 
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5.1 Abstract 
Postprandial exercise has been shown to improve postprandial glucose (PPG) response to a 
greater degree than preprandial exercise, suggesting an important, yet under-acknowledged 
role for exercise timing on glycaemic control. Despite this accumulating evidence, the diurnal 
impact of exercise performance on glycaemic control remains unknown. Purpose: This study 
aimed to determine the diurnal effect of exercise timing on PPG response in individuals 
enrolled into a 12-week supervised multi-modal exercise training program. Methods: Forty 
sedentary overweight individuals (17 males, 23 female; age: 51 ± 13 years; BMI: 30.9 ± 4.2 
kg/m2) with (n = 20) or without T2DM diagnosis were randomly allocated to either a morning 
(amEX) or evening (pmEX) exercise training group. All participants completed a 12-week 
supervised multi-modal exercise training program (3 days per week), which consisted of 30 
minutes of aerobic exercise (walking protocol) and 4 resistance-based exercises (3 sets of 12-
18 repetitions). The amEX and pmEX training sessions occurred between 0700-0900h and 
1700-1900h, respectively. Changes in postprandial glucose (PPG) and insulin (PPI) responses, 
along with incremental area under the curve (iAUC), during a mixed meal tolerance test 
(MMTT) were the primary outcome measures of the study and were assessed at baseline and 
post-intervention at 12 weeks. All data is displayed as mean differences ± SD. Results: 
Exercise training reduced (main effect of time, p < 0.01) PPG and PPI responses during the 
MMTT, with no group differences observed (all p ≥ 0.65).  Reductions in PPI iAUC (main 
effect of time, p < 0.01) were observed at post-intervention, with no group differences reported 
(p = 0.2) Conclusions: Irrespective of the diurnal timing of exercise performance, 12-weeks 
of multi-modal exercise training significant improved PPG and PPI responses in both 
overweight non-T2DM and T2DM individuals.  
 
Key Words: diabetes mellitus, postprandial, diurnal timing, multi-modal 
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Trial Registration: ANZCTR ACTRN12616001172493    
5.2 Introduction 
Skeletal muscle glucose uptake increases during and immediately after acute exercise via non-
insulin dependent pathways, and this can persist for up to 48 h following exercise via insulin 
dependent pathways (1). When exercise is performed close to carbohydrate ingestion the 
increased skeletal muscle glucose uptake can cause a decrease in systemic glucose 
concentration relative to no exercise taking place (2-5), although this is not always the case (6-
10) that the systemic glucose concentrations may remain stable or even be elevated by 
exercising close to carbohydrate intake are surprising. A number of detailed mechanistic 
studies have explored this issue and have shown that the increase in skeletal muscle glucose 
uptake (5, 10, 11) can be partly or fully compensated by an increase in endogenous glucose 
release (11) from the liver and an increased splanchnic release of exogenous glucose (10-13). 
The timing of exercise relative to meal ingestion has therefore become an area of interest (14-
16) which has culminated in a number of reviews (17-20) suggesting improved postprandial 
glucose (PPG) responses when exercise is performed in the postprandial period (≤30 min post-
ingestion). These acute benefits of postprandial exercise (2-5, 14, 16) have been shown to 
translate to longer-term improvements in glycemic control (20, 21) and PPG responses (22). 
 
Effective management of glycemia in individuals with type 2 diabetes mellitus (T2DM) 
requires maintenance of circulating glucose within tight limits which is achieved via reducing 
both fasting glucose (FG) as well as the PPG excursions (23). The importance of managing 
PPG excursions throughout the day in individuals with T2DM or individuals at risk of 
developing T2DM, are increasingly acknowledged (24-31). Given exercise improves 
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glycaemic management via direct effects on both FG and PPG (32), a principal 
recommendation for management of individuals with T2DM is to increase exercise volume 
(duration and frequency) (23), intensity—with due consideration—and adopt multiple exercise 
types (33). Lifestyle interventions, comprising both dietary and physical activity education in 
individuals at risk of developing T2DM (overweight with impaired glucose tolerance), have 
demonstrated a 58% relative risk reduction in developing T2DM compared to 31% reduction 
through medication (31), while a ‘physical-activity-only’ intervention, resulted in a 46% 
relative risk reduction in development of T2DM in an at-risk cohort has been observed (34). 
 
It is noteworthy the PPG response in prior research is classically assessed using a single meal 
(i.e., oral glucose tolerance test) and often using only a single time-point (e.g., 2 h post 
ingestion, (22)). However, the PPG response to one meal has been shown to be affected by 
prior food ingestion, such that the PPG response is blunted in a subsequent meal relative to the 
first meal (35-38). This response, coined the second meal phenomenon, is moderated by the 
composition of the meals (35), is evident in individuals with and without T2DM (35, 37, 39-
41) and whilst likely moderated by diurnal changes in insulin sensitivity, occurs in the morning 
and evening (42, 43). Additionally, the second meal phenomenon is acutely moderated by 
exercise performed in the postprandial state between the first and second meal (37, 44). 
Specifically, the PPG response to the second meal has been shown to increase when exercise 
was performed relative to no exercise, indicating the second meal phenomenon may be acutely 
reduced with exercise (37, 44).  
 
Given the associated benefits of exercise in individuals with T2DM (23) and individuals at-
risk of developing T2DM (34), the aims of the current study were to determine the effects of a 
12-week supervised exercise training program performed in the postprandial period on 
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glycemic control and the PPG response to two mixed-meal challenges. A second aim of this 
study was to determine the effect of conducting the exercise training at two different diurnal 
times (i.e., morning versus evening) on the habitual PPG response. We hypothesised that (i) 
the 12-week exercise training would improve glycemic control as measured by glycosylated 
haemoglobin (HbA1c), as well as the fasting glucose and PPG (measured by the glucose area 
under the curve, glucose-AUC); (ii) that the improvements in HbA1c would be more strongly 
associated with improvements in the total PPG response, than changes in fasting glucose; (iii) 
PPG and insulin responses would be improved to a greater degree in individuals performing 
the exercise training in the evening than compared to individuals performing the exercise 
training in the morning.   
 
5.3 Methods 
Experimental Design 
This single blind, parallel-group clinical trial in overweight individuals with or without T2DM 
was conducted between October 2016 and December 2017 at Murdoch University (Western 
Australia). Findings from the study are currently under review (45) and details of the study 
design have been previously published (Trial Registration: ANZCTR 
ACTRN12616001172493). 
 
Participants were randomly assigned to the morning (amEX) or evening (pmEX) training 
groups by an investigator (TF) using a unique study I.D. Specifically, a numbered list 
consisting of 1’s and 2’s was computer-generated using randomly permuted blocks (each block 
n = 2-6; http://www.randomisation.com) for males (with and without T2DM) and females (with 
and without T2DM). The final group allocation remained sealed in the envelope and revealed 
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only prior to the first training session by an independent individual (KM; blinded to the 
recruitment process). Recruitment for individuals with (n=20) and without T2DM (n=20) was 
closed when the respective numbers were achieved. Written informed consent was obtained 
from all participants prior to commencement of the study. All investigations were conducted 
according to the principles expressed in the Declaration of Helsinki, and the conduct of this 
study was approved by the Murdoch University Human Research Ethics Committee, Western 
Australia. The CONSORT checklist is available as supporting information (Appendix I) 
 
Study Participants 
Sedentary overweight males and females (defined as accrual of < 150min of exercise/week 
with a BMI ≥ 27kg/m2) between the ages of 18-65 years both with and without a T2DM 
diagnosis were eligible for participation in the study. Individuals were not eligible for this study 
if they were unable to complete exercise or have a condition which is known to be aggravated 
by exercise assessed using the Exercise and Sports Science Australia pre-exercise screening 
tool. In addition, the exclusion criteria included the use of insulin, having had surgery for 
weight loss, previous history of heart, lung, kidney, endocrine or liver disease and recent weight 
loss ≥ 4kg in previous month.  
 
Experimental Protocol 
Participants were assessed at baseline (Week 0) and post-intervention (Week 12). The primary 
outcome measures of the study were the changes in postprandial glucose (PPG) and insulin 
(PPI) responses. Specifically, the maximum (Max, represented by the peak), the range (Max – 
Min, where Min represents the nadir), the AUC (4-h, 2-h) and the incremental AUC for glucose 
and insulin were the variables of interest in response to ingestion of a mixed meal tolerance 
test (MMTT). To assess the relative contributions of PPG to glycaemic control, associations 
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between glycosylated haemoglobin (HbA1c), fasting glucose (FG) and the glucose-iAUC and 
glucose-AUC were analysed. Body anthropometrics and cardiovascular fitness were presented 
herein for descriptive purposes and secondary analyses comparing responders to non-
responders. All participants continued with their normal daily dietary intake and oral 
hypoglycaemic medications (T2DM individuals) while participating in the study. 
 
Exercise Intervention 
Participants from both conditions completed three individually supervised (trained exercise 
physiologist) exercise training sessions per week, for a total of 12 weeks, at the Strength and 
Conditioning laboratory in Murdoch University. Participants in both the amEX and pmEX 
groups completed their training sessions between 0800-1000h and 1700-1900h, respectively. 
Participants were required to consume a snack/meal at least 1 hour prior to the start of the each 
training session.  
 
Each training session consisted of both an aerobic (AER) and resistance (RE) exercise 
component, with an approximate session duration of 60 min. Each training session started off 
with the AER which was a walking protocol that was completed on a treadmill at 70% VO2max 
for 30 min. This intensity was prescribed in accordance to the American Heart Association 
scientific statement (46). Thereafter, participants performed four different RE involving the 
major muscle groups on both the weight machines and free weights (i.e. Leg press, Bench 
press, Military press and Lat-pulldown). Three sets of each exercise were performed at 45%, 
50% and 55% of 1RM for 18, 15 and 12 repetitions with 60s of rest in between sets during 
Week 1 – 4, Week 5 – 8 and Week 9 – 12; respectively. These training intensities has been 
shown to be effective in improving glycaemic control, with no adverse events being reported 
other than mild muscle soreness in obese and/or elderly diabetic patients (47).  
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Mixed Meal Tolerance Test Procedure 
Participants were requested to refrain from any physical activity 24h prior to the MMTT. After 
an overnight fast, participants arrived at the Murdoch University Exercise Physiology 
laboratory between 7:00am and 7:30am. Upon arrival, a venous catheter for was inserted into 
the forearm vein for blood sampling. Thereafter, participants were given a 4-h meal challenge 
(Meal 1 and Meal 2). The standardized meals provided during the MMTT were liquid 
SUSTAGEN® Diabetic beverages (1057kJ; 52% carbohydrate, 22% fat and 24% protein) 
containing approximately 25g of carbohydrate. Blood samples were collected for Meal 1 (0, 
15, 30, 45, 60, 90 and 120 min) and Meal 2 (130, 150, 165, 180, 195, 210, 225 240 min) for 
plasma glucose and insulin measurements (Appendix K) 
 
Biochemical Analyses 
The fasting blood samples collected prior to the ingestion of each 4-h meal challenge (pre-
training, post-training) were used to assess HbA1c via an independent, commercial pathology 
laboratory (Western Diagnostic Pathology, Perth, Western Australia). The assessment of 
glucose and insulin were conducted on plasma samples, which was separated by centrifugation 
at 1300 RCF (relative centrifugal force) for 10min immediately following blood collection and 
stored at -800C until analysis. Plasma glucose was measured using the COBAS analyser 
(COBAS Integra 400 plus, Roche Diagnostics Ltd, Switzerland). Plasma insulin (FI) was 
measured according to kit instructions using an enzyme-linked immunoassay (Mercodia; 
Uppsala, Sweden). 
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Body anthropometric and maximal oxygen consumption assessments 
Body mass was calculated using a calibrated electronic digital scale and body composition was 
measured using dual-energy X-ray absorptiometry (DXA) to assess total body fat mass (BF) 
and fat free mass (FFM). Waist circumference was measured on a horizontal plane at the 
narrowest point between the lower costal border (10th rib) and the uppermost lateral border of 
the iliac crest.  
 
Cardiorespiratory fitness (VO2max) was measured during a modified Bruce treadmill test 
protocol by breath-by-breath analysis of oxygen consumption and carbon dioxide production 
(ParvoMedics TrueOne 2400) as described previously (45). Attainment of VO2max was 
accepted when two of three criteria were met: (i) a plateau in VO2; (ii) a respiratory exchange 
ratio > 1.15 and/or; (iii) volitional exhaustion. 
 
Sample Size 
Prior to the commencement of the trial, we determined that a sample size of 34 participants 
would provide 80% power to detect a difference (Effect size, f = 0.25; repeated measures, 
within-between interaction) in PPG and glycaemic control where the α-error probability value 
was set at 0.05. To account for a potential attrition, the sample size of 40 was deemed to provide 
sufficient power to assess differences in these variables. The primary investigator of the study 
(ST), through public advertisements, recruited potential participants.  
 
Data Analysis 
Surrogate markers of muscle and liver insulin sensitivity were adopted using glucose and 
insulin concentrations (48). Muscle insulin sensitivity was calculated according to the slope 
(dG/dt) represented by the line of the least square fit from the peak to nadir glucose 
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concentration, divided by the mean plasma insulin concentration (herein calculated as: insulin-
AUC/time). Hepatic insulin sensitivity was calculated according to the glucose0-30AUC 
multiplied by the insulin0-30AUC.       
 
Secondary analysis of responders and non-responders were based on all participants (n=40). 
Participants were stratified into respective responder and non-responder categories according 
to changes in VO2 peak and body-fat. An increase in VO2 peak above 3.5 ml/min/kg and a decrease 
in total body fat (kg; ≥ 2.1 kg body fat) was used as the responder/non-responder cut-point as 
previously described (45). 
 
All statistical analyses were performed using SPSS (v.24, IBM, Chicago, IL, USA). Treatment 
effects were estimated using linear mixed models (LMM) to assess for any changes over time 
(pre- and post-intervention) in the primary and secondary outcome measures between the two 
intervention groups (amEX and pmEX). The hypothesis of interest was the group by time 
interaction (modelled as fixed effects; random intercept) which was examined with pairwise 
comparisons of the estimated marginal means. The magnitude of change for each outcome 
measure was reported using Hedge’s g, and interpreted as small (g = 0.2), moderate (g = 0.5) 
or large (g = 0.8) (49). Pearson bivariate correlations and hierarchical linear regression models 
(two-step) adopting both forced and stepwise methods of entry were used to explore 
associations of interest.  Statistical significance was set at p < 0.05. All data are presented as 
means ± standard deviation. 
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5.4 Results 
As previously reported (45), sedentary overweight males (n = 17) and females (n = 23) (age: 
51 ± 13 years; BMI: 30.9 ± 4.2 kg/m2) with (n = 20) or without T2DM diagnosis completed 
the study with no drop-outs or adverse events reported (Appendix J). No significant between 
group differences were reported at baseline for T2DM duration (amEX: 13 ± 1 y; pmEX: 13 ± 
2 y; p =.62), HbA1c (amEX: 6.9 ± 1.2 y; pmEX: 6. 8± 1.7 y; p =.89), HOMA-IR (amEX: 1.8 ± 
0.7 y; pmEX: 1.7 ± 0.7 y; p =.70), BMI (amEX: 31.2 ± 3.8 y; pmEX: 30.9 ± 4.2 y; p =.81), 
total body fat mass (amEX: 27.3 ± 7.9 y; pmEX: 28.8 ± 7.4 y; p=.55) or VO2 peak (amEX: 
22.5 ± 6.1 y; pmEX: 22.8 ± 4.5 y; p =.86). However, the amEX participants (57 ± 5 years) were 
older (p = .004) than pmEX (51 ± 13 years) participants at baseline. Adherence to the 12-week 
training intervention were similar for the amEX (32 ± 2 out of 36 sessions) and pmEX (31 ± 2 
out of 36 sessions) training groups. 
 
Changes in glycaemic control 
When the entire cohort (n=40) were analysed, significant main effects for time (All p<.01) 
were observed in HbA1c (pre to post change: amEX, -0.27 ± 0.24%; pmEX, -0.25 ± 0.23%), 
FG (pre to post change: amEX, -0.9 ± 0.68 mmol/L; pmEX, -1.18 ± 1.40 mmol/L) and FI (pre 
to post change: amEX, -23.87 ± 27.78 ρmol/L; pmEX, -22.35 ± 22.72 ρmol/L). There were 
however, no significant differences between groups (group x time interaction: All p ≥ 0.42).    
 
When only individuals with T2DM (n = 20) were analysed, the response was similar to the 
entire cohort, with the exception that the magnitude of improvement was greater. Specifically, 
s significant main effects for time (All p<.01) were observed in HbA1c (pre to post change: 
amEX, -0.57 ± 0.13%; pmEX, -0.4 ± 0.12%), FG (pre to post change: amEX, -1.27 ± 0.75 
mmol/L; pmEX, -1.80 ± 1.77 mmol/L) and FI (pre to post change: amEX, -19.18 ± 17.76 
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ρmol/L; pmEX, -20.85 ± 17.18 ρmol/L). There were however, no significant differences 
between groups (group x time interaction: All p ≥ 0.39). 
 
 
Postprandial Glucose and insulin responses 
Postprandial glucose responses are presented in Figure 5-1, with the raw data and outcomes of 
data analyses in Table 5-1. Overall, significant reductions in PPG concentrations (main effect 
of time, all p < 0.01) were observed in the postprandial period following the training 
intervention, with moderate effects in the maximum PPG response and total AUC for both 
amEX (maximum PPG: g = 0.47; 4-h AUC: g = 0.46) and pmEX (maximum PPG: g = 0.39; 
4-h AUC: g = 0.43) identified. These effects were moderate-large when only the T2DM cohort 
were assessed (amEX: g = 0.62, g = 0.51; pmEX: g = 0.75, g = 0.71; maximum PPG, 4-h AUC, 
respectively). There were no time by group interactions reported in any primary outcome 
measure (all p ≥ .13).  
 
Postprandial insulin responses are presented in Figure 5-1 and the raw data and outcomes of 
data analyses in Table 5-2. Overall, significant reductions in PPI concentrations (main effect 
of time, all p ≤ 0.02) were observed in the postprandial period following the training 
intervention, with magnitude of effect across all reported insulin variables ranging from g = 
0.35 to g = 0.76 for both amEX and pmEX training groups. The primary variable of interest, 
AUC-insulin demonstrated moderate to large effects in both amEX (Overall cohort: g = 0.76; 
T2DM cohort: g = 0.87) and pmEX groups (Overall cohort: g = 0.63; T2DM cohort: g = 0.60). 
There were no time by group interactions reported in any primary outcome measure (all p ≥ 
.84).  
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Figure 5-1. Changes in postprandial glucose and insulin during the 4-h mixed meal tolerance 
test for non-T2DM and T2DM individuals
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Table 5-1. Changes in PPG responses from baseline to post-intervention for the overall cohort (non-T2DM and T2DM) and T2DM only. 
  Overall (n = 40)  T2DM (n = 20) 
  amEX 
(n = 20) 
pmEX 
(n =20) 
 p – value  amEX 
(n = 10) 
pmEX 
(n =10) 
 p – value 
 Time 
Effect 
Group 
Effect 
Group 
Interaction 
  Time 
Effect 
Group 
Effect 
Group 
Interaction 
               
Maximum PPG 
(mmol/L) 
Week 0 10.74 ± 2.66 11.35 ± 4.63      13.07 ± 1.48 14.81 ± 3.41     
Week 12 9.58 ± 2.21  9.69 ± 3.56      11.2 ± 0.86 12.44 ± 2.55     
Change -1.16 ± 1.36 -1.66 ± 1.44  < 0.01† 0.72 0.36  -1.87 ± 1.17 -2.37 ± 2.27  < 0.01† 0.22 0.56 
∆ Max-Min PPG 
(mmol/L) 
Week 0 3.18 ± 1.25 3.33 ± 1.85      4.09 ± 1.08 4.51 ± 1.87     
Week 12 2.77 ± 0.96 2.91 ± 1.4      3.06 ± 0.56 3.87 ± 1.19     
Change -0.41 ± 1.12 -0.42 ± 1.28  0.04† 0.72 0.98  -1.03 ± 1.01 -0.64 ± 1.52  0.01† 0.25 0.53 
4-h AUC 
(mmol/L/min) 
Week 0 9.41 ± 2.35 10.12 ± 4.21      11.31 ± 1.46 13.3 ± 3.77     
Week 12 8.39 ± 1.95 8.5 ± 3.17      9.9 ± 0.85 10.8 ± 2.89     
Change -1.02 ± 0.98 -1.62 ± 1.52  < 0.01† 0.68 0.15  -1.41 ± 1.05 -2.5 ± 1.68  < 0.01† 0.22 0.11 
2-h AUC  
Meal 1 
(mmol/L/min) 
Week 0 10.04 ± 2.51 10.68 ± 4.53      12.12 ± 1.42 14.1 ± 4.08     
Week 12 8.98 ± 2.13 9.15 ± 3.38      10.61 ± 0.91 11.65 ± 2.99     
Change -1.06 ± 1.1 -1.53 ± 1.63  < 0.01† 0.7 0.32  -1.51 ± 0.90 -2.45 ± 1.87  < 0.01† 0.23 0.22 
2-h AUC  
Meal 2 
(mmol/L/min) 
Week 0 9.49 ± 2.43 10.33 ± 4.26      11.38 ± 1.73 13.55 ± 3.83     
Week 12 8.43 ± 1.95 8.48 ± 3.21      9.95 ± 1.06 10.79 ± 1.51     
Change -1.06 ± 1.02 -1.85 ± 1.57  < 0.01† 0.65 0.07  -1.43 ± 1.19 -2.76 ± 1.73  < 0.01† 0.22 0.07 
4-h iAUC 
(mmol/L) 
Week 0 390 ± 237 456 ± 367      504 ± 258 657 ± 312     
Week 12 378 ± 198 308 ± 192      441 ± 179 475 ± 191     
Change -11.86 ± 211 -88.4 ± 268  0.21 0.68 0.34  -62.53 ± 281 -181 ± 324  0.11 0.31 0.42 
2-h iAUC  
Meal 1 
(mmol/L) 
Week 0 226 ± 121 254 ± 173      289 ± 127 367 ± 173     
Week 12 226 ± 113 228 ± 117      265 ± 96 295 ± 113     
Change No change -26.18 ± 145  0.56 0.7 0.54  -23.64 ± 154 -72.28 ± 178  0.24 0.27 0.54 
2-h iAUC  
Meal 2 
(mmol/L) 
Week 0 176 ± 130 217 ± 150      232 ± 149 312 ± 158     
Week 12 162 ± 96 152 ± 87      189 ± 94 196 ± 91     
Change -13.68 ± 117 -66.98 ± 140  0.06 0.66 0.21  -45.52 ± 156 -116 ± 169  0.05 0.36 0.35 
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Overall: combined results of non-T2DM and T2DM individuals; T2DM: only results of T2DM individuals. Data are mean ± SD. †Significant difference between baseline and 
post-intervention (p < 0.05). T2D: type 2 diabetes mellitus; amEX: morning exercise group; pmEX: evening exercise group; HbA1c: glycosylated haemoglobin; PPG: 
postprandial glucose; AUC: area under the curve (values above absolute zero); iAUC: incremental area under the curve (values above baseline value). 
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Table 5-2. Changes in the PPI responses to meal ingestion from baseline to post-intervention for the overall cohort (non-T2DM and T2DM) and 
T2DM only. 
  Overall (n = 40)  T2DM (n = 20) 
  amEX 
(n = 20) 
pmEX 
(n =20) 
 p – value  amEX 
(n = 10) 
pmEX 
(n =10) 
 p – value 
 Time 
Effect 
Group 
Effect 
Group 
Interaction 
  Time 
Effect 
Group 
Effect 
Group 
Interaction 
               
Average PPI 
(pmol/L) 
Week 0 344 ± 89 303 ± 76      333 ± 89 290 ± 81     
Week 12 243 ± 63 206 ± 59      230 ± 50 193 ± 50     
Change -101 ± 111 -97 ± 120  < 0.01† 0.32 0.90  -103 ± 62 -97 ± 169  < 0.01† 0.46 0.92 
Maximum PPI 
(pmol/L) 
Week 0 501 ± 240 432 ± 269      501 ± 249 409 ± 305     
Week 12 371 ± 146 309 ± 165      342 ± 152 268 ± 132     
Change -130 ± 157 -123 ± 206  < 0.01† 0.3 0.92  -159 ± 117 -141 ± 296  < 0.01† 0.37 0.86 
∆ Max-Min PPI 
(pmol/L) 
Week 0 315 ± 211 268 ± 204      320 ± 242 239 ± 248     
Week 12 250 ± 129 204 ± 147      217 ± 130 152 ± 127     
Change -65 ± 150  -64 ± 181  0.02† 0.37 0.98  -103 ± 139 -87 ± 254  0.06 0.37 0.87 
Maximum PPI 
Increment 
(pmol/L) 
Week 0 395 ± 225 344 ± 254      420 ± 244 308 ± 295     
Week 12 307 ± 143 250 ± 153      279 ± 155 202 ± 124     
Change -88 ± 154 -94 ± 197  < 0.01† 0.36 0.93  -141 ± 107 -106 ± 273  0.02† 0.31 0.73 
4-h PPI AUC 
(pmol/L/min) 
Week 0 230.23 ± 104.8 199.75 ± 109.38      227.82 ± 92.45 201.21 ± 124.18     
Week 12 165.66 ± 54.65 133.23 ± 97.14      157.81 ± 57.2 125.65 ± 115.38     
Change -64.57 ± 75.65 -66.52 ± 28.91  < 0.01† 0.3 0.92  -70.01 ± 45.22 -75.56 ± 29.83  < 0.01† 0.22 0.76 
4-h PPI iAUC 
(pmol/L/min) 
Week 0 164 ± 95.34 136.45 ± 63.61      166.5 ± 85.9 133.48 ± 50.74     
Week 12 117.25 ± 53.55 91.99 ± 56.11      110.88 ± 55.58 84.36 ± 46.12     
Change -46.75 ± 79.28 -44.46 ± 18.86  < 0.01† 0.2 0.90  -55.62 ± 37.36 -49.12 ± 19.13  < 0.01† 0.36 0.65 
Overall: combined results of non-T2DM and T2DM individuals; T2DM: only results of T2DM individuals. Data are mean ± SD. †Significant difference between baseline and 
post-intervention (p < 0.05). T2DM: type 2 diabetes mellitus; amEX: morning exercise group; pmEX: evening exercise group; PPI: postprandial insulin; iAUC: incremental 
area under the curve. 
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No significant interaction (time x group; where group = amEX or pmEX) was found in any of 
the surrogate markers of insulin sensitivity (muscle or hepatic insulin sensitivity). However, 
consistent with the raw glucose and insulin results there was a significant improvement in 
hepatic insulin sensitivity associated with the exercise training intervention for the overall 
cohort (amEX: g = 1.05; pmEX: g = 0.82), individuals with T2DM (amEX: g = 1.35; pmEX: 
g = 1.16) and individuals without T2DM (amEX: g = 0.80; pmEX: g = 0.57) (All p ≤ .01), 
however, no improvements were observed in muscle insulin sensitivity in any groups (All p ≥ 
.14), albeit the pmEX training was associated with greater effects than the amEX training 
(Overall cohort; amEX: g = 0.11; pmEX: g = 0.27).       
 
There was an observed second meal phenomenon with the iAUC response to meal 2 (196.6 ± 
143.2 mmol/L.120min) being smaller (p <.01) than the response to the first meal (240.3 ± 150.4 
mmol/L.120min) in the overall cohort. This phenomenon persisted post-training (Meal 1: 227.5 
± 115.6 mmol/L.120min; Meal 2: 156.3 ± 92.3 mmol/L.120min; p ≤ .01) and occurred in both 
T2DM (Meal 1: 226.8 ± 113.4 mmol/L.120min; Meal 2: 162.5 ± 96.3 mmol/L.120min; p ≤ 
.01) and non-T2DM (Meal 1: 228.3 ± 117.8 mmol/L.120min; Meal 2: 156.3 ± 87.5 
mmol/L.120min; p ≤ .01) cohort.  
 
Associations between HbA1c, FG and PPG 
Significant associations (All n = 80; pre- and post-training) between HbA1c and FG (r = .741), 
HbA1c and 4-h glucose AUC (r = .842) and HbA1c and iAUC (r = .551) were observed. 
Regression modelling revealed the best predictor of HbA1c was the 4-h glucose AUC value 
(Adjusted r2 = .705). Addition of FG with either the 4-h glucose AUC (Adjusted r2 = .702) or 
4-h glucose iAUC (Adjusted r2 = .690) did not significantly improve either fit (F change 
associated with addition of FG to the regression model between HbA1c and 4-h AUC: p = .723). 
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The 2-h glucose AUCs from meal 1 (r = .853) and meal 2 (r = .823) demonstrated similar 
correlations with HbA1c as compared with the 4-h glucose AUC. 
 
Improvements in HbA1c (All n = 40; pre-training subtract post-training) were associated with 
improvements in the 4h glucose AUC (r = .470) and FG (r = .469). When changes in HbA1c 
were compared with changes in the 2-h glucose AUC for meal 1 (r = .480) and 2 (r = .436), the 
responses were similar.            
 
Glycaemic outcomes in responders and non-responders 
While responders tended to demonstrate more consistent improvements (VO2 peak responders: 
g = 0.33-1.16, n = 23; total body fat responders: g = 0.46-0.67, n = 21; across stated glycaemic 
measures) versus non-responders (VO2 peak non-responders: g = 0.48-0.65, n = 17; total body 
fat non-responders: g = 0.34-0.68, n = 19) these did not reach statistical significance (All p ≥ 
0.21) (Figure 5-2A and 5-3A). However, with T2DM individuals, there were no significant 
differences across stated glycaemic measures (All p ≥ 0.27) between responders (VO2 peak 
responders: g = 0.49-0.76, n = 12; total body fat responders: g = 0.62-0.71, n = 14; across 
stated glycaemic measures) and non-responders (VO2 peak non-responders: g = 0.65-0.92, n = 
8; total body fat non-responders: g = 0.7-0.74, n = 6) (Figure 5-2B and 5-3B). 
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Figure 5-2. Individuals changes in body composition for both the overall (n = 40; 2A) and T2DM (n = 20; 2B) cohort from baseline to post-
intervention and comparison of changes in 4-h PPG AUC (postprandial glucose area under the curve), 2-h PPG AUC for Meal 1 and Meal 2 and 
4-h PPI (postprandial insulin) AUC responses between responders (black column) and non-responders (grey column). 
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Figure 5-3. Individuals changes in VO2peak for both the overall (n = 40; 3A) and T2DM (n = 20; 3B) cohort from baseline to post-intervention and 
comparison of changes in 4-h PPG AUC (postprandial glucose area under the curve), 2-h PPG AUC for Meal 1 and Meal 2 and 4-h PPI 
(postprandial insulin) AUC responses between responders (black column) and non-responders (grey column). 
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5.5 Discussion 
The main findings of this study were i) 12-weeks of multi-modal exercise training resulted in 
significant improvements in glycaemic control (HbA1c) along with significant improvements 
in PPG (glucose-AUC) and PPI (insulin-AUC) responses; ii) HbA1c and glucose-AUC were 
more strongly correlated than HbA1c and FG overall, however, the improvements in HbA1c 
were associated to a similar extent with improvements in FG and glucose-AUC; iii) under the 
current free-living conditions, there appeared to be no benefit in performing the exercise in the 
morning or evening on any glycaemic outcomes measured; iv) the second meal phenomenon 
was observed in both the overall and T2DM cohorts, and was preserved post-training with no 
apparent effect of exercise timing (morning versus evening) on this response. Consistent with 
previous research and in accordance with our hypotheses, the adopted 12-week exercise 
training program was sufficient to significantly improve HbA1c levels and the postprandial 
glucose response. In contrast to our hypotheses, improvements in HbA1c were similarly 
correlated with improvements in glucose-AUC and FG, while the glycaemic benefits occurred 
independent of the timing of exercise.  
 
The postprandial benefits resulting from exercise training were a 2.0 mmol/L and a 0.7 mmol/L 
decrease in glucose concentrations over the 4-h study period in individuals with T2DM and 
without T2DM, respectively. Unsurprisingly, the improvements in insulin (4-h AUC g = 0.60–
0.87) were greater than those observed with glucose (4-h AUC g = 0.43–0.71), wherein insulin 
concentrations were reduced by 100.1 ρmol/L and 98.2 ρmol/L over the 4-h study period in 
individuals with and without T2DM, respectively. The similar insulin responses to the exercise 
training in individuals with T2DM and without T2DM suggests both the presence of some level 
of insulin resistance in individuals without T2DM in this cohort, and highlights the continued 
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responsiveness in those with T2DM in the current cohort. These observations are supported by 
changes in the surrogate measures of insulin sensitivity adopted herein. Specifically, the 
hepatic insulin sensitivity was significantly improved in response to training in both the non-
T2DM and T2DM cohorts, and this occurred independent of the timing of exercise. The lack 
of change in insulin sensitivity, according to the adopted measure, was surprising given we 
anticipated a greater change in muscle insulin sensitivity than hepatic insulin sensitivity. 
However, it accords with the observed improvements in fasting glucose. A plausible 
explanation may relate to the intensity of exercise not being sufficient to stimulate the 
necessary metabolic or molecular changes required to up-regulate insulin sensitivity, despite 
the exercise intensity meeting current guidelines (23, 33).   The significant postprandial benefits 
associated with the exercise training program occurred independent of the timing of exercise. 
The lack of effect associated with the exercise-timing is contrary to our hypothesis, however, 
as indicated in our previous study (45), this hypothesis was underpinned by proposed changes 
in the circadian rhythm, which was not observed (as measured by peripheral temperature) in 
the current study. 
 
Ketema et al. (50) systematically reviewed the correlations between FG and PPG with HbA1c 
and concluded that PPG (r = 0.68) had a closer association with HbA1c than FG (r = 0.61). 
Within these associations, the relative contributions of PPG and FG vary according to HbA1c 
levels (glycaemic control), with greater contributions from PPG when HbA1c levels < 7.3% 
(i.e., good control; ~70% contribution from PPG) and greater contributions from FG when 
HbA1c levels >10.2% (i.e., poor control; ~70% contribution from FG) (41, 51). These support 
the associations observed in our cohort (HbA1c levels ~6.8%), wherein the 4-h glucose AUC 
was more strongly correlated with HbA1c (r = 0.84) than FG (r = 0.74) although both were 
significant, explaining 71% and 55% of the variance in HbA1c, respectively. These associations 
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are stronger than those reported in the meta-analysis of Ketema et al. (50), which included 
studies in individuals with T2DM (n = 11) and studies recruiting both T2DM and type 1 
diabetes (n = 3). The strong association between HbA1c and the AUC-glucose in the current 
study is likely to be associated with the adopted test-meal (mixed-meal), given the association 
between HbA1c and the 4-h glucose AUC was similar to the 2-h glucose AUC (r = 0.85). In 
contrast to previous observations of an increased contribution of PPG response to [excess] 
hyperglycaemia in subsequent meals (41), we found similar associations between the PPG 
response in meal 1 and meal 2. However, the analysis, meal composition and time-interval 
(each meal separated by 4 hours) were quite different between studies and likely explain this 
difference. The multiple linear regression models suggested there was no benefit of combining 
FG with either the glucose-iAUC or glucose-AUC in the current study, although given the 
strength of the existing associations this may not be completely surprising. In contrast to our 
stated hypothesis, the improvement in HbA1c demonstrated similar associations between 
improvements in FG (r = 0.46) and the glucose-AUC (r = 0.47).   
 
In accordance with expectations of the second meal phenomenon, and despite the relatively 
short interval between eating occasions, the glucose response to the second meal (glucose-
AUC) was significantly blunted. The circadian pattern in glucose tolerance has long been 
acknowledged (52), with a general worsening of tolerance (i.e., exaggerated glucose AUC) in 
the late afternoon and evening, culminating in a characteristic rise in circulating glucose during 
the early morning period (i.e. dawn phenomenon) in individuals with T2DM (53-55). 
Superimposed on this circadian rhythm, is the second meal phenomenon, which is presumed to 
be associated with changes in the gastric emptying rate (i.e., slowed following the first meal), 
or an altered plasma metabolic or endocrine milieu following the previous meal (37). While 
acute exercise has been shown to affect the second meal response (37, 44), the findings of the 
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current study are that this response appears to remain unaffected (relative to the first PPG meal 
response) following a 12-week exercise training program.  
 
To assess whether individuals demonstrating the greatest response to training were also those 
demonstrating the greatest improvements in glycaemic measures (4-h glucose AUC, Meal-1 
2h glucose AUC, Meal-2 2h glucose AUC, 4-h insulin AUC), data from all individuals were 
collapsed into two categories (responders and non-responders). These categories were based 
on changes in VO2 peak and body-fat, wherein an increase in VO2 peak above 3.5 ml/min/kg and 
a decrease in total body fat (kg; ≥ 2.1 kg body fat) was the responder/non-responder cut-point 
(45). While responders tended to demonstrate more consistent improvements (VO2 peak 
responders: g = 0.33-1.16, n = 23; total body fat responders: g = 0.46-0.67, n = 21; across 
stated glycaemic measures) versus non-responders (VO2 peak non-responders: g = 0.48-0.65, n 
= 23; total body fat non-responders: g = 0.34-0.68, n = 21) these did not reach statistical 
significance (All p ≥ 0.29).  
 
The main strength of the study were the implementation of a multimodal, supervised exercise 
training protocol and the adoption of a 4 h study period comprising two separate, mixed-meals. 
The different components of the exercise training program allow for optimal beneficial effects 
of exercise for the management of glycaemic control based on the strategic manipulation of the 
FITT (frequency, intensity, type and time) principle (56). The total duration of exercise 
performance per week in this study was approximately 180 min, which is expected to achieve 
greater reductions in HbA1c levels when compared to durations of ≤150mins (-0.80% vs. -
0.36%, respectively) (57). The multi-modal exercise protocol has been shown to result in 
greater improvements in HbA1c as compared to aerobic and resistance exercise performed 
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individually (58), while supervision has been identified as being important to improve 
adherence (59).  
 
The main limitations of this study were the relative small sample size and the absence of a 
sedentary control group. These factors were attributed to the difficulty in recruiting T2DM 
individuals that were able and willing to participate in the intervention for a period of 12 weeks. 
An increase in sample size would have allowed additional sub-cohort analyses (i.e. four sub-
groups: pmEX OW, pmEX T2DM, amEX OW, amEX T2DM) or to explore individual 
differences more thoroughly using advanced multiple linear regression analyses, particularly 
given the main outcome measure of glucose control. As previously identified (45), the absence 
of a more rigid dietary control, and specifically controlling the diurnal timing of meal ingestion 
(beyond the postprandial-exercise requirement), may have masked the magnitude-change 
observed. It is however important to note, the impetus behind inclusion of a morning and 
evening exercise training protocol was to identify whether the timing of exercise was important 
for glucose control. While the study did not specifically control dietary intake, which can post 
Hoc be identified as a limitation, we adopted a pragmatic study design, specifically whether 
the diurnal-timing of exercise of three supervised exercise training sessions per week over 12 
weeks were important. Based on the findings herein, we can conclude that the exercise training 
resulted in significant improvements in glycaemic control and PPG responses, but that without 
additional dietary controls, the diurnal timing of exercise did not moderate this relationship.    
 
5.6 Conclusions 
The 12-week multi-modal exercise training program adopted in the present study  was effective 
in improving PPG and PPI responses to ingestion of a mixed meal in both T2DM and non-
T2DM individuals. These improvements occurred independent of exercise timing (morning or 
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evening), suggesting that the diurnal timing of exercise performance may not be a significant 
factor in improving glycemic control. While the second meal phenomenon was observed, the 
PPG improvements were similar between the first and second meal. Given the importance of 
exercise intensity (60) in increasing insulin sensitivity, and the likely importance of frequency 
or routine in altering circadian patterns (61), it may be prudent for future research to increase 
the intensity and frequency (i.e., 5 sessions per week) of exercise sessions to comprehensively 
exclude a role for diurnal timing of exercise in altering glycemic control. The strong association 
between improvements in HbA1c and PPG-AUC evident in the present study supports the 
importance of addressing both FG and PPG, in order to better improve glycemic control for 
both T2DM individuals and individuals who are at risk of developing T2DM (62). Three 
supervised exercise sessions per week performed either in the morning or in the evening were 
equally as effective in improving FG, PPG and overall glycemic control in just 12 weeks in 
individuals with T2DM and at risk of developing T2DM.    
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Chapter 6  General Discussion 
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6.1 Conclusions 
Obesity is considered the single most imperative risk factor for the development of type 2 
diabetes mellitus (T2DM) (1). The classical progression from obesity to T2DM is characterised 
by overlapping manifestations of insulin resistance, hyperinsulinemia, hyperglycaemia, 
dyslipidaemias and inflammation (2). With the global prevalence of obesity and DM estimated 
at 650 and 415 million respectively (3), along with the economic burden associated with both 
conditions, they are considered a major health problem of pandemic proportions. Management 
of T2DM requires the maintenance of tight glycaemic control as measured by glycosylated 
haemoglobin (HbA1c) levels of <7% (4). In addition, a United Kingdom Prospective Diabetes 
Study (5) showed that for every 1% reduction in HbA1c level resulted in significant reductions 
in the risk of diabetes related complications for T2DM individuals. Management of individuals 
identified as overweight or obese includes achieving a body mass index (BMI) of < 25kg/m2 
which has been shown to reduce the risk of T2DM by approximately 50-75% (6). 
 
Exercise training is an important adjunct in the prevention of T2DM (7) and a principal 
recommendation within glycaemic control management guidelines of T2DM (8). Despite the 
universal acknowledgement of exercise being a cornerstone of T2DM prevention and 
management, the importance of exercise timing and its influence on glycaemic control has only 
been recently considered. This is surprising, given i) the extensive research in the sports 
nutrition literature concerning the optimal timing of energy intake and macronutrient content 
for performance (before, during and after) (e.g., (9)); ii) “ the best time of day to exercise” is 
often discussed and debated in popular media (e.g., https://www.webmd.com/fitness-
exercise/features/whats-the-best-time-to-exercise#1).  
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From a clinical perspective, the association between the timing of exercise and meal 
consumption has only been recently identified to potentially having an important role in 
maintaining glycaemic control (10-13). The current position statement by the American 
Diabetes Association (ADA) includes reference to differences in glycaemic control when 
exercise is performed in the fasted, pre-prandial or postprandial state (14). Furthermore, recent 
findings have indicated that postprandial exercise appears to result in greater improvements in 
glycaemia as compared to pre-prandial exercise (10-12). More importantly, there is limited 
research that have explored the potential association between exercise and diurnal time on 
glycaemic control, given the acknowledgement of a circadian rhythm that exist with diurnal 
glucose fluctuations (15).  
 
Despite existing evidence suggesting an important role for exercise timing relative to meal 
ingestion, these have not been systematically reviewed for individuals with T2DM. In addition, 
and to the best of our knowledge, the importance of diurnal exercise timing playing a critical 
role in glycaemic control has not been previously investigated. Therefore, the overreaching aim 
of this thesis was to identify the impact of exercise timing, in relation to both meal ingestion 
and diurnal time, on glycaemic control and associated outcomes in individuals with T2DM and 
individuals at risk of T2DM from both an acute and chronic perspective. 
 
To this end, we first sought to systematically review the literature examining the effect of 
exercise timing relative to meal ingestion on glycaemic control in individuals with T2DM 
(Chapter 2) and the effects of diurnal exercise timing on glycaemic control in individuals with 
T2DM (Chapter 3). Despite having insufficient evidence to directly compare the benefits of 
exercise performance in the pre-prandial and postprandial periods on acute glycaemia and long-
term glucose control, comparing outcomes between studies in Chapter 2 showed that the 
 138 
 
performance of postprandial exercise 30-60 minutes after meal consumption appeared to result 
in more consistent improvements on acute glycaemia as compared to pre-prandial exercise. 
Indeed, pre-prandial exercise was sometimes associated with elevations in the glucose area 
under the curve, if the meal was ingested close to exercise performance (16).  This is likely due 
to the combination of increased free fatty acids in circulation when exercise is performed in 
the fasted (or pre-prandial) state, which is known to decrease insulin sensitivity (17); increased 
glucose output from the liver and concerted increase in hepatic gluconeogenesis (18) and 
increased rate of exogenous glucose uptake from the splanchnic region (18).  
 
With respect to the importance of diurnal exercise timing on glycaemic control in individuals 
with T2DM, there was insufficient evidence to support a role for either morning or evening 
exercise. In spite of the mechanistic rational for an optimal exercise-time from research 
conducted in exercise and circadian clock literature (19-22), there were no studies which had 
previously investigated this question. As such, clinical relevance of the diurnal timing of 
exercise performance remained to be explored.  
 
Based on the aforementioned systematic reviews, it is clear that the importance of exercise 
timing in the management of glycaemic control has not been unequivocally established. Given 
the indirect evidence on exercise timing relative to meal ingestion was strong, yet the evidence 
behind the diurnal timing of exercise on glycaemic control was absent, we decided to assess 
the effects of a medium-term (12-week) multi-modal exercise-training program, which was 
performed either in the morning or evening on longer-term glycaemic control (Chapter 4) and 
changes in postprandial glucose (PPG) responses (Chapter 5). In accordance with current best-
evidence, we implemented the training during the postprandial period. The findings from 
Chapter 4 and Chapter 5 indicate that, irrespective of the diurnal timing of exercise 
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performance, 12-weeks of multi-modal exercise training is an effective strategy for improving 
long term glycaemic control. The potential temporal optimization of exercise prescription via 
the manipulation of diurnal exercise timing appears to provide little to no additional benefits. 
However, it is important to note that the chronic circadian rhythm—as measured via peripheral 
skin temperature—was unaffected by the training program. This may indicate that more 
intensive exercise training (most likely greater volume through increased frequency) may be 
required to induce a shift in the diurnal rhythmicity and once achieved, it may be plausible that 
one diurnal training pattern is deemed superior relative to the other.  
 
Given the important role that postprandial hyperglycaemia plays in the aetiology of DM and 
diabetes associated complications (23), findings from Chapter 5 indicated that 12-weeks of 
multi-modal exercise training significantly improved PPG responses. However, the diurnal 
timing of exercise performance did not result in additional benefits to changes in PPG 
responses, which may be due to the aforementioned factor that no significant shift in circadian 
rhythm was observed during the 12-week intervention. In addition, the strong association 
between improvements in HbA1c and PPG responses present in Chapter 5 supports the 
importance of controlling PPG levels being a vital component for the achievement of 
recommended HbA1c targets in the management of T2DM (24). More importantly, given that 
the changes in HbA1c were strongly correlated to both changes in FG and PPG, this suggests 
that both FG and PPG should be addressed concurrently, rather than individually, for improved 
glycaemic control for both T2DM individuals and individuals at risk of developing T2DM (25). 
 
In conclusion, the findings presented in this thesis indicate that 12-weeks of multi modal 
exercise training is an effective tool in improving measures of glycaemic control in both T2DM 
and non-T2DM individuals. When specifically considering the impact of exercise time on 
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glycaemia, evidence from existing literature and the findings of this thesis demonstrate that the 
timing of exercise in relation to meal ingestion (i.e. postprandial exercise) may be an effective 
complementary tool in prescribing exercise for glycaemic control management. Conversely, 
the diurnal timing of exercise performance may not have a profound effect on glycaemic 
control. Considering, however, chronic circadian patterns were not significantly shifted during 
the intervention, numerous factors such as: i) the timing and quantity of meals consumed; ii) 
individual chronotypes and; iii) the influence of sleep, may potentially have masked some of 
the differences that may exist with the effect of diurnal exercise timing. Thus, with respect to 
exercise prescription for glycemic control management, the intensity and frequency of exercise 
seem to be the key components for improvements in glycaemic control, while the timing of 
exercise performance may potentially be an effective supplementary tool to further enhance 
the benefits of exercise for the management of glycaemic control in T2DM individuals and 
individuals at risk of T2DM. 
 
6.2 Clinical Significance 
There were a number of significant clinical outcomes arising from this study. While it is 
acknowledged that exercise provides benefits to individuals with T2DM, there are a number of 
key findings which are worthy of highlighting. This is particularly true, given the intervention 
included three supervised exercise sessions only, with no additional dietary information 
provided or restrictions placed on participants. This was decided a priori and based on the 
difficulty in monitoring dietary adherence and actual dietary changes. In addition, while greater 
exercise volume in this freely-living population may likely have increased some of the 
outcomes within the study, approximately 56% of the population in Australia do not obtain 150 
minutes of PA (inclusive of any movement such as for transport) (26) and therefore the three 
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sessions per week were identified as realistic, but not excessive. Nevertheless, the primary 
findings of clinical significance were: 
 
1. The performance of a multi-modal exercise training program similar in prescription to 
that outlined in the American Diabetes Association guidelines (27) is an effective 
management tool for both the management and prevention of T2DM in overweight 
T2DM/non-T2DM individuals. At baseline, 45% (n = 18) of T2DM individuals had 
HbA1c levels of >7%, but at post-intervention, it was reduced to 25% (n = 10) of T2DM 
individuals, representing a 56% reduction in T2DM individuals having HbA1c levels 
that are considered as poor management (Figure 6-1). In addition, 20% (n = 4) of T2DM 
individuals had HbA1c levels of < 6.5% (HbA1c ≥ 6.5%; baseline vs. post-intervention 
(n): 20 vs. 16) (Figure 6-2A). For the non-T2DM individuals (Figure 6-2B), 63% (n = 
5) of IFG/IGT individuals at baseline, had HbA1c levels of < 6% at post-intervention 
(HbA1c between 6.0 and 6.4%; baseline vs. post-intervention (n): 8 vs. 3). 
 
2. Ning et al. (28) reported that a 2h-PPG concentration level that is higher than fasting 
glucose concentration is associated with a 10 to 20% increased risk for heart disease or 
stroke. Our findings showed that after 12-weeks of exercise training, 27% (n=5) of the 
individuals who had 2h-PPG levels lower than FG level at post-intervention (2h-PPG 
> FG; baseline vs. post-intervention (n): 27 vs. 22) (Figure 6-3).  
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3. Kokkinos et al. (29) stated that for every 1MET (3.5ml/kg/min) increase in 
cardiovascular fitness, mortality risk is reduced by approximately 10 to 25%. As such, 
12-weeks of multi-modal exercise training can be used as a complementary 
Figure 1. T2DM management based on HbA1c levels. 1A: Number of individuals with 
poor/good T2DM management at baseline; 1B: Number of individuals with poor/good 
T2DM management at post-intervention. 
 
 
 
 
Figure 2. Number of individuals with HbA1c levels categorise as T2DM (HbA1c ≥ 6.5%; 
2A) or IFG/IGT (HbA1c between 6.0 and 6.4%; 2B) at baseline (dark grey bars) and post-
intervention (grey bars). 
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management tool for the reduction in overall mortality risk based on improvements in 
cardiovascular health, with 55% (22 out of 40 participants) reporting an improvement 
of ≥ 3.5ml/kg/min in maximal oxygen consumption (VO2max). 
 
 
 
6.3 Future Research Directions 
Despite the growing body of evidence indicating the possible temporal optimization of exercise 
prescription for improved glycaemic control outcomes through the strategic manipulation of 
exercise timing, the results from this thesis has shown that the diurnal timing of exercise 
performance may not have any additional benefit to glycaemic control management in T2DM 
and non-T2DM individuals.  
 
Figure 3. 2h-postprandial glucose vs. fasting glucose concentration. 3A: baseline results; 
2B: post-intervention results. 
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With regards to exercise time relative to meal ingestion, current evidence (11, 30) along with 
the findings from Chapter 2 suggests that postprandial exercise (when compared to a control 
condition) significantly improves glycaemic control (11, 30, 31). However, findings from the 
limited number of studies (12, 32) that have directly compared preprandial and postprandial 
exercise on glycaemic control showed mixed results indicating that the impact of exercise time 
(in relation to meal ingestion) on glycaemia remains inconclusive. In regards to diurnal exercise 
time, findings of Chapter 4 and 5, along with the limited number of studies that have 
investigated the diurnal time of exercise (Chapter 3) indicate that the extent to which diurnal 
exercise time impacts upon glycaemic control management remains inconclusive.  
 
Based upon the findings highlighted in the aforementioned paragraph, and given that a 
pragmatic approach was utilised in the study design of Chapter 4 and 5 to investigate the effect 
of exercise timing on glycemic control, a more viable option, which future research should 
consider, would be to include additional intervention groups (i.e. amEX-preprandial vs. amEX-
postprandial vs. pmEX-preprandial vs. pmEX-postprandial) to specifically identify which facet 
of exercise time that has the greatest impact on glycaemia. To do so, the proposed study design 
would require a greater number of participants (approximately n = 25 per group), which was 
deemed impractical for us due to restraints that include: i) limited resources, ii) time line and; 
iii) limited participant enrolment. In addition, individuals recruited to the proposed study would 
have to be primarily T2DM to identify any changes in glycaemia. Again, this was a limitation 
for the current study due to the underwhelming interest from T2DM individuals in participating 
in the intervention. 
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In regards to the exercise prescription for glycemic control management, numerous studies 
have indicated that the intensity of exercise training is considered one of the main determinants 
of subsequent improvements in glycemic control (33-36). In addition, it has been stated that 
the frequency at which exercise is performed represents another impact factor that may 
modulate the impact of exercise on glycemic control (37). These findings are supported by the 
results presented in Chapter 4 and 5, whereby our findings indicate that the intensity and 
frequency of the exercise intervention may have been insufficient, consequently, masking any 
potential differences that may exist with the diurnal timing of exercise performance on chronic 
glycaemia. Our exercise intervention of 3 supervised multi-modal exercise session per week 
(each session: approximately 60mins) was chosen, firstly, due to it meeting the current exercise 
guidelines (38) for T2DM management and, secondly, it was deemed as a pragmatic program 
given that the participants of the study were sedentary individuals (weekly physical activity of 
<150mins). However, in the context of exercise frequency, Umpierre et al. (39) showed that 
each additional exercise session per week corresponded to an additional 0.39% improvement 
in HbA1c levels. Additionally, a review by Grace et al. (40) stated that higher intensity exercise 
may result in superior fitness benefits and greater reductions in HbA1c levels as compared to 
moderate intensity exercise. Taking the aforementioned factors into account and the relatively 
small changes we observed for glycaemic control measures in Chapter 4 and 5, future research 
should consider increasing the intensity and frequency of exercise performance to truly 
observed the impact that diurnal exercise time has on glycemic control. 
 
Other factors such as diet has also been shown to positively affect glycaemic control in both 
the prevention and management of T2DM (41). Consequently, in Chapter 4 and 5 participants 
were instructed to continue with their normal dietary habits throughout the 12-week 
intervention, resulting in a large variabilities in meal composition, quantity and times within 
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participants that could potentially have affected glycaemic control improvements observed in 
the study. As such, future research should consider maintaining participants’ meal caloric 
intake and composition within a set range while restricting meal times based on their 
intervention groups (i.e. morning or evening) to isolate the effect that diurnal exercise timing 
has on glycaemia. In addition, the use of a mixed meal tolerance test (MMTT) in Chapter 5 as 
compared to a traditional oral glucose tolerance test (OGTT) was primarily chosen to as it was 
considered more ‘ecological’ and represented a typical daily dietary behaviour of an individual. 
However, the glucose concentration in the MMTT (24.5g) was approximately half the amount 
compared to the glucose solution in a 2-h OGTT (50g). This difference in glucose concentration 
may have resulted in blunted PPG responses, as such, future research should consider choosing 
a MMTT of greater glucose concentration to allow for a clearer representation of changes in 
PPG responses.  
 
Within circadian clock literature, sleep quantity and quality has been shown to play a critical 
role in circadian rhythm through the phase advancement/delay of diurnal melatonin onset (42). 
As such, variability in participants’ sleep patterns may potentially have an effect on changes in 
diurnal glucose rhythm. Findings from Chapter 4 and 5 did not indicate a significant shift in 
chronic circadian rhythm (as measured through peripheral skin temperature), consequently, this 
may explain the insignificant differences observed in glycaemic control when comparing 
between morning and evening exercise. Future research should consider controlling habitual 
sleeping behaviour to isolate the impact exercise has on chronic circadian rhythm. Lastly, it 
may be feasible that an individual’s chronotype influences the efficacy of morning or evening 
exercise, whereby, the impact of chronotypes on circadian rhythm remains remains currently 
unknown given that the participants’ chronotypes were not identified in Chapter 4 and 5, and 
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that future research should consider identifying individual chronotypes (e.g. Munich 
Chronotype Questionnaire) to control for circadian rhythm changes. 
 
In all, despite the growing interest in this field of research, many questions remain. Whether 
the strategic manipulation of the diurnal timing of exercise performance may result in 
meaningful changes in glycaemic control, remains to be explored. Further research adopting 
complimentary techniques that could potentially isolate the differences that may exist between 
morning and evening exercise performance are required, in order to better understand the 
impact of exercise timing on glycaemic control for the prevention and management of T2DM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 148 
 
6.4 References 
1. Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and 
 recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185. 
2. Kaput J, Klein KG, Reyes EJ, Kibbe WA, Cooney CA, Jovanovic B, et al. Identification 
 of genes contributing to the obese yellow Avy phenotype: caloric restriction, genotype, 
 diet× genotype interactions. Physiol Genomics. 2004;18(3):316-24. 
3. Abarca-Gómez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, 
 Acuin C, et al. Worldwide trends in body-mass index, underweight, overweight, and 
 obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement 
 studies in 128· 9 million children, adolescents, and adults. Lancet. 
 2017;390(10113):2627-42. 
4. Association AD. 6. Glycemic targets: standards of medical care in diabetes—2018. 
 Diabetes Care. 2018;41:S55-S64. 
5. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. 
 Association of glycaemia with macrovascular and microvascular complications of type 
 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-
 12. 
6. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WCJD. Obesity, fat 
 distribution, and weight gain as risk factors for clinical diabetes in men. 
 1994;17(9):961-9. 
7. Khavandi K, Amer H, Ibrahim B, Brownrigg J. Strategies for preventing type 2  
 diabetes: an update for clinicians. Ther Adv Chronic Dis. 2013;4(5):242-61. 
8. Buresh R, Berg K. Exercise for the management of type 2 diabetes mellitus: factors to 
 consider with current guidelines. J Sports Med Phys Fitness. 2018;58(4):510-24. 
 149 
 
9. Mosoni L, Mirand PP. Type and timing of protein feeding to optimize anabolism. 
 Curr Opin Clin Nutr Metab Care. 2003;6(3):301-6.  
10. Chacko E. Exercising tactically for taming postmeal glucose surges. Scientifica. 
 2016. 
11. Haxhi J, Di Palumbo AS, Sacchetti M. Exercising for metabolic control: is timing 
 important? Ann Nutr Metab. 2013;62(1):14-25. 
12. Heden TD, Winn NC, Mari A, Booth FW, Rector RS, Thyfault JP, et al. Postdinner 
 resistance exercise improves postprandial risk factors more effectively than predinner 
 resistance exercise in patients with type 2 diabetes. J Appl Physiol.  2014;118(5):624-
 34. 
13. Holmstrup M, Fairchild T, Keslacy S, Weinstock R, Kanaley J. Multiple short bouts of 
 exercise over 12-h period reduce glucose excursions more than an energy-matched 
 single bout of exercise. Metabolism. 2014;63(4):510-9. 
14. Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, et al. 
 Physical activity/exercise and diabetes: a position statement of the American Diabetes 
 Association. Diabetes Care. 2016;39(11):2065-79. 
15. Kalsbeek A, la Fleur S, Fliers E. Circadian control of glucose metabolism. Molecular 
 Metabolism. 2014;3(4):372-83. 
16. Hatamoto Y, Goya R, Yamada Y, Yoshimura E, Nishimura S, Higaki Y, et al. Effect 
 of exercise timing on elevated postprandial glucose levels. 2017. 
17. Delarue J, Magnan CJ, Care M. Free fatty acids and insulin resistance. 
 2007;10(2):142-8. 
18. Knudsen SH, Karstoft K, Pedersen BK, van Hall G, Solomon TP. The immediate 
 effects of a single bout of aerobic exercise on oral glucose tolerance across the glucose 
 tolerance continuum. Physiological Reports. 2014;2(8):e12114. 
 150 
 
19. Gachon F, Loizides-Mangold U, Petrenko V, Dibner C. Glucose homeostasis: 
 regulation by peripheral circadian clocks in rodents and humans. Endocrinology. 
 2017;158(5):1074-84. 
20. Hong S, Zhou W, Fang B, Lu W, Loro E, Damle M, et al. Dissociation of muscle insulin 
 sensitivity from exercise endurance in mice by HDAC3 depletion. Nat Med. 
 2017;23(2):223. 
21. Schroder EA, Esser KA. Circadian rhythms, skeletal muscle molecular clocks and 
 exercise. Exerc Sport Sci Rev. 2013;41(4). 
22. Shi M, Zheng X. Interactions between the circadian clock and metabolism: there are 
 good times and bad times. Acta Biochim Biophys Sin. 2013;45(1):61-9. 
23. Ceriello AJD. Postprandial hyperglycemia and diabetes complications: is it time to 
 treat? 2005;54(1):1-7. 
24. Woo V, Shestakova M, Ørskov C, Ceriello AJIjocp. Targets and tactics: the relative 
 importance of HbA1c, fasting and postprandial plasma glucose levels to glycaemic 
 control in type 2 diabetes. 2008;62(12):1935-42. 
25. Kelly PJ, Guelfi KJ, Wallman KE, Fairchild TJJM, sports si, exercise. Mild dehydration 
 does not reduce postexercise appetite or energy intake. 2012;44(3):516-24. 
26. Hayes A, Lung T, Bauman A, Howard KJIjoo. Modelling obesity trends in Australia: 
 unravelling the past and predicting the future. 2017;41(1):178. 
27. Blair SN, Kohl HW, Barlow CE, Paffenbarger RS, Gibbons LW, Macera CA. Changes 
 in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy 
 men. JAMA. 1995;273(14):1093-8. 
28. Ning F, Zhang L, Dekker JM, Onat A, Stehouwer CD, Yudkin JS, et al. Development 
 of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma 
 glucose levels in the normal range. Cardiovasc Diabetol. 2012;11(1):76. 
 151 
 
29. Kokkinos P. Physical activity, health benefits, and mortality risk. Cardiology. 
 2012;2012. 
30. Chacko EJS. Exercising tactically for taming postmeal glucose surges. 2016. 
31. Teo SY, Kanaley JA, Guelfi KJ, Cook SB, Hebert JJ, Forrest MR, et al. Exercise 
 Timing in Type 2 Diabetes Mellitus: A Systematic Review. 2018;50(12):2387-97. 
32. Colberg SR, Zarrabi L, Bennington L, Nakave A, Somma CT, Swain DP, et al. 
 Postprandial walking is better for lowering the glycemic effect of dinner than pre-dinner 
 exercise in type 2 diabetic individuals. 2009;10(6):394-7. 
33. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. 
 Exercise and type 2 diabetes: the American College of Sports Medicine and the 
 American Diabetes Association: joint position statement. 2010;33(12):e147-e67. 
34. Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, et al. 
 Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific 
 statement from the American Heart Association. 2009;119(25):3244-62. 
35. Praet SF, Van Loon LJJJoap. Optimizing the therapeutic benefits of exercise in type 2 
 diabetes. 2007. 
36. Zanuso S, Jimenez A, Pugliese G, Corigliano G, Balducci SJ. Exercise for the 
 management of type 2 diabetes: a review of the evidence. 2010;47(1):15-22. 
37. van Dijk J-W, van Loon LJJDS. Exercise strategies to optimize glycemic control in 
 type 2 diabetes: a continuing glucose monitoring perspective. 2015;28(1):24-31. 
38. Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, et al. 
 Physical activity/exercise and diabetes: a position statement of the American Diabetes 
 Association. 2016;39(11):2065-79. 
 152 
 
39. Umpierre D, Ribeiro P, Schaan B, Ribeiro JJD. Volume of supervised exercise training 
 impacts glycaemic control in patients with type 2 diabetes: a systematic review with 
 meta-regression analysis. 2013;56(2):242-51. 
40. Grace A, Chan, E., Giallauria, F., Graham, P. L., & Smart, N. A. Clinical outcomes and 
 glycaemic responses to different aerobic exercise training intensities in type II diabetes: 
 a systematic review and meta-analysis.. Cardiovasc Diabetol. 2017;16(1): 37. 
41. Sami W, Ansari, T., Butt, N. S., & Ab Hamid, M. R. . Effect of diet on type 2 diabetes 
 mellitus: A review. International journal of health sciences, 11(2), 65. Int J Health Sci 
 Res. 2017;11(2): 65. 
42. Zisapel NNpotromihs, circadian rhythms and their regulation. British journal of 
 pharmacology, 175(16), 3190-3199. New perspectives on the role of melatonin in 
 human sleep, circadian rhythms and their regulation. Br J Pharmacol. 2018 175(16), 
 3190-3199. 
 
 
 
 
 
 
 
 
 
 
 
 153 
 
Appendices 
 
Appendix A: PRISMA 2009 Checklist for Systematic Review One (Chapter 2) 
Appendix B: Search Strategy for Systematic Review One (Chapter 2) 
Appendix C: Risk of Bias Assessment for Systematic Review One (Chapter 2) 
Appendix D: PRISMA 2009 Checklist for Systematic Review Two (Chapter 3) 
Appendix E: Search Strategy for Systematic Review Two (Chapter 3) 
Appendix F: Risk of Bias Assessment for Systematic Review Two (Chapter 3) 
Appendix G: Murdoch University Human Research Ethics Approval (Chapter 4 and 5) 
Appendix H: CONSORT 2010 Checklist for Study Part One (Chapter 4)  
Appendix I: CONSORT 2010 Checklist for Study Part Two (Chapter 5) 
Appendix J: Participant Flow (Chapter 4 & 5) 
Appendix K: Blood sampling schematic for baseline and post-intervention assessment  
PRISMA 2009 Checklist            Appendix A 
154 
 
Section/topic  # Checklist item  
Reported on 
page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  Page 10 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review registration number.  
Page 11 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  Page 12 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
Page 12 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
Page 13 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
Page 14 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
Page 13 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
Appendix B 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
Page 14 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
Page 15 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions 
and simplifications made.  
Page 14 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this 
was done at the study or outcome level), and how this information is to be used in any data synthesis.  
Page 15 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  Page 14-16 
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Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
Page 15 
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
Page 15 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
Page 15 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
Page 16-17 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
Page 16-17 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  Page 22 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
Page 18-23 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  Page 24-25 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  Page 22 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
Page 22-25 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
Page 25-29 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval 
of identified research, reporting bias).  
Page 29-30 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
Page 31 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders 
for the systematic review.  
NA 
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Search Strategy  
The search strategy below was conducted on Medline [PubMed]. All keywords used in the search are free text terms unless stated otherwise; MeSH = Medical subject heading; * = for any 
character 
 
Search for Type 2 Diabetes Mellitus (T2DM)  
MeSH Terms Type 2 diabetes, Non-insulin-dependent diabetes, Gestational diabetes, Diabetes insipidus 
Keywords Type 2 diabetes, Type 2 diabetes mellitus, Type II diabetes, Type II diabetes mellitus, Impaired glucose tolerance, Insulin resistance, MODY, NIDDM, 
T2DM, Non-insulin-dependent diabetes mellitus, Gestational diabetes, Diabetes insipidus 
Combined 
Search (a) 
((((type 2 diabetes[MeSH Terms]) OR non-insulin-dependent diabetes[MeSH Terms]) OR ((((((((((type 2 diabetes) OR type 2 diabetes mellitus) OR 
type II diabetes) OR type II diabetes mellitus) OR impaired glucose tolerance) OR insulin resistance) OR MODY) OR NIDDM) OR T2DM) OR non-
insulin-dependent diabetes mellitus))) NOT ((((gestational diabetes) OR gestational diabetes[MeSH Terms]) OR diabetes insipidus) OR diabetes 
insipidus[MeSH Terms]) 
Results 217, 784 
 
Search for Exercise 
MeSH Terms Exercise, Physical training, Physical fitness, Sports 
Keywords Exercis*, Physical activity, physical fitness, walking, weight lifting, strength training, resistance training, circuit weight training, sports, physical* 
active*, physical training, weight training, aerobic training, circuit training, interval training, combine* exercise training 
Combined 
Search (b) 
(((((exercise[MeSH Terms]) OR physical training[MeSH Terms]) OR physical fitness[MeSH Terms]) OR sports[MeSH Terms])) OR 
(((((((((((((((exercise) OR physical activity) OR physical fitness) OR walking) OR weight lifting) OR strength training) OR resistance training) OR 
circuit weight training) OR sports) OR weight training) OR endurance training) OR aerobic training) OR circuit training) OR interval training) OR 
combine exercise training) 
Results 692, 043 
 
Search for Glucose Control 
MeSH Terms Glucose control 
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Keywords Glucose control, Blood glucose control, Glycaemic control, Glycemic control, Glycaemic variability, Glycemic variability, Glucose tolerance, Glucose 
metabolism, Postprandial glucose, Postprandial blood glucose, Fasting glucose, Fasting blood glucose, Glycosylated haemoglobin, Glycosylated, 
hemoglobin, Glycated haemoglobin, Glycated haemoglobin 
Combined Search 
(c) 
(glucose control[MeSH Terms]) OR (((((((((((((((((((glucose control) OR blood glucose control) OR glycaemic control) OR glycemic control) OR 
glycaemic variability) OR glycemic variability) OR glucose tolerance) OR glucose metabolism) OR postprandial glucose) OR postprandial blood 
glucose) OR PPG) OR fasting glucose) OR fasting blood glucose) OR glycosylated haemoglobin) OR glycosylated hemoglobin) OR glycated 
haemoglobin) OR glycated hemoglobin) OR HbA1c) OR A1c) 
Results 422, 531 
 
 
Filter for Randomized Controlled Trials (RCTs) & Humans 
Publication Type Randomized – controlled trials, Controlled – clinical trials, Clinical trials 
MeSH Terms Randomized – controlled-trials, Double – method, Single – blind method, Random allocation, Clinical trials, Placebo, Research design, Human 
Keywords Clinical trial, Placebo*, Random* Latin Square 
Combined Search 
(d) 
((((((((((randomized-controlled-trials[MeSH Terms]) OR double-blind method[MeSH Terms]) OR single-blind method[MeSH Terms]) OR random 
allocation[MeSH Terms]) OR clinical trials[MeSH Terms]) OR placebos[MeSH Terms]) OR research design[MeSH Terms])) OR ((((clinical trial) 
OR placebo) OR random) OR latin square))) AND humans[MeSH Terms] 
Results 1, 313, 551 
 
 
Complete Search Filtered for RCTs and Humans 
Combined Search 
(e) 
(a) AND (b) AND (c) AND (d) 
Results 2, 197 
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Assessment for risk of bias in included randomized controlled trials 
Authors 
Sequence 
Generation 
Allocation 
Concealment 
Blinding of 
Participants and 
Personnel 
Blinding of 
Outcome 
Assessment 
Incomplete 
Outcome Data 
Selective 
Reporting 
Other Sources of 
Bias 
Colberg (2009)(36) ? ? + ? + ? ? 
Colberg (2014)(35) ? ? + ? ? ? ? 
Erickson (2017)(37) ? - + ? + ? + 
Gill (2007)(38) ? ? + ? + ? ? 
Heden (2014)(20) ? - + - + + ? 
Karstoft (2014)(39) ? ? + - + + + 
Larsen (1997)(40) ? ? + ? + ? ? 
Larsen (1999)(41) ? ? + ? + ? ? 
Manders (2010)(42) ? ? + ? + ? ? 
Moreira (2012)(43) ? ? + ? ? ? ? 
Oberlin (2014)(44) ? ? + ? + ? ? 
Rasmussen (1999)(45) ? ? + ? + ? ? 
Tobin (2008)(46) ? ? + ? + ? ? 
Vancea (2009)(51) ? ? + ? ? ? ? 
Van Dijk (2012)(48) ? ? + ? + + + 
Van Dijk (2012)(49) ? ? + ? + + + 
Van Dijk (2013)(50) ? ? + ? ? + + 
Van Dijk (2013)(47) ? ? + ? + + + 
Wycherley (2010)(52) ? ? + ? + ? + 
 
(+): Low risk of bias; (-): High risk of bias; (?): Unclear 
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Section/topic  # Checklist item  
Reported on 
page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  Page 39 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review registration number.  
Page 40 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  Page 41-43 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
Page 41-43 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
Page 43-44 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
Page 44 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
Page 43-44 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
Appendix E 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
Page 45-46 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
Page 45-46 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions 
and simplifications made.  
Page 44 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this 
was done at the study or outcome level), and how this information is to be used in any data synthesis.  
Page 46 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  Page 46 
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Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
Page 46 
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
Page 46 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
Page 46 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
Page 47-48 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) 
and provide the citations.  
Page 47-48 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  Page 54 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
Page 49-53 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  Page 55 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  Page 54 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
Page 56 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance 
to key groups (e.g., healthcare providers, users, and policy makers).  
Page 56-59 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
Page 59-60 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
Page 60-61 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for 
the systematic review.  
NA 
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Search Strategy  
The search strategy below was conducted on Medline [PubMed]. All keywords used in the search are free text terms unless stated otherwise; MeSH = Medical subject heading; * = for any 
character 
 
Search for Type 2 Diabetes Mellitus (T2DM)  
MeSH Terms Type 2 diabetes, Non-insulin-dependent diabetes, Gestational diabetes, Diabetes insipidus 
Keywords Type 2 diabetes, Type 2 diabetes mellitus, Type II diabetes, Type II diabetes mellitus, Impaired glucose tolerance, Insulin resistance, MODY, NIDDM, 
T2DM, Non-insulin-dependent diabetes mellitus, Gestational diabetes, Diabetes insipidus 
Combined 
Search (a) 
((((type 2 diabetes[MeSH Terms]) OR non-insulin-dependent diabetes[MeSH Terms]) OR ((((((((((type 2 diabetes) OR type 2 diabetes mellitus) OR 
type II diabetes) OR type II diabetes mellitus) OR impaired glucose tolerance) OR insulin resistance) OR MODY) OR NIDDM) OR T2DM) OR non-
insulin-dependent diabetes mellitus))) NOT ((((gestational diabetes) OR gestational diabetes[MeSH Terms]) OR diabetes insipidus) OR diabetes 
insipidus[MeSH Terms]) 
Results 217, 784 
 
Search for Exercise 
MeSH Terms Exercise, Physical training, Physical fitness, Sports 
Keywords Exercis*, Physical activity, physical fitness, walking, weight lifting, strength training, resistance training, circuit weight training, sports, physical* 
active*, physical training, weight training, aerobic training, circuit training, interval training, combine* exercise training 
Combined 
Search (b) 
(((((exercise[MeSH Terms]) OR physical training[MeSH Terms]) OR physical fitness[MeSH Terms]) OR sports[MeSH Terms])) OR 
(((((((((((((((exercise) OR physical activity) OR physical fitness) OR walking) OR weight lifting) OR strength training) OR resistance training) OR 
circuit weight training) OR sports) OR weight training) OR endurance training) OR aerobic training) OR circuit training) OR interval training) OR 
combine exercise training) 
Results 692, 043 
 
Search for Glucose Control 
MeSH Terms Glucose control 
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Keywords Glucose control, Blood glucose control, Glycaemic control, Glycemic control, Glycaemic variability, Glycemic variability, Glucose tolerance, Glucose 
metabolism, Postprandial glucose, Postprandial blood glucose, Fasting glucose, Fasting blood glucose, Glycosylated haemoglobin, Glycosylated, 
hemoglobin, Glycated haemoglobin, Glycated hemoglobin 
Combined Search 
(c) 
(glucose control[MeSH Terms]) OR (((((((((((((((((((glucose control) OR blood glucose control) OR glycaemic control) OR glycemic control) OR 
glycaemic variability) OR glycemic variability) OR glucose tolerance) OR glucose metabolism) OR postprandial glucose) OR postprandial blood 
glucose) OR PPG) OR fasting glucose) OR fasting blood glucose) OR glycosylated haemoglobin) OR glycosylated hemoglobin) OR glycated 
haemoglobin) OR glycated hemoglobin) OR HbA1c) OR A1c) 
Results 422, 531 
 
 
Filter for Randomized Controlled Trials (RCTs) & Humans 
Publication Type Randomized – controlled trials, Controlled – clinical trials, Clinical trials 
MeSH Terms Randomized – controlled-trials, Double – method, Single – blind method, Random allocation, Clinical trials, Placebo, Research design, Human 
Keywords Clinical trial, Placebo*, Random* Latin Square 
Combined Search 
(d) 
((((((((((randomized-controlled-trials[MeSH Terms]) OR double-blind method[MeSH Terms]) OR single-blind method[MeSH Terms]) OR random 
allocation[MeSH Terms]) OR clinical trials[MeSH Terms]) OR placebos[MeSH Terms]) OR research design[MeSH Terms])) OR ((((clinical trial) 
OR placebo) OR random) OR latin square))) AND humans[MeSH Terms] 
Results 1, 313, 551 
 
 
Complete Search Filtered for RCTs and Humans 
Combined Search 
(e) 
(a) AND (b) AND (c) AND (d) 
Results 2, 497 
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Supplementary Table 2. Assessment for risk of bias in included randomized controlled trials 
Authors 
Sequence 
Generation 
Allocation 
Concealment 
Blinding of 
Participants and 
Personnel 
Blinding of 
Outcome 
Assessment 
Incomplete 
Outcome Data 
Selective 
Reporting 
Other Sources of 
Bias 
Belli (2011)37 + ? + ? + + ? 
Colberg (2009)38 ? ? + ? + ? ? 
Colberg (2014)39 ? ? + ? ? ? ? 
Erickson (2017)54 ? - + ? + ? + 
Heden (2014)40 ? - + - + + ? 
Karstoft (2014)41 ? ? + - + + + 
Larsen (1997)42 ? ? + ? + ? ? 
Larsen (1999)43 ? ? + ? + ? ? 
Manders (2010)44 ? ? + ? + ? ? 
Moreira (2012)45 ? ? + ? ? ? ? 
Oberlin (2014)46 ? ? + ? + ? ? 
Rasmussen (1999)47 ? ? + ? + ? ? 
Tobin (2008)48 ? ? + ? + ? ? 
Vancea (2009)53 ? ? + ? ? ? ? 
Van Dijk (2012)50 ? ? + ? + + + 
Van Dijk (2012)51 ? ? + ? + + + 
Van Dijk (2013)52 ? ? + ? ? + + 
Van Dijk (2013)49 ? ? + ? + + + 
 
(+): Low risk of bias; (-): High risk of bias; (?): Unclear 
  
           Appendix G 
164 
 
  
           Appendix H 
165 
 
CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic 
Item 
No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title Page 71 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) Page 72 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale Page 73-74 
2b Specific objectives or hypotheses Page 73-74 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio Page 75 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons Page 75 
Participants 4a Eligibility criteria for participants Page 75 
4b Settings and locations where the data were collected Page 76 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they 
were actually administered 
Page 77 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
Page 78-79 
6b Any changes to trial outcomes after the trial commenced, with reasons NA 
Sample size 7a How sample size was determined Page 75 
7b When applicable, explanation of any interim analyses and stopping guidelines NA 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence Page 76 
8b Type of randomisation; details of any restriction (such as blocking and block size) Page 76 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), 
describing any steps taken to conceal the sequence until interventions were assigned 
Page 76-77 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to 
interventions 
Page 76-77 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those 
assessing outcomes) and how 
Page 76-77 
11b If relevant, description of the similarity of interventions NA 
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Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes Page 79 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses NA 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
Appendix J 
13b For each group, losses and exclusions after randomisation, together with reasons Appendix J 
Recruitment 14a Dates defining the periods of recruitment and follow-up Page 76 
14b Why the trial ended or was stopped Page 76 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group Table 4-1 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis 
was by original assigned groups 
Appendix J 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
Page 82-87 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended Page 82-87 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
Page 82-87 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) NA 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses Page 92-93 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings Page 93 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence Page 88-92 
Other information 
 
Registration 23 Registration number and name of trial registry Page 72 
Protocol 24 Where the full trial protocol can be accessed, if available Page 72 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders NA 
 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we also 
recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic trials. 
Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org. 
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CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic 
Item 
No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title Page 101 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) Page 102 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale Page 103-105 
2b Specific objectives or hypotheses Page 103-105 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio Page 105 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons Page 106 
Participants 4a Eligibility criteria for participants Page 106 
4b Settings and locations where the data were collected Page 106-107 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were 
actually administered 
Page 106-107 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
Page 108-109 
6b Any changes to trial outcomes after the trial commenced, with reasons NA 
Sample size 7a How sample size was determined Page 109 
7b When applicable, explanation of any interim analyses and stopping guidelines NA 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence Page 105-106 
8b Type of randomisation; details of any restriction (such as blocking and block size) Page 105-106 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), 
describing any steps taken to conceal the sequence until interventions were assigned 
Page 105-106 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to 
interventions 
Page 105-106 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those 
assessing outcomes) and how 
Page 105-106 
11b If relevant, description of the similarity of interventions NA 
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Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes Page 109 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses NA 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
Appendix J 
13b For each group, losses and exclusions after randomisation, together with reasons Appendix J 
Recruitment 14a Dates defining the periods of recruitment and follow-up Page 105 
14b Why the trial ended or was stopped Page 105 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group Figure 114-
116 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was 
by original assigned groups 
Figure 114-
116 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
Page 113-120 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended Page 113-120 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
Page 113-120 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) NA 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses Page 124-125 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings Page 121-125 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence Page 121-125 
Other information 
 
Registration 23 Registration number and name of trial registry Page 103 
Protocol 24 Where the full trial protocol can be accessed, if available Page 103 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders NA 
 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we also 
recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic trials. 
Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org. 
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